Академический Документы
Профессиональный Документы
Культура Документы
Transmitted
Disease
Surveillance
2008
Division of STD Prevention
November 2009
Acknowledgments
Publication of this report would not have been possible without the contributions of the State and Territorial
Health Departments, the Sexually Transmitted Disease Control Programs, the Regional Infertility Prevention
Projects, and Public Health Laboratories. We also acknowledge the contributions of staff within the Division
of STD Prevention, the Statistics and Data Management Branch and the Epidemiology and Surveillance
Branch.
ii
Copyright Information
All material contained in this report is in the public domain and may be used and reprinted without special
permission; citation to source, however, is appreciated.
Suggested Citation
Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2008. Atlanta, GA: U.S.
Department of Health and Human Services; November 2009.
Printed copies and the on-line version of this report can be obtained at the following web site: http://www.
cdc.gov/std/pubs/
http://wonder.cdc.gov/std.html
http://www.cdc.gov/std/healthcomm/fact_sheets.htm
http://www.cdc.gov/STD/treatment/
http://www.cdc.gov/std/program/pupestd.htm
http://www.cdc.gov/std/program/default.htm
Behavioral Surveillance
iii
Foreword
STDs are hidden epidemics of enormous health and
economic consequence in the United States. They
are hidden because many Americans are reluctant
to address sexual health issues in an open way and
because of the biologic and social characteristics of
these diseases. All Americans have an interest in STD
prevention because all communities are impacted
by STDs and all individuals directly or indirectly
pay for the costs of these diseases. STDs are public
health problems that lack easy solutions because
they are rooted in human behavior and fundamental
societal problems. Indeed, there are many obstacles to
effective prevention efforts. The first hurdle will be to
confront the reluctance of American society to openly
confront issues surrounding sexuality and STDs.
Despite the barriers, there are existing individual- and
community-based interventions that are effective
and can be implemented immediately. That is why
a multifaceted approach is necessary to both the
individual and community levels.
Preface
Sexually Transmitted Disease Surveillance, 2008
presents statistics and trends for sexually transmitted
diseases (STDs) in the United States through 2008.
This annual publication is intended as a reference
document for policy makers, program managers,
health planners, researchers, and others who are
concerned with the public health implications of
these diseases. The figures and tables in this edition
supersede those in earlier publications of these
data.
The surveillance information in this report is based
on the following sources of data: (1) notifiable disease
reporting from state and local STD programs; (2)
projects that monitor STD prevalence in various
settings including; the Regional Infertility Prevention
Projects (IPP); the National Job Training Program;
the Indian Health Service; the Men Who Have Sex
With Men (MSM) Prevalence Monitoring Project;
the Gonococcal Isolate Surveillance Project (GISP);
and (3) national surveys implemented by federal and
private organizations.
The STD surveillance systems operated by state and
local STD control programs, which provide the case
report data for chlamydia, gonorrhea, syphilis, and
chancroid are the data sources of many of the figures
and most of the statistical tables in this publication.
These systems are an integral part of program
management at all levels of STD prevention and
control in the United States. Because of incomplete
diagnosis and reporting, the number of STD cases
reported to the Centers for Disease Control and
Prevention (CDC) is less than the actual number
of cases occurring in the United States population.
National summary data of case reports for other
STDs are not available because they are not nationally
notifiable diseases.
vi
Guide to Acronyms
Add Health
CDC
CSF
DHHS
DSTDP
GISP
GPRA
HEDIS
HIV
HP2010
HPV
HSV
IPP
MICs
MMWR
MPC
MSA
MSM
NAATs
NDTI
NGU
NHANES
NHDS
OMB
P&S
PID
QRNG
RPR
STD
VDRL
vii
Contents
Acknowledgments........................................................................................................................................... ii
Foreword..........................................................................................................................................................v
Preface.............................................................................................................................................................vi
Guide to Acronyms........................................................................................................................................vii
Figures in the National Profile..........................................................................................................................x
Figures in the Special Focus Profiles................................................................................................................xii
Tables in the National Profile........................................................................................................................ xiv
Census Regions of the United States............................................................................................................. xvii
National Overview of Sexually Transmitted Diseases (STDs), 2008..................................................................1
National Profile
Introduction.............................................................................................................................................5
Chlamydia................................................................................................................................................7
Gonorrhea..............................................................................................................................................17
Syphilis...................................................................................................................................................31
Other Sexually Transmitted Diseases (STDs)..........................................................................................43
Tables
National Summary.................................................................................................................................85
Chlamydia..............................................................................................................................................87
Gonorrhea..............................................................................................................................................98
Syphilis.................................................................................................................................................110
Chancroid............................................................................................................................................131
Selected STDs......................................................................................................................................132
Appendix
Interpreting STD Surveillance Data ....................................................................................................133
Table A1. Selected STDsPercentage of unknown, missing, or invalid values for
selected variables by state and by nationally notifiable STD, 2008................................... 140
Table A2. Reported cases of sexually transmitted disease by reporting source and sex:
United States, 2008......................................................................................................... 141
Table A3. Healthy People 2010 Sexually Transmitted Diseases Objective Status.............................. 142
Table A4. Government Performance and Results Act (GPRA) Sexually Transmitted
Diseases Goals and Measures........................................................................................... 143
STD Surveillance Case Definitions.......................................................................................................145
Contributors.........................................................................................................................................154
STD Surveillance 2008
ix
Chlamydia
Figure 1.
Figure 2.
Figure 3.
Figure 4.
Figure 5.
Figure 6.
Figure 7.
Figure 8.
Gonorrhea
Figure 13.
Figure 14.
Figure 15.
Figure 16.
Figure 17.
Figure 18.
Figure 19.
Figure 20.
Figure 21.
Figure 22.
Figure 23.
Figure 24.
Figure 25.
Figure 26.
Figure 27.
Syphilis
Figure 30. SyphilisReported cases by stage of infection: United States, 19412008........................ 35
Figure 31. Primary and secondary syphilisRates: Total and by sex and
male-to-female rate ratios: United States, 19892008........................................................ 35
Figure 32. Primary and secondary syphilisRates by region: United States, 19992008................... 36
Figure 33. Primary and secondary syphilisRates by state: United States and
outlying areas, 2008.......................................................................................................... 36
Figure 34. Primary and secondary syphilisRates by county: United States, 2008............................ 37
Figure 35. Primary and secondary syphilisAge- and sex-specific rates:
United States, 2008........................................................................................................... 37
Figure 36. Primary and secondary syphilisAge-specific rates among
women 15 to 44 years of age: United States, 19992008................................................... 38
Figure 37. Primary and secondary syphilisAge-specific rates among
men 15 to 44 years of age: United States, 19992008....................................................... 38
Figure 38. Primary and secondary syphilisRates by race/ethnicity:
United States, 19992008................................................................................................. 39
Figure 39. Primary and secondary syphilisReported cases by stage and
sexual orientation, 2008.................................................................................................... 39
Figure 40. Primary and secondary syphilisReported cases by sexual orientation
and race/ethnicity, 2008.................................................................................................... 40
Figure 41. Primary and secondary syphilisReported cases by
reporting source and sex: United States, 19992008......................................................... 40
Figure 42. Primary and secondary syphilisPercentage of reported cases
by sexual orientation and selected reporting sources, 2008................................................ 41
Figure 43. Congenital syphilis (CS)Reported cases for infants <1 year of age
and rates of primary and secondary syphilis among women:
United States, 19992008................................................................................................. 41
xi
ChlamydiaRates among women by state: United States and outlying areas, 2008.......... 54
ChlamydiaPositivity in 15- to 24-year-old women tested in prenatal
clinics by state: United States and outlying areas, 2008...................................................... 54
GonorrheaRates among women by state: United States and outlying areas, 2008.......... 55
GonorrheaPositivity in 15- to 24-year-old women tested in prenatal
clinics by state: United States and outlying areas, 2008...................................................... 55
Primary and secondary syphilisRates among women by state:
United States and outlying areas, 2008.............................................................................. 56
Congenital syphilisRates for infants <1 year of age by state:
United States and outlying areas, 2008.............................................................................. 56
Pelvic inflammatory diseaseHospitalizations of women 15 to 44 years
of age: United States, 19972006...................................................................................... 57
Pelvic inflammatory diseaseInitial visits to physicians offices by women
15 to 44 years of age: United States, 19992008............................................................... 57
Ectopic pregnancyHospitalizations of women 15 to 44 years of age:
United States, 19972006................................................................................................. 58
xii
Figure V.
xiii
Chlamydia
Table 2.
Table 3.
ChlamydiaReported cases and rates by state, ranked by rates: United States, 2008........ 87
ChlamydiaReported cases and rates by state/area and region listed in
alphabetical order: United States and outlying areas, 20042008...................................... 88
Table 4.
ChlamydiaWomenReported cases and rates by state/area and region
listed in alphabetical order: United States and outlying areas, 20042008......................... 89
Table 5.
ChlamydiaMenReported cases and rates by state/area and region
listed in alphabetical order: United States and outlying areas, 20042008......................... 90
Table 6.
ChlamydiaReported cases and rates in selected metropolitan statistical
areas (MSAs) listed in alphabetical order: United States, 20042008................................. 91
Table 7.
ChlamydiaWomenReported cases and rates in selected metropolitan
statistical areas (MSAs) listed in alphabetical order: United States, 20042008.................. 92
Table 8.
ChlamydiaMenReported cases and rates in selected metropolitan
statistical areas (MSAs) listed in alphabetical order: United States, 20042008.................. 93
Table 9.
ChlamydiaCounties and independent cities ranked by number of
reported cases: United States, 2008................................................................................... 94
Table 10. ChlamydiaReported cases and rates per 100,000 population by age
group and sex: United States, 20042008......................................................................... 95
Table 11 A. ChlamydiaReported cases by race/ethnicity, age group and sex:
United States, 20042008................................................................................................. 96
Table 11 B. ChlamydiaRates per 100,000 population by race/ethnicity,
age group and sex: United States, 20042008................................................................... 97
Gonorrhea
Table 12.
Table 13.
Table 14.
Table 15.
Table 16.
Table 17.
Table 18.
Table 19.
Table 20.
GonorrheaReported cases and rates by state, ranked by rates: United States, 2008........ 98
GonorrheaReported cases and rates by state/area and region
listed in alphabetical order: United States and outlying areas, 20042008......................... 99
GonorrheaWomenReported cases and rates by state/area
and region listed in alphabetical order: United States and outlying areas, 20042008...... 100
GonorrheaMenReported cases and rates by state/area and
region listed in alphabetical order: United States and outlying areas, 20042008............ 101
GonorrheaReported cases and rates in selected metropolitan
statistical areas (MSAs) listed in alphabetical order: United States, 20042008................ 102
GonorrheaWomenReported cases and rates in selected metropolitan
statistical areas (MSAs) listed in alphabetical order: United States, 20042008................ 103
GonorrheaMenReported cases and rates in selected metropolitan
statistical areas (MSAs) listed in alphabetical order: United States, 20042008................ 104
GonorrheaCounties and independent cities ranked by number of
reported cases: United States, 2008................................................................................. 105
GonorrheaReported cases and rates per 100,000 population by
age group and sex: United States, 20042008................................................................. 106
xiv
Syphilis
Table 22.
xv
Table 40.
Table 41.
Chancroid
Table 42.
Selected STDs
Table 43.
xvi
Midwest
Northeast
South
West
Midwest
South
Northeast
Alaska
Arizona
California
Colorado
Hawaii
Idaho
Montana
Nevada
New Mexico
Oregon
Utah
Washington
Wyoming
Illinois
Indiana
Iowa
Kansas
Michigan
Minnesota
Missouri
Nebraska
North Dakota
Ohio
South Dakota
Wisconsin
Alabama
Arkansas
Delaware
District of Columbia
Florida
Georgia
Kentucky
Louisiana
Maryland
Mississippi
North Carolina
Oklahoma
South Carolina
Tennessee
Texas
Virginia
West Virginia
Connecticut
Maine
Massachusetts
New Hampshire
New Jersey
New York
Pennsylvania
Rhode Island
Vermont
xvii
Chlamydia
In 2008, 1,210,523 cases of sexually transmitted
Chlamydia trachomatis infection were reported to
CDC (Table 1). This is the largest number of cases
ever reported to CDC for any condition. This
case count corresponds to a rate of 401.3 cases per
100,000 population, an increase of 9.2% compared
with the rate in 2007. Rates of reported chlamydial
infections among women have been increasing
annually since the late 1980s when public programs
for screening and treatment of women were first
established to avert pelvic inflammatory disease (PID)
and related complications. In 2008, the chlamydia
rate in black men was 12 times higher than that in
white men; the chlamydia rate in black women was
eight times higher than that in white women.
The continued increase in chlamydia case reports in
2008 most likely represents a continued increase in
screening for this infection, more sensitive tests, and
more complete national reporting but it may also
reflect a true increase in morbidity.
In 2008, the overall rate of chlamydial infection
in the United States among women (583.8 cases
per 100,000 females) was almost three times the
rate among men (211.1 cases per 100,000 males),
STD Surveillance 2008
Gonorrhea
Following a 74% decline in the rate of reported
gonorrhea from 1975 to 1997, overall gonorrhea rates
have plateaued over the past eleven years. In 2008,
336,742 cases of gonorrhea were reported in the
United States, corresponding to a rate of 111.6 cases
Overview
Syphilis
The rate of primary and secondary (P&S) syphilis
reported in the United States decreased during the
1990s and in 2000 was the lowest since reporting
began in 1941. The low rate of syphilis and the
concentration of the majority of syphilis cases
in a small number of geographic areas led to the
development of the National Plan to Eliminate
Syphilis, which was announced by the Surgeon
General in 1999 and updated in 2006.2 The rate of
P&S syphilis in the United States declined 89.7%
between 1990 and 2000. However, the rate of P&S
syphilis has increased each year since 2001, mostly
in men, but also in women for the past four years. In
2008, 13,500 cases of P&S syphilis were reported to
CDC. This is the highest number of cases since 1995
and corresponds to a rate of 4.5 cases per 100,000
population, an 18% increase from 2007. Since 2004,
the rate of P&S syphilis has increased 67%. After
14 years of decline, the rate of congenital syphilis
increased in 2006 and 2007. There were 431 cases
of congenital syphilis reported in 2008, the same
number reported in 2007.
Although wide disparities exist in the rates of STDs
among racial and ethnic groups, there has been a
reduction in these differences for syphilis over the
past ten years. The P&S syphilis rate for 2008 in
blacks was eight times the rate in whites, which is
substantially lower than the disparity observed in
1999, when the rate among blacks was 29 times
greater than that among whites (Table 34B).
Overview
Overview
NATIONAL PROFILE
NATIONAL PROFILE
National Profile
The National Profile section contains figures showing trends and the distribution of nationally reportable
STDs (chlamydia, gonorrhea, syphilis and chancroid) by age, sex, race/ethnicity, and location for the United
States.
National Profile
Chlamydia
Background
Chlamydia trachomatis infections are the most
commonly reported notifiable disease in the United
States. They are among the most prevalent of all
STDs and, since 1994, have comprised the largest
proportion of all STDs reported to CDC (Table 1).
Recent studies also demonstrate the high prevalence
of chlamydial infections in the general U.S.
population. Among young adults (1826 years of age)
participating in the nationally-representative National
Longitudinal Study of Adolescent Health (Add
Health) from 2001 to 2002, chlamydia prevalence
was 4.2%.1
Chlamydial infections are usually asymptomatic
and, in women, may result in PID, which is a major
cause of infertility, ectopic pregnancy, and chronic
pelvic pain. Data from a randomized controlled trial
of chlamydia screening in a managed care setting
suggested that screening programs can lead to a
reduction in the incidence of PID by as much as
60%.2 As with other inflammatory STDs, chlamydial
infection can facilitate the transmission of Human
Immunodeficiency Virus (HIV) infection.3 In
addition, pregnant women infected with chlamydia
can pass the infection to their infants during
delivery, potentially resulting in neonatal ophthalmia
and pneumonia. Because of the large burden of
disease and risks associated with infection, CDC
recommends annual chlamydia screening of all
sexually active women younger than 26 years of age.4
The increase in reported chlamydial infections
during the last 20 years reflects the expansion of
chlamydia screening activities, use of increasingly
sensitive diagnostic tests, an increased emphasis
on case reporting from providers and laboratories,
and improvements in the information systems for
reporting. However, many women who are at risk
are still not being tested, reflecting, in part, lack of
awareness among some health care providers and
limited resources available to support screening.
Chlamydia screening and reporting are likely to
continue to expand further in response to the
STD Surveillance 2008
ChlamydiaUnited States
In 2008, 1,210,523 chlamydial infections were
reported to CDC from 50 states and the District of
Columbia (Table 1). This case count corresponds to a
rate of 401.3 cases per 100,000 population, an increase
of 9.2% compared with the rate of 367.5 in 2007.
Over the past 20 years, from 1989 through 2008,
the rate of reported chlamydial infection increased
from 102.5 to 401.3 cases per 100,000 population
(Figure 1, Table 1).
Chlamydia by Region
Between 1999 and 2008, overall rates were similar
in the Midwest, West, and South (Figure 2, Table 3).
Rates have consistently remained lowest in the
Northeast.
Chlamydia by State
In 2008, chlamydia rates per 100,000 population by
state ranged from 160.3 cases in New Hampshire to
728.1 cases in Mississippi (Figure 3, Table 2).
Chlamydia by County
Counties in the United States with the highest
chlamydia case rates per 100,000 population
were located primarily in the Southeast and West,
including Alaska (Figure 4). In 2008, 681 (21.7%)
of 3,141 counties had rates greater than 400.0 cases
per 100,000 population. Fifty-four counties and
independent cities reported 40% of all chlamydia
cases in 2008 (Table 9).
Chlamydia by Sex
In 2008, the overall rate of reported chlamydial
infection among women in all 50 states and the
District of Columbia (583.8 cases per 100,000
females) was almost three times higher than the rate
among men (211.1 cases per 100,000 males), likely
reflecting a greater number of women screened for
this infection (Figure 1, Tables 4 and 5). The lower
rates among men also suggest that many of the sex
partners of women with chlamydia are not being
diagnosed or reported as having chlamydia. However,
with the advent of highly sensitive nucleic acid
amplification tests (NAATs) that can be performed
on urine, symptomatic and asymptomatic men
are increasingly being diagnosed with chlamydial
infection. From 2004 through 2008, the chlamydial
infection rate in men increased by 45.0% (from 145.6
to 211.1 cases per 100,000 males) compared with a
21.5% increase in women during the same period
(from 480.6 to 583.8 cases per 100,000 females).
Chlamydia by Age
Among women, the highest age-specific rates of
reported chlamydia in 2008 were among those 15 to
19 years of age (3,275.8 cases per 100,000 females)
and 20 to 24 years of age (3,179.9 cases per 100,000
females) (Figure 5, Table 10). Age-specific rates among
men, while substantially lower than the rates among
women, were highest in the 20- to 24-year-old age
group (1,056.1 cases per 100,000 males) (Figure 5,
Table 10).
Chlamydia by Race/Ethnicity
In 2008, chlamydia rates increased for all racial and
ethnic groups (Figure 6, Table 11B). The rate of
chlamydia among blacks was over eight times higher
than that of whites (1,519.3 and 173.6 cases per
100,000, respectively). The rates among American
Indian/Alaska Natives (808.8) and Hispanics (510.4)
were 4.7 and 2.9 times higher, respectively, than that
of whites.
Chlamydia Summary
Both prevalence and reported cases of genital
Chlamydia trachomatis infections remain high across
age groups, racial/ethnic groups, geographic locales,
and both sexes. The burden of chlamydia appears
higher among women, especially those of younger
age (15 to 19 and 20 to 24 years of age), but this
may be a reflection of screening recommendations.
Racial differences also persist; case rates among blacks
continue to be substantially higher than rates among
other racial/ethnic groups.
Figure 1.
500
400
300
200
100
0
1989
1991
1993
1995
1997
1999
2001
2003
2005
2007
2009
NOTE: As of January 2000, all 50 states and the District of Columbia had regulations requiring the reporting of chlamydia cases.
Figure 2.
400
300
West
Midwest
Northeast
South
200
100
10
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
Figure 3.
331
324
300
276
287
280
Guam
396
302
377
407
375
371
228
391
395
314
460 349
332
409
470
711
466
340
411
287
422
499
528
Puerto Rico
174
535
192
160
271
314
357
258
447
439
1177
183 405
414
455
728
422
458
446
314
VT
NH
MA
RI
CT
NJ
DE
MD
DC
198
597
447
<300.0
(n=13)
300.1400.0 (n=17)
Virgin
Islands
535
389
>400.0
(n=24)
NOTE: The total rate of chlamydia for the United States and outlying areas (Guam, Puerto Rico and Virgin Islands) was 398.5 per 100,000 population.
For further information on chlamydia reporting, see Appendix (Chlamydia Morbidity Reporting).
Figure 4.
<300.0
(n=2,070)
300.1400.0 (n=390)
>400.0
(n=681)
11
Figure 5.
Men
3500
2100
1400
700
0
13.9
700
Age 0
129.9
1014
1400
2100
2800
1519
701.6
3179.9
2529
565.9
1240.6
3034
271.7
140.8
498.9
3539
205.6
78.3
4044
34.4
4554
10.4
5564
8.4
65+
2.1
2.7
211.7
3500
3275.8
2024
1056.1
Figure 6.
Women
85.8
30.9
Total
585.6
1500
1000
500
12
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
Figure 7.
400
300
200
100
0
1999
Figure 8.
2000
2001
2002
2003
2004
2005
2006
2007
2008
Prevalence, %
16
Non-Hispanic White
Non-Hispanic Black
Mexican-American
12
1419
2029
3039
Age
NOTE: Error bars indicate 95% confidence intervals.
SOURCE: National Health and Nutrition Examination Survey. Ann Intern Med 2007;147(2):8996.
13
Figure 9.
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
NOTE: As of 1997, all 10 DHHS regions, representing all 50 states, the District of Columbia, and outlying areas, reported chlamydia positivity data. See
Appendix for definitions of DHHS regions.
DATA SOURCE: Prevalence Monitoring Project (Regional Infertility Prevention Projects), Office of Population Affairs, Local and State STD Control Programs, Centers for Disease
Control and Prevention.
Figure 10.
8.4
6.5
4.7
5.9
Guam
396
7.6
5.9
8.5
6.4
6.9
12.5
8.7
7.5
6.1
7.3
7.0
6.8
8.1
5.4
9.3
6.5
7.9
8.4
4.7
7.4
12.3
Puerto Rico
7.4
11.3
3.7
3.9
5.1
7.6
7.4
8.4
8.6
5.8
9.5
3.1 7.3
7.9
6.2
10.3
13.8
12.4
5.0
6.9
7.1
VT
NH
MA
RI
CT
NJ
DE
MD
DC
6.2
11.8
10.8
Positivity (%)
<5.0
(n=5)
5.09.9 (n=39)
Virgin
Islands
15.0
9.3
>10.0
(n=9)
NOTE: Includes states and outlying areas that reported chlamydia positivity data on at least 500 women aged 1524 years screened during 2008.
DATA SOURCE: Prevalence Monitoring Project (Regional Infertility Prevention Projects), Office of Population Affairs, Local and State STD Control Programs, Centers for Disease
Control and Prevention.
14
Figure 11.
04
04 05 06 07 08
04 05 06 07 08
Region V
Region I
05
06
07
08
Region X
05
06
07
08
VIII
Region IX
05
06
07
Region II
IV
VI
08
04 05 06 07 08
III
VII
IX
II I
04 05 06 07 08
Region VIII
Region III
04
05
06
07
10.2
7.4 7.4 7.9 8.8
04 05 06 07 08
04 05 06 07 08
Region VII
Region IV
Region VI
Figure 12.
Percent
100
80
60
40
20
0
04
Percent
100
80
60
40
20
0
04
05
06
Region I
05
06
Region V
07
07
08
Percent
100
80
60
40
20
0
04
08
Percent
100
80
60
40
20
0
04
Percent
100
80
60
40
20
0
04
05
06
Region II
07
08
Percent
100
80
60
40
20
0
04
05
06
Region III
07
08
Percent
100
80
60
40
20
0
04
08
Percent
100
80
60
40
20
0
04
Percent
100
80
60
40
20
05
06
07
08
05
06
07
08
Region VI
04
05
06
Region VII
07
05
06
07
08
05
06
07
08
Region IV
Region VIII
Percent
05
06
Region IX
07
08
100
80
60
40
20
0
04
Region X
15
Gonorrhea
Background
Gonorrhea is the second most commonly-reported
notifiable disease in the United States. Infections due
to Neisseria gonorrhoeae, like those resulting from
Chlamydia trachomatis, are a major cause of PID in
the United States. PID can lead to serious outcomes
in women such as tubal infertility, ectopic pregnancy,
and chronic pelvic pain. In addition, epidemiologic
and biologic studies provide strong evidence that
gonococcal infections facilitate the transmission of
HIV infection.1
From 1975 through 1997, the national gonorrhea
rate declined 74% following implementation of the
national gonorrhea control program in the mid-1970s
(Figure 13). For the past 12 years, however, gonorrhea
rates appear to have reached a plateau (Figure 14 and
Table 1).
Increases in gonorrhea rates in eight western states
from 2000 to 2005 have been described among
a wide variety of populations in the affected
states.2 Increases in quinolone resistant Neisseria
gonorrhoeae (QRNG) in 2007 led to changes in
national guidelines that now limit the recommended
treatment of gonorrhea to a single class of drugs,
the cephalosporins.3 The combination of increases
in gonorrhea morbidity in some populations with
increases in resistance and decreased treatment
options have reinforced the need for better
understanding of the epidemiology of gonorrhea.
Although gonorrhea case reporting is useful for
monitoring trends in gonorrhea, true increases
or decreases in disease burden may be masked
by changes in screening practices (affected by
concomitant testing for chlamydia and broader use
of urine-based testing), use of diagnostic tests with
differing test performance, and changes in reporting
practices.4
GonorrheaUnited States
In 2008, 336,742 cases of gonorrhea were reported in
the United States, a rate of 111.6 cases per 100,000
population (Figure 13 and Table 1), reflecting a small
decrease of 5.4% since 2007. Gonorrhea rates have
remained relatively stable over the past 12 years.
Gonorrhea by Region
As in previous years, in 2008 the South had the
highest gonorrhea rate among the four regions of
the country (152.4 cases per 100,000 population).
Rates in the South and Midwest have remained
substantially higher than rates in the Northeast and
West. Rates in all regions over the last year have
shown little change (Figure 15 and Table 13).
Gonorrhea by State
In 2008, gonorrhea rates per 100,000 population by
state ranged from 6.0 cases in Vermont to 256.8 cases
in Mississippi (Figure 16, Table 12).
17
Gonorrhea by County
In 2008, 1,305 (41.6%) of 3,141 counties in the
United States had gonorrhea rates at or below the
HP2010 national target of 19 cases per 100,000
population. (See the Appendix [Interpreting STD
Surveillance Data section] for an explanation of
HP2010 target setting methods.) Rates per 100,000
population were between 19 and 100 in 1,136
counties (36.2%), and greater than 100 in 700
counties (22.3%). The majority of counties with
greater than 100 cases per 100,000 population were
located in the South (Figure 17).
In 2008, 50% of reported gonorrhea cases occurred
in just 71 counties or independent cities (Table 19).
Gonorrhea by Sex
Prior to 1996, rates of gonorrhea among men were
higher than rates among women. For the eighth
consecutive year, however, gonorrhea rates among
women and men were similar (Figure 14). In 2008,
the gonorrhea rate among women was 119.4 and
the rate among men was 103.0 cases per 100,000
population (Tables 14 and 15).
Gonorrhea by Age
Gonorrhea by Race/Ethnicity
In 2008, gonorrhea rates remained highest among
blacks (625.0 cases per 100,000 population, Figure 21
and Table 21B). Similar to recent years, the rate among
blacks was 20.2 times greater than the rate among
whites (31.0 cases per 100,000 population). Gonorrhea
rates were 3.6 times greater among American Indian/
Alaska Natives (110.2 cases per 100,000 population),
and 2.2 times greater among Hispanics (66.8 cases
per 100,000 population) than among whites in 2008.
Rates among whites were 1.6 times higher than those
among Asian/Pacific Islanders (20.0 cases per 100,000
population) in 2008 (Figure 21).
Between 2004 and 2008, gonorrhea rates showed
no marked changes for any racial or ethnic group.
(Figure 21 and Table 21B). Additional information
on gonorrhea among minority populations can be
found in the Special Focus Profiles.
Prevalence Monitoring
Gonorrhea test positivity data are primarily available
from family planning clinic settings. Screening
criteria and practices may vary by state and over time.
In 2008, the median state-specific gonorrhea test
positivity among 15- to 24-year-old women screened
in selected family planning clinics in 43 states, the
District of Columbia, Puerto Rico, and the Virgin
Islands was 0.9% (range: 0.0% to 3.8%) (Figure 23).
Susceptibility to Ceftriaxone
Susceptibility testing for ceftriaxone began in 1987.
Figure 25 shows the distribution of Minimum
Inhibitory Concentrations (MICs) to ceftriaxone
among GISP isolates from 2004 to 2008. There was a
small increase in the proportion of GISP isolates with
MICs of 0.06 g/ml since 2006 but no increases were
observed at higher MIC values.
There have been four isolates with decreased
susceptibility to ceftriaxone in GISP; all four had
MICs of 0.5 g/ml. Their locations and years were:
San Diego-1987, Cincinnati-1992 and 1993, and
Philadelphia-1997. No isolates with decreased
susceptibility to ceftriaxone were seen in 2008.
Susceptibility to Azithromycin
GISP began monitoring azithromycin susceptibility
in 1992. Figure 26 shows the distribution of MICs
to azithromycin among GISP isolates from 2004 to
2008. The proportion of GISP isolates at MICs of
0.5 g/ml and 1.0 g/ml for azithromycin has been
increasing since 2004.
Susceptibility to Spectinomycin
All isolates were susceptible to spectinomycin in
2008. There have been five spectinomycin-resistant
isolates in GISP; their locations and years were: St.
Louis-1988, Honolulu-1989, San Francisco-1989,
Long Beach-1990, and West Palm Beach-1994.
Susceptibility to Ciprofloxacin
Resistance to ciprofloxacin (a fluoroquinolone in the
quinolone family of antimicrobials) was first identified
in GISP sites in 1991. However since 1999, quinolone
resistant Neisseria gonorrhoeae (QRNG) prevalence
has steadily increased, first in Hawaii and the Pacific
Islands, then in the Western states, and then among
MSM.6,8,9 In 2008, 775 (13.5%) of 5,723 GISP
isolates collected were identified as QRNG, a decrease
from 2007, when 891/6,009 (14.8%) isolates were
identified as QRNG (Figure 27).
19
QRNG by Region
The number of isolates submitted from Honolulu
demonstrating ciprofloxacin-resistance increased from
20 (28.6%) of 70 isolates in 2007 to 32 (40.5%) of
79 isolates in 2008. Other Western sites reporting
increases in QRNG prevalence from 2007 to 2008
include: Phoenix (8.7% in 2007 to 16.5% in 2008);
Portland (28.6% to 51.6%); and Seattle (29.3%
to 31.3%). In contrast, a number of Western sites
reported a decrease in QRNG prevalence from 2007
to 2008, including Albuquerque (16.7% in 2007 to
6.9% in 2008), Denver (17.0% to 10.7%), Las Vegas
(18.7% to 17.7%), Los Angeles (22.4% to 16.8%),
Orange County (41.0% to 33.3%), San Diego (36.3%
to 29.1%) and San Francisco (31.3% to 26.1%).
In the South from 2007 to 2008, a few sites continued
to observe increases in the prevalence of QRNG,
including Atlanta (from 2.6% in 2007 to 10.3%
in 2008), Baltimore (2.0% in 2007 to 5.4%) and
Richmond (17.9% to 21.8%). Southern sites reporting
a decrease in the prevalence of QRNG from 2007 to
2008 include Birmingham (from 9.4% in 2007 to 8.3%
in 2008), Dallas (7.5% to 7.1%), Greensboro (5.3% to
3.6%), Miami (19.6% to 16.2%), New Orleans (18.1%
to 14.9%), and Oklahoma City (6.0% to 4.4%).
A majority of the Midwestern sites reported decreases
in QRNG prevalence including Chicago (from 8.6%
in 2007 to 5.3% in 2008), Detroit (1.7% to 1.1%),
Kansas City (16.4% to 7.5%), and Minneapolis
(10.7% to 7.6%). The sites that showed an increase
in QRNG prevalence were Cincinnati (from 1.2%
in 2007 to 2.2% in 2008) and Cleveland (0.7% to
4.1%).
In the Northeast, New York City reported a slight
increase in QRNG prevalence from 14.9% in 2007
to 15.5% in 2008. In Philadelphia, the prevalence
of resistant isolates to ciprofloxacin decreased from
29.1% in 2007 to 20.6% in 2008.
20
Gonorrhea Summary
In summary, the national gonorrhea rate has
remained relatively unchanged for more than ten
years. Of particular concern are the persistent high
rates in some geographic areas, adolescents and young
adults, and some racial/ethnic groups.
GISP continues to monitor for the emergence
of decreased susceptibility and resistance to
cephalosporins and for increases in decreased
susceptibility to azithromycin.
Centers for Disease Control and Prevention. Fluoroquinoloneresistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased
susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.
MMWR 2000;49:833837.
10
11
Wang SA, Lee MV, Iverson CJ, Ohye RG, Whiticar PM, Hale
JA, Trees DL, Knapp JS, Effler PV, Weinstock HS. Multi-drug
resistant Neisseria gonorrhoeae with decreased susceptibility to
cefixime, Hawaii, 2001. CID 2003;37:84952.
12
13
21
Figure 13.
1941
Figure 14.
1946
1951
1956
1961
1966
1971
1976
1981
1986
1991
1996
2001
2006
Men
Women
Total
300
200
100
22
1989
1991
1993
1995
1997
1999
2001
2003
2005
2007
Figure 15.
West
Midwest
Northeast
South
250
200
150
100
50
0
1999
2000
Figure 16.
2001
2002
2003
2004
2005
2006
2007
2008
48.3
12.7
22.4
58.4
32.7
12.5
Guam
62.8
23.7
84.7
70.5
108.7
47.1
54.4
77.3
71.2
84.6
47.5
89.0
146.5
160.9
138.2
41.2 134.0
107.2
136.3
176.3
142.6
159.2
214.2
170.5
256.8
210.5
56.9
81.9
143.3
134.7
88.7
169.4
82.3
18.0
VT
NH
MA
RI
CT
NJ
DE
MD
DC
7.3
220.2
Puerto Rico
6.9
127.8
Virgin
Islands
109.3
6.0
7.6
33.0
29.0
80.0
61.0
120.8
118.6
451.5
<19.0
(n=7)
19.1100.0 (n=24)
>100.0
(n=23)
NOTE: The total rate of gonorrhea for the United States and outlying areas (Guam, Puerto Rico, and Virgin Islands) was 110.3 per 100,000 population.
23
Figure 17.
<19.0
(n=1,305)
19.1100.0 (n=1,136)
>100.0
Figure 18.
Men
750
450
300
150
0
5.8
150
Age 0
31.0
1014
Women
300
1519
278.3
71.7
4044
40.1
14.0
3.5
103.3
119.0
3539
99.6
4554
750
269.4
3034
163.3
600
608.6
2529
269.9
450
636.8
2024
433.6
24
(n=700)
55.2
28.9
11.2
5564
2.5
65+
0.5
Total
119.7
Figure 19.
3034
3539
4044
1519
2024
2529
800
600
400
200
0
1999
Figure 20.
2000
2001
2002
2003
2004
2005
2006
2007
2008
3034
3539
4044
1519
2024
2529
600
450
300
150
0
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
25
Figure 21.
400
200
0
1999
Figure 22.
2000
2001
2002
2003
2004
2005
2006
2007
2008
160
120
80
40
0
26
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
Figure 23.
1.0
0.5
3.8
0.1
Guam
396
0.5
0.9
1.8
0.3
0.8
0.6
0.5
1.4
0.4
0.4
1.4
1.0
0.6
0.2
0.8
2.4
Puerto Rico
0.2
2.7
0.3
0.7
1.3
1.4
2.0
1.4
0.8
1.9
0.0
0.4 1.2
0.6
2.9
2.1
0.9
1.6
1.4
1.0
0.8
VT
NH
MA
RI
CT
NJ
DE
MD
DC
0.0
2.5
Positivity(%)
2.2
Virgin
Islands
3.0
1.7
See*
(n=7)
<1.0
(n=23)
1.01.9 (n=14)
>2.0
(n=9)
Figure 24.
Seattle
Portland
Minneapolis
Denver
San Francisco
Detroit
Chicago
Kansas City
Cleveland
Cincinnati
Baltimore
Richmond
Las Vegas
Los Angeles
Orange Co.
Albuquerque
San Diego Phoenix
Greensboro
Oklahoma City
Birmingham
Atlanta
Sentinel Sites
Dallas
New Orleans
Tripler AMC
Honolulu
Miami
27
Figure 25.
Percent
100
2004
2005
2006
80
2007
2008
60
40
20
<0.008
0.015
0.03
0.06
0.125
0.25
MIC (g/ml)
Figure 26.
Percent
60
2004
2005
2006
48
2007
2008
36
24
12
<0.03
0.06
0.125
0.25
0.5
16
MIC (g/ml)
28
Figure 27.
Percent
16
Resistance
Intermediate resistance
12
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
NOTE: Resistant isolates have ciprofloxacin MICs >1 g/ml. Isolates with intermediate resistance have ciprofloxacin MICs of 0.1250.5 g/ml.
Susceptibility to ciprofloxacin was first measured in GISP in 1990.
Figure 28.
0.9%
1.7%
1.6%
7.4%
4.0%
Susceptible
7.4%
PenR
1.5%
TetR
75.6%
QRNG
PenR/TetR
PenR/QRNG
TetR/QRNG
PenR/TetR/QRNG
NOTE: PenR=penicillinase producing N. gonorrhoeae and chromosomally mediated penicillin-resistant N. gonorrhoeae; TetR=chromosomally and
plasmid mediated tetracycline-resistant N. gonorrhoeae; QRNG=ciprofloxacin-resistant N. gonorrhoeae.
29
Figure 29.
Percent
100 Tetracyclines
Other
Penicillins
Ofloxacin
80
Ciprofloxacin
60
Cefixime
40
20
Ceftriaxone 250 mg
Spectinomycin
0
1988
Ceftriaxone 125 mg
Other Cephalosporins
1990
1992
1994
1996
1998
2000
2002
2004
2006
2008
Note: For 2008, Other includes no therapy (1.3%), azithromycin 2g (1.2%), levofloxacin (0.02%), and other less frequently used drugs.
30
Syphilis
Background
Syphilis, a genital ulcerative disease, causes significant
complications if untreated and facilitates the
transmission of HIV. Untreated early syphilis in
pregnant women results in perinatal death in up to
40% of cases and, if acquired during the four years
preceding pregnancy, may lead to infection of the
fetus in 80% of cases.1
The rate of P&S syphilis reported in the United States
decreased during the 1990s; in 2000, the rate was the
lowest since reporting began in 1941 (Figure 30). The
low rate of infectious syphilis and the concentration
of the majority of syphilis cases in a small number
of geographic areas in the United States led to the
development of the CDCs National Plan to Eliminate
Syphilis, which was announced by Surgeon General
David Satcher in October 1999 and revised in May
2006.2
Although the rate of P&S syphilis in the United
States declined 89.7% between 1990 and 2000, the
rate of P&S syphilis increased annually between
2001 and 2008. Overall increases in rates between
2001 and 2008 were observed primarily among men
(increasing from 3.0 cases per 100,000 population to
7.6 cases per 100,000 population). After persistent
declines from 1992 to 2003, the rate of P&S
syphilis among women increased from 0.8 cases per
100,000 population in 2004 to 1.5 cases per 100,000
population in 2008.
Syphilis remains an important problem in the South
and in urban areas in other regions of the country.
Increases in cases among MSM (including men
who have sex with women and men) have occurred
and have been characterized by high rates of HIV
co-infection and high-risk sexual behaviors.3-7
The estimated proportion of P&S syphilis cases
attributable to MSM increased from 4% in 2000 to
62% in 2004.8,9 In 2005, CDC requested that all
state health departments report sex of sex partners for
persons with syphilis. In 2008, 63% of those P&S
syphilis cases in 44 states and Washington, D.C.
STD Surveillance 2008
31
Syphilis Summary
In recent years, MSM have accounted for an
increasing number of syphilis cases in the United
States;9 63% of reported P&S syphilis cases in the
United States are among MSM, based on information
from 44 states and Washington, D.C. Although the
majority of U.S. syphilis cases have occurred among
MSM, syphilis among heterosexuals is an emerging
problem.10
33
10
Chen SY, Gibson S, Katz MH, Klausner JD, Dilley JW, Schwarcz
SK, Kellogg TA, McFarland W. Continuing increases in sexual
risk behavior and sexually transmitted diseases among men
who have sex with men: San Francisco, California, 19992001
[Letter]. Am J Public Health 2002;92:13878.
34
Figure 30.
500
400
300
200
100
0
1941
Figure 31.
1946
1951
1956
1961
1966
1971
1976
1981
1986
1991
1996
2001
2006
Primary and secondary syphilisRates: Total and by sex and male-to-female rate
ratios: United States, 19892008
25
16:1
Male Rate
Female Rate
Total Rate
Male-to-Female Rate Ratio
20
8:1
15
4:1
10
2:1
5
0
1989
1991
1993
1995
1997
1999
2001
2003
2005
2007
1:1
35
Figure 32.
West
Midwest
Northeast
South
1999
2000
Figure 33.
2001
2002
2003
2004
2005
2006
2007
2008
Primary and secondary syphilisRates by state: United States and outlying areas,
2008
2.8
0.7
0.0
2.2
0.7
0.5
Guam
3.5
3.0
6.0
1.2
0.1
0.6
0.9
5.0
2.6
0.5
4.3
1.1
2.4
2.2
0.1
2.3
2.2
3.1
2.2
3.2
6.7
7.3
16.5
Puerto Rico
4.2
9.7
1.8
1.5
3.3
1.7
1.0
2.6
1.9
6.7
24.8
0.7 3.4
2.2
3.8
6.3
5.9
6.3
2.1
0.8
VT
NH
MA
RI
CT
NJ
DE
MD
DC
0.8
2.2
9.6
Virgin
Islands
0.0
5.7
<0.2
(n=4)
0.212.2
(n=23)
>2.2
(n=27)
NOTE: The total rate of P&S syphilis for the United States and outlying areas (Guam, Puerto Rico, and Virgin Islands) was 4.5 per 100,000 population.
36
Figure 34.
<0.2
(n=2,184)
0.212.2
(n=373)
>2.2
(n=584)
NOTE: In 2008, 2,180 (69.3%) of 3,141 counties in the United States reported no cases of P&S syphilis.
Figure 35.
Primary and secondary syphilisAge- and sex-specific rates: United States, 2008
Men
20
12
0
0.1
Age 0
0.2
1014
1519
5.3
17.3
2024
17.2
2529
14.7
3539
2.3
4554
0.6
7.6
65+
20
1.8
4044
5564
16
3.9
2.5
2.6
12
5.1
3034
8.3
3.0
15.0
14.4
Women
1.1
0.3
0.0
Total
1.5
37
Figure 36.
1519
2024
2529
3034
3539
4044
8
6
4
2
0
1999
Figure 37.
2000
2001
2002
2003
2004
2005
2006
2007
2008
3034
3539
4044
1519
2024
2529
15
10
38
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
Figure 38.
32
24
16
8
0
1999
Figure 39.
2000
2001
2002
2003
2004
2005
2006
2007
2008
Cases
6000
Primary
Secondary
5000
4000
3000
2000
1000
0
Heterosexual Men
Women
MSM
* 20% of reported male cases of P&S syphilis were missing sex of sex partner information.
39
Figure 40.
Cases
3000
White
2500
Black
Hispanic
2000
Other
1500
1000
500
0
Heterosexual Men
Women
MSM
* 20% of reported male cases of P&S syphilis were missing sex of sex partner information; 2% of reported male cases with sex of partner data were
missing race/ethnicity data.
Figure 41.
7
6
5
4
3
2
1
0
40
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
Figure 42.
Percent
Correctional Facility
50
40
STD Clinic
30
20
10
Heterosexual Men
Women
MSM
* 20% of reported male cases of P&S syphilis were missing sex of sex partner information; 3% of reported male cases with sex of partner data were
missing source of information data.
Figure 43.
Congenital syphilis (CS)Reported cases for infants <1 year of age and rates of
primary and secondary syphilis among women: United States, 19992008
0.8
CS Cases
P&S Rate
0.6
0.4
0.2
0.0
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
41
43
44
Trichomoniasis
Case reporting data are not available for
trichomoniasis and trend data for this infection is
limited to estimates of initial physician office visits
from NDTI (Figure 49 and Table 43). NHANES
data from 20012004 demonstrated an overall
prevalence of 3.1% (95% CI: 2.34.3), with the
highest prevalence observed among blacks 13.3%
(95% CI: 10.017.7).7
Figure 44.
1981
1983
Figure 45.
1985
1987
1989
1991
1993
1995
1997
1999
2001
2003
2005
2007
Prevalence, %
45
Low-risk HPV
40
High-risk HPV
35
30
25
20
15
10
5
0
1419
2024
2529
3039
4049
5059
Age
NOTE: Error bars indicate 95% confidence intervals. Both high-risk and low-risk HPV types were detected in some females.
SOURCE: National Health and Nutrition Examination Survey. JAMA, 2007;297:813819. 2007 American Medical Association. All rights reserved.
45
Figure 46.
400
300
200
100
1966
1969
1972
1975
1978
1981
1984
1987
1990
1993
1996
1999
2002
2005
2008
NOTE: See Appendix (Other Data Sources) and Table 43. The relative standard error for genital warts estimates range from 18% to 30%.
SOURCE: IMS Health, Integrated Promotional Services, IMS Health Report, 19662008 Hardcopy.
Figure 47.
1966
1969
1972
1975
1978
1981
1984
1987
1990
1993
1996
1999
2002
2005
2008
NOTE: See Appendix (Other Data Sources) and Table 43. The relative standard error for genital herpes estimates range from 18% to 30%.
SOURCE: IMS Health, Integrated Promotional Services, IMS Health Report, 19662008 Hardcopy.
46
Figure 48.
Percent
100
80
Non-Hispanic Whites
60
40
20
All Ages*
1419
2029
3039
4049
3039
4049
Percent
100
80
Non-Hispanic Blacks
60
40
20
All Ages*
1419
19761980
2029
19881994
19992004
* Age-adjusted using the 2000 U.S. Census civilian, noninstitutionalized population aged 14 to 49 years as the standard.
NOTE: Error bars indicate 95% confidence intervals.
SOURCE: National Health and Nutrition Examination Survey. JAMA 2006;296:964973. 2006 American Medical Association. All rights reserved.
47
Figure 49.
Trichomoniasis
Other Vaginitis
3,600
2,700
1,800
900
0
1966
1969
1972
1975
1978
1981
1984
1987
1990
1993
1996
1999
2002
2005
2008
Note: See Appendix (Other Data Sources) and Table 43. The relative standard error for trichomoniasis estimates range from 16% to 27% and for other
vaginitis estimates range from 8% to 13%.
SOURCE: IMS Health, Integrated Promotional Services, IMS Health Report, 19662008 Hardcopy.
48
49
Observations
ChlamydiaUnited States
Between 2007 and 2008, the rate of chlamydial
infections in women increased from 539.8 to 583.8
per 100,000 females (Figure 1, Table 4). Chlamydia
rates exceeded gonorrhea rates among women in all
states (Figures A and C, Tables 4 and 14).
GonorrheaUnited States
Like chlamydia, gonorrhea is often asymptomatic
in women. Gonorrhea screening, therefore, is an
important strategy for the identification of gonorrhea
among women. Large-scale screening programs for
gonorrhea in women began in the 1970s. After an
initial increase in cases detected through screening,
gonorrhea rates for both women and men declined
steadily throughout the 1980s and early 1990s, and
51
Prevalence Monitoring
Prenatal ClinicsIn 2008, the median statespecific gonorrhea test positivity among 15- to
24-year-old women screened in selected prenatal
clinics in 20 states, Puerto Rico, and the Virgin
Islands was 1.0% (range: 0.0% to 5.0%) (Figure D).
Family Planning ClinicsIn 2008, the median
state-specific gonorrhea test positivity among 15- to
24-year-old women who were screened during visits
in selected family planning clinics in 43 states, the
District of Columbia, Puerto Rico, and the Virgin
Islands was 0.9% (range: 0.0% to 3.8%) (Figure 23).
Congenital Syphilis
Trends in congenital syphilis usually follow trends
in P&S syphilis among women, with a lag of one
to two years (Figure 43). The congenital syphilis
rate peaked in 1991 at 107.3 cases per 100,000
live births, and declined by 92.4% to 8.2 cases per
100,000 live births in 2005 (Table 40). The rate of
P&S syphilis among women declined 95.0% (from
17.3 to 0.8 cases per 100,000 females) between 1990
and 2004 (Figure 31). However, the rate in women
has increased since 2004. The rate of P&S syphilis in
2008 was 1.5 cases per 100,000 women (Table 26).
The highest rates of P&S syphilis in women are
observed in the South (Figure E).
After 14 years of decline, the rate of congenital
syphilis increased 6.1% between 2005 and 2006
(from 8.2 to 8.7 cases per 100,000 live births)
(Table 40), and 16.1% between 2006 and 2007 (from
8.7 to 10.1 cases per 100,000 live births) (Table 40).
The rate for 2008 remained unchanged from 2007.
The highest of rates of congenital syphilis are observed
in the South and West (Figure F).
52
Ectopic Pregnancy
Evidence suggests that health care practices associated
with clinical management of ectopic pregnancy
changed in the late 1980s and early 1990s. Before
that time, treatment of ectopic pregnancy usually
required admission to a hospital. Hospitalization
statistics were therefore useful for monitoring
trends in ectopic pregnancy. From 1997 to 2006,
hospitalizations for ectopic pregnancy have remained
generally stable (Figure I). As of the date of
publication of this report, 2007 data are not available.
Data suggest that nearly half of all ectopic pregnancies
are treated on an outpatient basis.14
10
11
12
13
14
53
Figure A.
ChlamydiaRates among women by state: United States and outlying areas, 2008
480
466
405
393
394
409
Guam
674
392
567
570
541
547
304
580
573
455
661 513
529
608
700
736
662
907
650
786
<400.0
(n=11)
400.1600.0 (n=21)
Puerto Rico
285
694
284
232
381
440
515
406
626
667
1431
269 590
650
782
660
478
596
399
602
1085
990
617
660
461
VT
NH
MA
RI
CT
NJ
DE
MD
DC
274
Virgin
Islands
776
562
>600.0
(n=22)
NOTE: The total chlamydial infection rate among women in the United States and outlying areas (Guam, Puerto Rico, and Virgin Islands) was 580.0 per
100,000 female population.
Figure B.
4.5
3.8
Guam
9.9
5.5
10.4
11.3 9.1
6.5
6.7
5.8
9.2
3.6
8.2
4.0
11.2
1.8
7.5
Positivity (%)
14.4
11.3
15.6
Puerto Rico
15.1
3.3
Virgin
Islands
19.2
7.0
See*
(n=29)
<5.0
(n=6)
5.09.9 (n=10)
>10.0
(n=8)
54
Figure C.
GonorrheaRates among women by state: United States and outlying areas, 2008
46.9
19.2
29.2
63.5
29.3
12.1
Guam
68.1
27.5
80.4
63.6
132.9
61.8
10.5
49.8
82.0
78.4
67.7
174.0 157.1
104.2
162.0
151.0
142.2
174.3
234.0
Puerto Rico
6.2
6.0
7.4
33.1
24.7
93.9
63.4
136.0
124.3
405.9
46.0
148.9
191.6
152.4
252.3
179.1
<19.0
(n=6)
19.1100.0 (n=24)
132.3
234.5
46.7
97.3
166.5
116.1
289.5
97.7
84.0
196.5
99.5
VT
NH
MA
RI
CT
NJ
DE
MD
DC
6.4
>100.0
Virgin
Islands
149.0
(n=24)
NOTE: The total gonorrhea infection rate among women in the United States and outlying areas (Guam, Puerto Rico, and Virgin Islands) was 117.8 per
100,000 female population.
Figure D.
0.1
Guam
396
1.0
0.0
2.2
1.8
0.6
1.0
0.0
0.0
2.6
0.4
0.0
0.8
2.3
0.4
1.3
Positivity (%)
2.7
1.6
5.0
Puerto Rico
0.4
Virgin
Islands
3.3
1.1
See*
(n=31)
<1.0
(n=10)
1.01.9 (n=6)
>2.0
(n=6)
55
Figure E.
Primary and secondary syphilisRates among women by state: United States and
outlying areas, 2008
0.2
0.2
0.0
0.2
0.1
0.1
Guam
1.2
1.1
0.6
0.5
0.3
0.8
0.1
1.8
0.1
0.2
0.6
0.4
1.0
1.4
0.6
0.5
0.4
0.6
0.5
2.0
7.2
13.9
Puerto Rico
1.4
1.1
0.0
0.0
0.2
0.0
0.0
0.5
1.3
2.7
2.3
0.9
3.8
5.6
3.8
0.3
1.1
0.6
4.4
0.0
0.5
1.2
0.3
VT
NH
MA
RI
CT
NJ
DE
MD
DC
0.0
Virgin
Islands
0.0
2.1
<0.2
(n=17)
0.214.0
(n=33)
>4.0
(n=4)
NOTE: The total rate of P&S syphilis among women in the United States and outlying areas (Guam, Puerto Rico, and Virgin Islands) was 1.5 per 100,000
female population.
Figure F.
Congenital syphilisRates for infants <1 year of age by state: United States and
outlying areas, 2008
0.0
0.0
0.0
0.0
0.0
0.0
Guam
0.0
22.5
11.0
1.4
0.0
0.0
0.0
29.3
0.0
0.0
2.5
5.6
0.0
0.0
4.8
1.7
3.7
3.2
19.0
7.4
36.3
Puerto Rico
16.5
0.0
0.0
0.0
0.0
4.8
3.5
0.0
29.7
0.0
7.8
11.9
22.0
0.0
31.8
5.4
2.0
11.1 0.0
0.0
13.4
9.2
7.8
0.0
VT
NH
MA
RI
CT
NJ
DE
MD
DC
0.0
Virgin
Islands
0.0
7.2
<1.0
(n=26)
1.110.0
(n=16)
>10.0
(n=12)
NOTE: The total rate of congenital syphilis for infants <1 year of age for the United States and outlying areas (Guam, Puerto Rico, and Virgin Islands) was
10.2 per 100,000 live births.
56
Figure G.
Acute, Unspecified
Chronic
30
15
0
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
NOTE: The relative standard error for these estimates of the total number of acute unspecified PID cases ranges from 11.9% to 17.2%. The relative
standard error for these estimates of the total number of chronic PID cases ranges from 11% to 18%. Data only available through 2006.
SOURCE: National Health Statistics Report, 2006 National Hospital Discharge Survey. 2008 July. Report Number 5. Atlanta: Centers for Disease Control and Prevention.
Figure H.
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
NOTE: The relative standard error for these estimates range from 21.6% to 29%. See Appendix (Other Data Sources) and Table 43.
SOURCE: IMS Health, Integrated Promotional Services, IMS Health Report, 19662008 Hardcopy.
57
Figure I.
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
NOTE: The relative standard error for these estimates is 14.2%. Data only available through 2006.
SOURCE: National Health Statistics Report, 2006 National Hospital Discharge Survey. 2008 July. Report Number 5. Atlanta: Centers for Disease Control and
Prevention.
58
Observations
Chlamydia
Chlamydia rates for persons 15 to 19 and 20 to 24
years of age continue to increase, as they have for all
age groups. Between 2007 and 2008, the increase for
those 15 to 19 years of age was 10.7%, and for those
20 to 24 years of age was 8.9% (Table 10).
15- to 19-Year-Old WomenAs in previous
years, in 2008, 15- to 19-year-old women had the
highest rate of chlamydia compared to any other age/
sex group (Figure 5 and Table 10). Chlamydia rates
for 15- to 19-year-old women increased 9.8% from
2,982.5 per 100,000 population in 2007 to 3,275.8
per 100,000 population in 2008.
20- to 24-Year-Old WomenIn 2008, as in
previous years, 20- to 24-year-old women had
the second highest rate of chlamydia (3,179.9 per
100,000 population) compared to any other age/sex
group. Chlamydia rates in women of this age group
increased 7.6% from 2007 to 2008.
15- to 19-Year-Old MenChlamydia rates for 15to 19-year-old men increased 14.8% from 611.0 per
100,000 population in 2007 to 701.6 per 100,000
population in 2008.
20- to 24-Year-Old MenAs in previous years,
in 2008, 20- to 24-year old men had the highest
rate of chlamydia among men (1,056.1 per 100,000
population). Chlamydia rates in men of this age
group increased 12.6% from 2007 to 2008.
Gonorrhea
In 2008 gonorrhea rates for persons 15 to 19 and 20
to 24 years of age decreased for the first time in four
years. Between 2007 and 2008, the decrease for those
15 to 19 years of age was 1.3%, and for those 20 to
24 years of age, it was 2.5% (Table 20).
15- to 19-Year-Old WomenIn 2008, as in previous
years, 15- to 19-year-old women had the highest rate of
gonorrhea (636.8 per 100,000 population) compared
to any other age/sex group (Figure 19 and Table 20).
Gonorrhea rates in women of this age group decreased
1.0% from 2007 to 2008. This is the first decrease in
this age group in the past four years.
20- to 24-Year-Old WomenIn 2008, as in
previous years, 20- to 24-year-old women had
the second highest rate of gonorrhea (608.6 per
100,000 population) compared to any other age/sex
group. Gonorrhea rates in women of this age group
decreased 1.2% from 2007 to 2008. This is the first
decrease in this age group in the past four years.
15- to 19-Year-Old MenIn 2008 gonorrhea rates
for 15- to 19-year-old men decreased 2.0% from 284.1
per 100,000 population in 2007 to 278.3 per 100,000
population. This is the first decrease in this age group
in the past four years. (Figure 20, Table 20).
20- to 24-Year-Old MenIn 2008, as in previous
years, 20- to 24-year old men had the highest rate
of gonorrhea among men (433.6 per 100,000
population). Gonorrhea rates in men of this age
group declined 4.2% between 2007 and 2008.
59
Prevalence Monitoring
Chlamydia test positivity among 15- to 19-year-old
women screened in family planning clinics fluctuated
in all 10 DHHS regions between 2004 and 2008
(Figure J). Positivity has remained fairly stable in four
regions (II, III, V, X). In the remaining six regions,
positivity rates increased slightly over this five-year
time frame. The positivity rates presented in Figure J
are not adjusted for changes in laboratory test
methods and associated increases in test sensitivity.
Mertz KJ, Ransom RL, St. Louis ME, Groseclose SL, Hadgu
A, Levine WC, Hayman C. Decline in the prevalence of
genital chlamydia infection in young women entering a
National Job Training Program, 19901997. Am J Pub Health
2001;91(8):12871290.
Figure J.
05
06
07
08
04 05 06 07 08
04 05 06 07 08
Region V
Region I
Region X
7.9 7.4 8.3 9.0 9.3
04
05
06
07
08
VIII
Region IX
II I
05
06
07
IV
VI
08
Region II
III
VII
IX
04 05 06 07 08
04 05 06 07 08
Region VIII
Region III
04
05
06
07
12.6
9.0 9.2 10.2 10.7
04 05 06 07 08
04 05 06 07 08
Region VII
Region IV
Region VI
Figure K.
VT
NH
MA
RI
CT
NJ
DE
MD
DC
5.4
11.0
7.0
12.7
17.2
Guam
12.9
8.4
16.0 11.0
7.5
14.6
13.7
11.6
12.3
14.3
9.4
12.8
10.1 10.4
14.9
20.7
17.2
19.8
14.1
9.6
15.4
20.8
Puerto Rico
11.3
19.0
8.5
6.5
12.1
13.1
10.4
13.3
18.6
20.1
18.1
Prevalence (%)
14.8
Virgin
Islands
See*
(n=12)
<10.0
(n=10)
10.014.9
(n=20)
>15.0
(n=11)
* Less than 100 women residing in these states/areas and entering the National Job Training Program were screened for chlamydia in 2008.
SOURCE: National Job Training Program, Department of Labor (in collaboration with the Center for Disease Detection, San Antonio, Texas).
61
Figure L.
3.3
4.5
4.2
3.2
Guam
396
7.7
4.2
3.3
5.0
1.8
4.9
5.6
4.2
8.2
6.9
10.5
Puerto Rico
4.0
12.3
3.7
0.8
6.6
10.0
5.2
9.1
12.9
8.6
12.5
10.9
4.2
7.1 8.4
9.2
7.0
14.4
10.1
6.7
11.0
10.1 8.7
7.4
6.6
7.8
9.5
3.1
VT
NH
MA
RI
CT
NJ
DE
MD
DC
4.9
12.0
Prevalence (%)
11.2
8.2
8.6
Virgin
Islands
See*
(n=3)
<10.0
(n=38)
10.014.9
(n=12)
>15.0
* Less than 100 men residing in these states/areas and entering the National Job Training Program were screened for chlamydia in 2008.
SOURCE: National Job Training Program, Department of Labor (in collaboration with the Center for Disease Detection, San Antonio, Texas).
Figure M.
VT
NH
MA
RI
CT
NJ
DE
MD
DC
1.3
1.8
0.0
Guam
396
1.0
3.1
0.4
4.7
0.8
4.0
2.7
0.0
5.0
2.7
3.8
4.1
2.8
3.5
1.8 3.4
2.6
3.1
0.0
1.2
5.0
2.9
Puerto Rico
0.4
4.8
1.1
0.7
3.0
2.0
1.6
2.5
2.9
2.8
3.7
Virgin
Islands
Prevalence (%)
3.0
See*
(n=14)
<2.0
(n=16)
2.04.9 (n=21)
>5.0
(n=2)
* Less than 100 women residing in these states/areas and entering the National Job Training Program were screened for gonorrhea by the national
contract laboratory in 2008.
NOTE: Many training centers test female students for gonorrhea using local laboratories; these results are not available to CDC. For this map, gonorrhea
test results for students at centers submitting specimens to the national contract laboratory were included if the number of gonorrhea tests submitted
was greater than 90% of the number of chlamydia tests submitted.
SOURCE: National Job Training Program, Department of Labor (in collaboration with the Center for Disease Detection, San Antonio, Texas).
62
Figure N.
0.0
0.0
0.8
Guam
396
0.3
1.2
0.0
0.4
0.0
1.3
1.7
2.8
2.2
1.0
Prevalence (%)
1.6
Puerto Rico
0.0
0.0
0.0
1.6
1.0
1.4
1.7
2.6
0.3
0.8 1.9
1.2
1.5
0.7
0.5
1.3
0.0
0.2
VT
NH
MA
RI
CT
NJ
DE
MD
DC
0.3
Virgin
Islands
0.7
See*
(n=17)
<2.0
(n=33)
2.04.9 (n=3)
>5.0
* Less than 100 men residing in these states/areas and entering the National Job Training Program were screened for gonorrhea by the national
contract laboratory in 2008.
NOTE: Many training centers test male students for gonorrhea using local laboratories; these results are not available to CDC. For this map, gonorrhea
test results for students at centers submitting specimens to the national contract laboratory were included if the number of gonorrhea tests submitted
was greater than 90% of the number of chlamydia tests submitted.
SOURCE: National Job Training Program, Department of Labor (in collaboration with the Center for Disease Detection, San Antonio, Texas).
63
Observations
Chlamydia
All racial and ethnic groups reported increases in
chlamydia rates from 2007 to 2008 (Table 11B).
From 2004 to 2008, chlamydia rates increased by
27.0% among blacks, 15.6% among American
Indian/Alaska Natives, 21.1% among Hispanics,
8.7% among Asian/Pacific Islanders, and 20.9%
among whites.
BlacksIn 2008, approximately 49% of all reported
chlamydia cases occurred among blacks (Table 11A).
Overall, the rate of chlamydia among blacks in the
United States was more than eight times that among
whites. The rate of chlamydia among black women
was nearly eight times higher than the rate among
white women (2,056.9 and 264.4 per 100,000
women, respectively) (Figure O, Table 11B). The
chlamydia rate among black men was almost 12 times
as high as the rate among white men (928.8 and 79.4
per 100,000 men, respectively).
American Indian/Alaska NativesIn 2008,
the chlamydia rate among American Indian/Alaska
Natives was 808.8 cases per 100,000 population, an
increase of 11.5% from the 2007 rate of 725.7. In
the most recent data available (2007), the chlamydia
positivity rate among females aged 1524 years
screened in Indian Health Service (IHS) clinics
ranged from 8.1% in DHHS region V to 11.6% in
region VIII.
Asian/Pacific IslandersIn 2008, the chlamydia
rate among Asian/Pacific Islanders was 151.9 cases per
100,000 population, a slight increase from the 2007
rate of 137.1.
65
Gonorrhea
Between 2007 and 2008 decreases in gonorrhea rates
were seen in whites, blacks, and Hispanics (decreases
of 10.7%, 4.7%, and 0.9%, respectively). Increases
were seen in Asian/Pacific Islanders and American
Indian/Alaska Natives (8.1% and 4.0%, respectively)
(Table 21B and Figure 21).
BlacksIn 2008, approximately 71% of the total
number of reported cases of gonorrhea occurred
among blacks (Table 21A). In 2008, the rate of
gonorrhea among blacks was 625.0 cases per 100,000
population. Overall, the rate of gonorrhea among
blacks in the United States was 20 times greater than
that among whites. This disparity has changed little
in recent years (20 times higher in 2003, 19 times in
2007) (Figure P, Table 21B). This disparity was higher
for black men (27.6 times higher) than for black
women (16.0 times higher) (Figure Q). As in 2007,
the disparity in gonorrhea rates for blacks in 2008
was higher in the Midwest and Northeast (28.4 and
28.1 times higher, respectively) than in the South or
the West (15.6 and 14.0 times higher, respectively)
(Figure R).
In 2008, gonorrhea rates were highest for blacks 15
to 19 and 20 to 24 years of age considering all racial,
ethnic, and age categories. Black women 15 to 19
years of age had a gonorrhea rate of 2,934.6 cases per
100,000 women. This rate was 16.2 times greater
than the rate among white women in the same age
category (181.3). Black men in the 15- to 19-year-old
age category had a 2008 gonorrhea rate of 1,488.6
cases per 100,000 men, which was 40.7 times higher
than the rate among 15- to 19-year-old white men of
36.6 per 100,000 men. Among men and women aged
20 to 24 years, the gonorrhea rate among blacks was
17.1 times greater than that among whites (2,556.0
and 149.1 cases per 100,000 population, respectively)
(Table 21B).
66
Congenital Syphilis
In 2008, the rate of congenital syphilis (based on the
mothers race/ethnicity) was 34.6 cases per 100,000
live births among blacks and 12.8 cases per 100,000
live births among Hispanics. These rates are 12.4
and 4.6 times higher, respectively, than the 2008
rate among whites (2.8 cases per 100,000 live births)
(Figure V, Table 41).
67
Figure O.
Men
2250
1350
900
450
0 Race
330.0
AI/AN
73.6
450
900
1350
1800
237.3
79.4
211.1
2250
1272.1
Asian/PI
225.9
Black
928.8
Figure P.
Women
2056.9
Hispanic
802.5
White
264.4
583.8
Total
Rate Ratio
32:1
16:1
8:1
4:1
2:1
1:1
1:2
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
* Rate ratios are calculated as the gonorrhea rate per 100,000 population for a given racial or ethnic minority population divided by the gonorrhea rate
per 100,000 population for non-Hispanic whites. Any population with a lower rate of gonorrhea than the non-Hispanic white population will have a
rate ratio less than 1:1.
68
Figure Q.
Men
750
450
300
150
75.0
19.1
150
AI/AN
Asian/PI
300
450
600
61.0
22.8
103.0
Hispanic
White
Total
750
144.2
20.8
Black
629.4
Figure R.
Race 0
Women
621.0
73.1
38.8
119.4
West
Rate Ratio
32:1
Midwest
Northeast
16:1
South
8:1
4:1
2:1
1:1
1:2
1:4
Black
Hispanic
Asian/PI
Am Ind/AK Nat
* Rate ratios are calculated as the gonorrhea rate per 100,000 population for a given racial or ethnic minority population divided by the gonorrhea rate
per 100,000 population for non-Hispanic whites. Any population with a lower rate of gonorrhea than the non-Hispanic white population will have a
rate ratio less than 1:1.
69
Figure S.
Men
30
18
12
Race
3.2
AI/AN
3.0
Asian/PI
Hispanic
8.2
4.0
7.6
Figure T.
White
Total
12
18
24
30
1.4
0.1
Black
28.0
Women
7.6
1.0
0.5
1.5
15
10
70
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
Figure U.
20
15
10
5
0
1999
Figure V.
2000
2001
2002
2003
2004
2005
2006
2007
2008
50
40
30
20
10
0
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
NOTE: Less than 1% of cases had missing maternal race/ethnicity information and were excluded.
71
Gonorrhea
Between 1999 and 2008 the trend in the number of
positive gonorrhea tests for all anatomic sites varied
by city (Figure W).
In 2008, 71% (range: 5795%) of MSM visits
included testing for urethral gonorrhea; 44%
(range: 353%) for rectal gonorrhea; and 64%
(range: 479%) with testing for pharyngeal
gonorrhea.
In 2008, median clinic urethral gonorrhea positivity
in MSM was 8% (range: 412%), median rectal
gonorrhea positivity was 6% (range: 311%), and
median pharyngeal gonorrhea positivity was 3%
(range: 112%).
Special Focus Profiles: STDs in Men Who Have Sex with Men
73
Chlamydia
In 2008, a median of 69% (range: 5894%) of MSM
visiting participating STD clinics were tested for
urethral chlamydia, compared to 65% (range: 57
68%) in 1999. In 2008, the median clinic urethral
chlamydia positivity was 7% (range: 59%).
Syphilis
In 2008, 86% (range: 5997%) of MSM visiting
participating STD clinics had a nontreponemal
serologic test for syphilis (RPR or VDRL) performed,
compared with 69% (range: 5393%) in 1999
(Figure X).
Overall, median clinic seroreactivity among MSM
tested for syphilis increased from 4% (range: 313%)
in 1999 to 11% (range: 817%) in 2008.
Syphilis seroreactivity is used as a proxy for syphilis
prevalence and has been correlated with prevalence of
P&S syphilis in this population.13
HIV Infection
Overall, the percent of MSM tested for HIV in STD
clinics increased between 1999 and 2008. In 2008,
a clinic-specific median of 72% (range: 3984%) of
MSM visiting STD clinics who were not previously
known to be HIV-positive were tested for HIV, while
44% (range: 2355%) were tested in 1999. In 2008,
median clinic HIV positivity in MSM was 3%
(range: 28%) (Figure Y).
HIV/STDs by Race/Ethnicity
Special Focus Profiles: STDs in Men Who Have Sex with Men
Fox KK, del Rio C, Holmes K, et. al. Gonorrhea in the HIV era:
A reversal in trends among men who have sex with men. Am J
Public Health 2001;91:959964.
Special Focus Profiles: STDs in Men Who Have Sex with Men
75
Figure W.
Total GC tests
SEATTLE
Positives
Total GC tests
Positives
8000
1200
3000
500
6000
900
2400
375
4000
600
2000
300
1999 00 01 02 03 04 05 06 07 08
1800
250
1200
125
600
1999 00 01 02 03 04 05 06 07 08
PHILADELPHIA
DENVER
Total GC tests
Positives
1200
Total GC tests
Positives
200
3000
500
900
150
2400
375
600
100
300
50
1999 00 01 02 03 04 05 06 07 08
1800
250
1200
125
600
1999 00 01 02 03 04 05 06 07 08
HOUSTON*
Total GC tests
Positives
Total GC tests
Positives
1200
200
3000
500
900
150
2400
375
600
100
300
50
1999 00 01 02 03 04 05 06 07 08
1800
250
1200
125
600
1999 00 01 02 03 04 05 06 07 08
CHICAGO
DISTRICT OF COLUMBIA
Total GC tests
Positives
1200
200
900
150
600
100
300
50
1999 00 01 02 03 04 05 06 07 08
Positive GC tests
Total GC tests
3000
2400
1800
1200
600
0
Positives
500
375
250
125
1999 00 01 02 03 04 05 06 07 08
Total tests
76
Special Focus Profiles: STDs in Men Who Have Sex with Men
Figure X.
Percent
Percent
SAN FRANCISCO
20
15
15
10
10
1999 00
01
02
03
04
05
06
07
08
Percent
15
10
10
5
01
02
03
04
05
06
07
08
Percent
15
10
10
5
01
02
03
04
05
06
07
08
Percent
CHICAGO
1999 00
05
06
07
08
01
02
03
04
05
06
07
08
06
07
08
07
08
1999 00
01
02
03
04
05
15
10
10
5
01
02
03
04
DISTRICT OF COLUMBIA
20
15
1999 00
04
Percent
20
03
DENVER
20
15
1999 00
02
Percent
HOUSTON*
20
01
20
15
1999 00
1999 00
Percent
PHILADELPHIA
20
SEATTLE
20
05
06
07
08
Seroreactivity
1999 00
01
02
03
04
05
06
Titer >1:16
* Data not reported in 2006, 2007, or 2008. Titer data not reported in 2004 or 2005.
Special Focus Profiles: STDs in Men Who Have Sex with Men
77
Figure Y.
1600
Number of tests
Positivity
1200
800
400
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
Figure Z.
Median positivity
25
White
Black
20
Hispanic
15
10
Urethral
gonorrhea
Rectal
gonorrhea
Pharyngeal
gonorrhea
Urethral
chlamydia
HIV*
Syphilis
Seroreactivity
78
Special Focus Profiles: STDs in Men Who Have Sex with Men
Figure AA.
Percent
25
20
15
10
1989
1991
Figure BB.
1993
1995
1997
1999
2001
2003
2005
2007
SEA
POR
MIN
DTR
CHI
SFO
DEN
LVG
KCY
RIC
GRB
ALB
PHX
OKC
BHM ATL
DAL
SDG
BAL
CIN
LAX
ORA
NYC
CLE
HON
PHI
% of Isolates
from MSM
100%
50%
TRP
NOR
MIA
NOTE: Not all sites participated in GISP for the last 4 years. Sites include: ALB=Albuquerque, NM; ATL=Atlanta, GA; BAL=Baltimore, MD;
BHM=Birmingham, AL; CHI=Chicago, IL; CIN=Cincinnati, OH; CLE=Cleveland, OH; DAL=Dallas, TX; DEN=Denver, CO; DTR=Detroit, MI; GRB=Greensboro,
NC; HON=Honolulu, HI; KCY=Kansas City, MO; LAX=Los Angeles, CA; LVG=Las Vegas, NV; MIA=Miami, FL; MIN=Minneapolis, MN; NOR=New Orleans, LA;
NYC=New York City, NY; OKC=Oklahoma City, OK; ORA=Orange County, CA; PHI=Philadelphia, PA; PHX=Phoenix, AZ; POR=Portland, OR; RIC=Richmond,
VA; SDG=San Diego, CA; SEA=Seattle, WA; SFO=San Francisco, CA; and TRP=Tripler Army Medical Center, HI (does not provide sexual risk behavior data).
Special Focus Profiles: STDs in Men Who Have Sex with Men
79
Description of Population
Chlamydia
Gonorrhea
81
Syphilis
In 2007, reports of P&S syphilis from correctional
facilities accounted for 7% of P&S syphilis among
heterosexual men, 6% among women, and 1%
among MSM. In 2008, reports of P&S syphilis
from correctional facilities accounted for 7% of P&S
syphilis among heterosexual men, 5% among women,
and 1% among MSM (Figure 42).
Joesoef MR, Weinstock HS, Kent CK, Chow JM, Boudov MR,
Parvez FM, Cox T, Lincoln T, Miller JL, Sternberg MS and the
Corrections STD Prevalence Monitoring Group. Sex and age
correlates of chlamydia prevalence in adolescents and adults
entering correctional facilities, 2005: Implications for screening
policy. Sex Transm Dis 2009;36:S67-71.
82
Figure CC.
Men
20
Positivity
16
12
0
1.0
Age
12
Women
0
12
3.6
10.0
13.1
14
5.5
15.2
15
7.5
16.4
16
17
8.2
8.7
14.4
13.2
18
Total
6.4
20
4.6
13
2.2
16
14.5
NOTE: Percent positivity is presented from facilities reporting >100 test results.
Figure DD.
Men
20
Positivity
16
12
Age
Women
0
12
<20
10.6
7.6
3034
3.9
2.2
7.0
11.7
2529
5.8
>35
20
16.5
2024
9.9
16
5.9
3.4
Total
8.5
NOTE: Percent positivity is presented from facilities reporting >100 test results.
83
Figure EE.
Men
20
Positivity
16
12
0
0.2
Age
12
0.4
13
0.6
Women
0
4.4
5.2
1.3
16
5.1
1.2
17
4.3
2.4
18
Total
1.1
20
3.1
15
1.7
16
1.2
14
0.9
12
4.6
NOTE: Percent positivity is presented from facilities reporting >100 test results.
Figure FF.
Men
20
Positivity
16
12
Age
2.0
<20
1.7
2024
Women
0
2.4
1.4
3034
2.2
1.4
Total
16
20
3.4
2529
>35
12
4.0
1.2
0.7
1.4
2.6
NOTE: Percent positivity is presented from facilities reporting >100 test results.
84
TABLES
TABLES
Table 1.
Cases of sexually transmitted diseases reported by state health departments and rates per
100,000 population: United States, 19412008
All Stages
Year* Cases
Primary and
Secondary
Syphilis
Early
Latent
Late and
Late Latent
Congenital
Rate
51.7
57.0
63.8
61.6
60.5
Cases
109,018
116,245
149,390
123,038
101,719
Rate
82.6
88.0
116.0
96.7
79.9
Cases
202,984
202,064
251,958
202,848
142,187
Rate
153.9
153.1
195.7
159.6
111.8
Cases
17,600
16,918
16,164
13,578
12,339
Rate
651.1
566.0
520.7
462.0
431.7
Rate
Chancroid
485,560
479,601
575,593
467,755
359,114
1946
1947
1948
1949
1950
363,647
355,592
314,313
256,463
217,558
271.7
252.3
218.2
175.3
146.0
94,957
93,545
68,174
41,942
23,939
70.9
66.4
47.3
28.7
16.7
107,924
104,124
90,598
75,045
59,256
80.6
73.9
62.9
51.3
39.7
125,248
122,089
123,312
116,397
113,569
93.6
86.6
85.6
79.5
70.2
12,106
12,200
13,931
13,952
13,377
354.9
319.6
383.0
382.4
368.3
NR
NR
NR
NR
NR
368,020
380,666
345,501
317,950
286,746
275.0
270.0
239.8
217.3
192.5
7,091
9,515
7,661
6,707
4,977
5.2
6.7
5.3
4.6
3.3
1951
1952
1953
1954
1955
174,924 116.1
167,762 110.2
148,573 95.9
130,687 82.9
122,392 76.2
14,485
10,449
8,637
7,147
6,454
9.6
6.9
5.6
4.5
4.0
43,316
36,454
28,295
23,861
20,054
28.7
24.0
18.3
15.1
12.5
98,311
105,238
98,870
89,123
86,526
65.2 11,094
69.1 8,553
63.8 7,675
56.5 6,676
53.8 5,354
290.4
218.8
193.9
164.0
130.7
NR
NR
NR
NR
NR
254,470
244,957
238,340
242,050
236,197
168.9
160.8
153.9
153.5
147.0
4,233
3,738
3,338
3,003
2,649
2.8
2.5
2.2
1.9
1.7
1956
1957
1958
1959
1960
130,201
123,758
113,884
120,824
122,538
78.7
73.5
66.4
69.2
68.8
6,392
6,576
7,176
9,799
16,145
3.9
3.9
4.2
5.6
9.1
19,783 12.0
17,796 10.6
16,556 9.7
17,025 9.8
18,017 10.1
95,097
91,309
83,027
86,740
81,798
57.5
54.2
48.4
49.7
45.9
5,491
5,288
4,866
5,130
4,416
130.4
123.0
114.6
119.7
103.7
NR
NR
NR
NR
NR
224,346
214,496
232,386
240,254
258,933
135.7
127.4
135.6
137.6
145.4
2,135
1,637
1,595
1,537
1,680
1.3
1.0
0.9
0.9
0.9
1961
1962
1963
1964
1965
124,658
126,245
124,137
114,325
112,842
68.8
68.7
66.5
60.4
58.9
19,851
21,067
22,251
22,969
23,338
11.0
11.5
11.9
12.1
12.2
19,486 10.8
19,585 10.7
18,235 9.8
17,781 9.4
17,458 9.1
79,304
79,533
78,076
68,629
67,317
43.8
43.3
41.8
36.3
35.1
4,163
4,070
4,031
3,516
3,564
97.5
97.7
98.4
87.3
94.8
NR
NR
NR
NR
NR
264,158
263,714
278,289
300,666
324,925
145.8
143.6
149.0
158.9
169.5
1,438
1,344
1,220
1,247
982
0.8
0.7
0.7
0.7
0.5
1966
1967
1968
1969
1970
105,159
102,581
96,271
92,162
91,382
54.2
52.2
48.4
45.7
44.8
21,414
21,053
19,019
19,130
21,982
11.0
10.7
9.6
9.5
10.8
15,950
15,554
15,150
15,402
16,311
8.2
7.9
7.6
7.6
8.0
63,541
61,975
58,564
54,587
50,348
32.7
31.5
29.4
27.1
24.7
3,170
2,894
2,381
2,074
1,953
87.9
82.2
68.0
57.6
52.3
NR
NR
NR
NR
NR
351,738
404,836
464,543
534,872
600,072
181.2
838
205.9
784
233.4
845
265.4 1,104
294.2 1,416
0.4
0.4
0.4
0.5
0.7
1971
1972
1973
1974
1975
95,997
91,149
87,469
83,771
80,356
46.4
43.6
41.4
39.3
37.3
23,783
24,429
24,825
25,385
25,561
11.5
11.7
11.7
11.9
11.9
19,417 9.4
20,784 9.9
23,584 11.2
25,124 11.8
26,569 12.3
49,993
43,456
37,054
31,854
27,096
24.2
20.8
17.5
14.9
12.6
2,052
1,758
1,527
1,138
916
57.7
54.0
48.7
36.0
29.1
NR
NR
NR
NR
NR
670,268
767,215
842,621
906,121
999,937
324.1 1,320
366.6 1,414
398.7 1,165
424.7
945
464.1
700
0.6
0.7
0.6
0.4
0.3
1976
1977
1978
1979
1980
71,761
64,621
64,875
67,049
68,832
33.0
29.4
29.2
29.9
30.3
23,731
20,399
21,656
24,874
27,204
10.9
9.3
9.8
11.1
12.0
25,363 11.7
21,329 9.7
19,628 8.8
20,459 9.1
20,297 8.9
21,905
22,313
23,038
21,301
20,979
10.1
10.2
10.4
9.5
9.2
626
463
434
332
277
19.8
13.9
13.0
9.5
7.7
NR
NR
NR
NR
NR
1,001,994
1,002,219
1,013,436
1,004,058
1,004,029
460.6
456.0
456.3
447.1
442.1
628
455
521
840
788
0.3
0.2
0.2
0.4
0.3
1981
1982
1983
1984
1985
72,799
75,579
74,637
69,872
67,563
31.7
32.6
31.9
29.6
28.4
31,266
33,613
32,698
28,607
27,131
13.6
14.5
14.0
12.1
11.4
21,033 9.2
21,894 9.5
23,738 10.2
23,131 9.8
21,689 9.1
20,168
19,799
17,896
17,829
18,414
8.8
8.5
7.7
7.6
7.7
287
259
239
305
329
7.9
7.0
6.6
8.3
8.7
NR
NR
NR
7,594
25,848
6.5
17.4
431.8
850
414.7 1,392
385.1
847
372.5
665
383.0 2,067
0.4
0.6
0.4
0.3
0.9
Cases
NR
NR
NR
NR
NR
Gonorrhea
1941
1942
1943
1944
1945
Cases
68,231
75,312
82,204
78,443
77,007
Chlamydia
Rate
368.2
363.4
447.0
367.9
282.3
Cases
193,468
212,403
275,070
300,676
287,181
Rate
146.7
160.9
213.6
236.5
225.8
Cases Rate
3,384
2.5
5,477
4.1
8,354
6.4
7,878
6.1
5,515
4.3
990,864
960,633
900,435
878,556
911,419
85
Table 1.
Cases of sexually transmitted diseases reported by state health departments and rates per
100,000 population: United States, 19412008 (continued)
All Stages
Year* Cases
Primary and
Secondary
Syphilis
Early
Latent
Cases
27,667
35,585
40,474
45,826
50,578
Rate
11.5
14.7
16.6
18.6
20.3
Cases
21,656
28,233
35,968
45,394
55,397
Rate
9.0
11.7
14.7
18.4
22.2
42,950
34,009
26,527
20,641
16,543
17.0
13.3
10.2
7.8
6.2
53,855
49,929
41,919
32,017
26,657
Late and
Late Latent Congenital
Chlamydia
Gonorrhea
Chancroid
1986
1987
1988
1989
1990
67,779
87,286
104,546
115,089
135,590
Rate
28.2
36.0
42.8
46.6
54.3
Cases
18,046
22,988
27,363
22,032
25,750
Rate
7.5
9.5
11.2
8.9
10.3
Cases Rate
410 10.9
480 12.6
741 19.0
1,837 45.5
3,865 92.9
Cases
58,001
91,913
157,854
200,904
323,663
Rate
35.2
50.8
87.1
102.5
160.2
Cases
892,229
787,532
738,160
733,294
690,042
Rate
371.5
325.0
301.9
297.1
276.4
Cases
3,045
4,986
4,891
4,697
4,212
Rate
1.3
2.1
2.0
1.9
1.7
1991
1992
1993
1994
1995
128,719
114,730
102,612
82,713
69,359
50.9
44.7
39.5
31.4
26.0
21.3
19.5
16.1
12.2
10.0
27,490
26,725
30,746
27,603
24,296
10.9
10.4
11.8
10.5
9.1
4,424
4,067
3,420
2,452
1,863
107.6
100.0
85.5
62.0
47.8
381,228
409,694
405,332
451,785
478,577
179.7
182.3
178.0
192.5
187.8
621,918
502,858
444,649
419,602
392,651
245.8
196.0
171.1
163.9
147.5
3,476
1,906
1,292
782
607
1.4
0.7
0.5
0.3
0.2
1996
1997
1998
1999
2000
53,240
46,716
38,289
35,385
31,618
19.8 11,405
17.1 8,556
13.9 7,007
12.7 6,617
11.2 5,979
4.2
3.1
2.5
2.4
2.1
20,187
16,631
12,696
11,534
9,465
7.5
6.1
4.6
4.1
3.4
20,366
20,447
17,743
16,655
15,594
7.6
7.5
6.4
6.0
5.5
1,282
1,082
843
579
580
32.9
27.9
21.4
14.6
14.3
492,631
537,904
614,250
662,647
709,452
190.6
205.5
231.8
247.2
251.4
328,169
327,665
356,492
360,813
363,136
121.8
120.2
129.2
129.3
128.7
386
246
189
110
78
0.1
0.1
0.1
0.0
0.0
2001
2002
2003
2004
2005
32,284
32,919
34,289
33,423
33,288
11.3
11.4
11.8
11.4
11.2
6,103
6,862
7,177
7,980
8,724
2.1
2.4
2.5
2.7
2.9
8,701
8,429
8,361
7,768
8,176
3.0
2.9
2.9
2.6
2.8
16,976
17,168
18,319
17,300
16,049
5.9
6.0
6.3
5.9
5.4
504
460
432
375
339
12.5
11.4
10.6
9.1
8.2
783,242
834,555
877,478
929,462
976,445
274.5
289.4
301.7
316.5
329.4
361,705
351,852
335,104
330,132
339,593
126.8
122.0
115.2
112.4
114.6
38
48
54
30
17
0.0
0.0
0.0
0.0
0.0
2006
2007
2008
36,958
40,921
46,277
12.3 9,756
13.6 11,466
15.3 13,500
3.3
3.8
4.5
9,186
10,768
12,401
3.1
3.6
4.1
17,644
18,256
19,945
5.9
6.1
6.6
372
431
431
8.7
10.1
10.1
1,030,911
1,108,374
1,210,523
19
23
25
0.0
0.0
0.0
* For 19411946, data were reported for the federal fiscal year ending June 30 of the year indicated. From 1947 to the present, data were reported for the calendar
year ending December 31. For 19411958, data for Alaska and Hawaii were not included.
Late and late latent syphilis includes late latent syphilis, latent syphilis of unknown duration, neurosyphilis, and late syphilis with clinical manifestations other than
neurosyphilis.
Rates include all cases of congenitally acquired syphilis per 100,000 live births. As of 1995, cases of congenital syphilis are obtained in hardcopy and electronic
format based on case reporting form CDC 73.126.
NOTE: Adjustments to the number of cases reported from state health departments were made for hardcopy forms and for electronic data submissions through
June 10, 2009 (see Appendix). The number of cases and the rates shown here supersede those published in previous reports. Cases and rates shown in this table
exclude the outlying areas of Guam, Puerto Rico, and Virgin Islands.
NR = No report.
86
Table 2.
ChlamydiaReported cases and rates by state, ranked by rates: United States, 2008
Rank*
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
State
Mississippi
Alaska
South Carolina
Alabama
Louisiana
Arkansas
New Mexico
Hawaii
Illinois
New York
Tennessee
Delaware
Georgia
Michigan
Maryland
Missouri
Texas
North Carolina
Ohio
Oklahoma
California
Virginia
U.S. TOTAL
Colorado
Arizona
Florida
Nevada
Wisconsin
South Dakota
Connecticut
Indiana
Pennsylvania
Kansas
Washington
Montana
Nebraska
Iowa
Rhode Island
Wyoming
North Dakota
Kentucky
Oregon
Idaho
Minnesota
Massachusetts
New Jersey
Utah
Maine
Vermont
West Virginia
New Hampshire
Cases
21,253
4,861
26,323
24,760
22,659
14,136
9,262
5,982
59,169
88,359
28,038
3,868
42,629
44,923
24,669
24,817
100,870
37,516
47,117
14,803
148,798
31,218
1,210,523
19,180
24,769
71,017
9,670
20,996
2,956
12,519
22,154
42,233
9,208
21,402
3,101
5,573
9,372
3,317
1,577
1,921
12,163
10,744
4,194
14,351
17,503
22,405
6,021
2,608
1,190
3,316
2,109
* States were ranked in descending order by rate, number of cases, and alphabetically by state.
Total includes cases reported by the District of Columbia with 6,924 cases and a rate of 1,177.0, but excludes outlying areas (Guam with 687 cases and rate of
395.9, Puerto Rico with 6,874 cases and rate of 174.4, and Virgin Islands with 587 cases and rate of 534.5).
Chlamydia Tables
87
Table 3.
State/Area
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
U.S. TOTAL
Northeast
Midwest
South
West
Guam
Puerto Rico
Virgin Islands
OUTLYING AREAS
TOTAL
88
2004
13,314
3,954
16,786
7,864
122,197
14,151
9,552
2,954
3,493
42,554
34,280
5,307
2,784
47,185
18,440
6,956
7,493
6,470
21,837
2,113
19,952
13,242
41,246
11,602
18,863
21,319
2,608
5,238
6,690
1,736
17,448
9,035
59,097
28,967
1,810
39,379
10,366
8,690
38,025
3,442
18,423
2,532
22,515
70,232
3,857
1,137
21,635
17,635
2,758
19,217
1,082
929,462
145,792
222,417
346,477
214,776
748
3,588
303
4,639
934,101
Cases
2005
2006
2007
2008
17,109
22,915
25,153
24,760
4,355
4,525
4,911
4,861
21,264
24,090
24,866
24,769
8,507
8,259
9,954
14,136
130,716
135,827
141,928
148,798
15,432
16,313
17,186
19,180
11,039
10,946
11,454
12,519
3,392
3,615
3,479
3,868
3,678
3,368
6,029
6,924
43,372
48,955
57,575
71,017
33,562
38,972
42,913
42,629
5,489
5,548
5,659
5,982
2,799
3,345
3,722
4,194
50,559
53,586
55,470
59,169
20,063
19,859
20,712
22,154
7,390
8,390
8,643
9,372
7,419
7,829
8,180
9,208
8,351
8,940
8,798
12,163
17,227
17,885
19,362
22,659
2,254
2,306
2,541
2,608
18,291
21,859
23,150
24,669
14,411
15,394
16,145
17,503
38,730
36,753
37,353
44,923
12,189
12,935
13,413
14,351
21,268
19,002
21,686
21,253
22,371
22,982
23,308
24,817
2,400
2,650
2,748
3,101
5,098
5,428
5,132
5,573
7,321
8,398
9,514
9,670
1,842
1,997
2,055
2,109
19,152
20,194
21,536
22,405
8,456
9,829
9,460
9,262
63,966
68,720
80,717
88,359
31,183
33,615
30,611
37,516
1,667
1,820
1,789
1,921
43,806
40,106
47,434
47,117
13,407
12,992
12,529
14,803
9,018
9,577
9,849
10,744
37,261
39,487
42,469
42,233
3,269
3,142
3,177
3,317
18,296
22,351
26,431
26,323
2,701
2,633
2,620
2,956
23,084
25,320
26,866
28,038
71,860
75,543
85,786
100,870
4,602
5,092
5,721
6,021
957
1,191
1,057
1,190
22,668
24,087
24,579
31,218
18,616
17,819
18,784
21,402
2,944
2,910
3,168
3,316
20,461
20,190
19,555
20,996
1,173
1,422
1,197
1,577
976,445 1,030,911 1,108,374 1,210,523
154,151
163,377
181,151
192,243
232,454
232,511
243,609
262,557
358,199
390,588
428,069
486,162
231,641
244,435
255,545
269,561
807
832
822
687
3,714
5,102
7,909
6,874
235
203
348
587
4,756
6,137
9,079
8,148
981,201 1,037,048 1,117,453 1,218,671
Chlamydia Tables
2004
293.9
603.3
292.2
285.7
340.4
307.5
272.6
355.7
631.0
244.6
388.2
420.2
199.8
371.1
295.6
235.4
273.9
156.1
483.6
160.4
359.0
206.4
407.9
227.4
649.8
370.5
281.4
299.8
286.5
133.6
200.6
474.7
307.4
339.1
285.3
343.7
294.2
241.8
306.5
318.5
438.8
328.5
381.5
312.3
161.4
183.0
290.0
284.3
151.9
348.8
213.6
316.5
267.2
338.4
327.0
318.6
450.4
92.1
278.6
111.3
313.6
2006
498.3
675.3
390.7
293.8
372.6
343.2
312.3
423.6
579.2
270.6
416.2
431.6
228.1
417.6
314.5
281.3
283.2
212.5
417.1
174.5
389.2
239.1
364.0
250.3
652.9
393.3
280.5
307.0
336.5
151.9
231.5
502.9
355.9
379.6
286.2
349.4
363.0
258.8
317.4
294.3
517.2
336.7
419.3
321.4
199.7
190.9
315.2
278.6
160.0
363.4
276.1
344.3
298.5
351.1
358.1
352.4
486.5
129.9
186.9
145.8
341.6
2007
543.5
718.5
392.3
351.1
388.3
353.5
327.0
402.3
1,024.8
315.5
449.6
440.9
248.2
431.6
326.4
289.3
294.7
207.4
451.0
192.9
412.0
250.3
370.9
258.1
743.0
396.5
286.9
289.2
370.9
156.2
247.9
480.2
418.3
337.8
279.7
413.7
346.4
262.8
341.6
300.3
599.7
329.1
436.4
358.9
216.3
170.1
318.7
290.4
174.8
349.1
228.9
367.5
331.3
366.9
387.6
364.6
473.7
200.6
316.9
214.8
365.4
2008
535.0
711.2
390.8
498.7
407.1
394.5
357.4
447.3
1,177.0
389.1
446.6
466.1
279.7
460.4
349.1
313.6
331.7
286.8
527.8
198.0
439.1
271.4
446.0
276.1
728.1
422.2
323.7
314.0
376.9
160.3
257.9
470.2
457.9
414.0
300.3
410.9
409.2
286.7
339.7
313.6
597.2
371.3
455.4
422.0
227.6
191.5
404.8
330.9
183.0
374.8
301.6
401.3
351.6
395.5
440.1
384.6
395.9
174.4
534.5
192.8
398.5
Table 4.
State/Area
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
U.S. TOTAL
Northeast
Midwest
South
West
Guam
Puerto Rico
Virgin Islands
OUTLYING AREAS
TOTAL
2004
11,685
2,671
12,896
6,252
88,439
10,283
7,383
2,140
2,948
34,437
27,656
4,019
2,157
35,996
14,217
5,208
6,195
5,027
17,549
1,532
16,108
9,781
32,624
8,521
15,097
16,306
1,916
3,812
4,857
1,265
14,491
6,876
44,975
23,916
1,206
30,377
8,237
6,090
27,740
2,502
15,925
1,824
16,237
57,470
2,720
861
16,578
12,835
2,105
13,913
820
716,675
110,530
170,199
279,367
156,579
608
3,240
232
4,080
720,755
2005
14,532
2,908
16,201
6,823
93,646
11,219
8,383
2,493
2,976
34,850
26,317
4,093
2,162
37,672
15,263
5,400
6,054
6,041
13,395
1,644
14,653
10,587
30,079
8,820
16,684
16,580
1,776
3,713
5,362
1,343
15,826
6,333
45,391
25,702
1,091
33,312
10,608
6,194
27,131
2,396
15,694
1,924
16,453
58,668
3,081
725
16,805
13,471
2,272
14,751
874
740,371
113,426
174,659
284,966
167,320
667
3,366
189
4,222
744,593
Cases
2006
17,915
3,067
18,485
6,604
97,170
12,037
8,205
2,625
2,510
38,536
30,546
4,161
2,435
39,705
14,907
6,157
6,286
6,336
14,290
1,672
17,339
11,175
27,915
9,243
14,853
16,938
1,932
3,956
6,185
1,484
16,560
7,456
48,568
27,301
1,231
30,483
9,678
6,585
28,503
2,175
19,055
1,923
18,352
60,327
3,457
897
17,682
13,021
2,208
14,606
1,051
775,788
119,239
173,350
306,157
177,042
692
4,091
144
4,927
780,715
2007
19,186
3,295
18,794
7,893
101,175
12,707
8,577
2,554
3,970
42,173
31,827
4,228
2,660
41,733
15,576
6,310
6,629
6,184
15,334
1,831
18,230
11,671
28,341
9,681
16,718
17,080
2,024
3,755
7,044
1,533
17,355
7,044
56,590
25,110
1,194
36,143
9,130
6,890
30,511
2,282
20,793
1,894
19,604
67,966
3,926
812
18,136
13,793
2,423
14,438
913
825,660
131,162
182,774
327,231
184,493
669
6,781
267
7,717
833,377
2008
18,744
3,253
18,358
10,643
104,201
13,825
9,239
2,789
4,438
52,206
31,515
4,422
3,048
43,112
16,513
6,882
7,401
8,622
17,260
1,847
19,337
12,646
33,719
10,266
16,323
18,116
2,227
4,123
7,131
1,548
18,001
6,986
61,280
30,693
1,291
35,021
11,117
7,433
30,509
2,400
20,492
2,185
20,479
79,002
3,982
896
23,172
15,581
2,490
15,229
1,011
893,004
138,366
193,858
369,322
191,458
574
5,834
448
6,856
899,860
2004
500.6
843.9
449.3
445.3
491.9
451.0
409.4
502.7
1,010.3
388.1
619.5
635.1
310.5
556.3
448.7
347.1
449.9
238.0
755.8
227.3
561.8
295.5
634.2
331.7
1,010.4
553.9
412.4
431.4
423.8
192.1
324.7
710.9
453.3
550.8
379.6
516.8
461.9
336.9
433.9
447.3
739.7
470.5
538.6
509.1
228.6
272.8
437.6
412.8
226.8
500.1
326.1
480.6
393.4
509.2
518.4
464.5
747.1
160.1
408.0
188.8
476.4
2006
756.0
947.7
600.1
460.8
532.9
510.0
456.2
597.6
812.7
418.6
642.7
648.0
334.4
609.5
465.4
407.9
451.4
295.4
649.0
247.6
598.1
336.6
544.6
355.7
989.4
566.9
409.3
443.7
504.2
222.7
371.1
753.3
488.1
604.6
389.0
518.4
533.3
353.8
445.8
394.5
859.3
491.4
594.3
511.5
272.7
283.1
455.0
406.1
238.0
522.5
413.8
510.8
423.8
515.8
551.6
511.0
824.7
200.3
253.6
225.7
506.7
2007
804.2
1,002.6
593.7
546.0
553.6
527.1
477.7
573.3
1,279.9
454.3
656.1
663.1
357.1
640.2
483.9
416.9
473.6
285.9
694.6
271.5
628.7
351.2
554.4
371.0
1,110.8
567.9
423.2
419.5
559.7
230.0
391.1
705.7
569.5
541.9
374.7
615.1
499.0
365.5
477.9
418.0
919.8
474.2
622.2
567.4
299.8
257.4
461.8
425.0
262.0
512.4
354.2
539.8
467.1
542.6
582.3
527.2
785.4
330.8
462.5
351.9
537.1
2008
785.7
989.8
579.9
736.2
570.2
573.4
514.6
626.1
1,430.8
562.4
649.7
693.6
409.2
661.3
513.0
454.7
528.8
398.6
781.8
273.9
666.8
380.5
659.6
393.4
1,084.5
602.4
465.7
460.6
566.6
232.2
405.7
699.9
616.7
662.4
405.1
596.0
607.5
394.3
477.9
439.6
906.5
547.1
650.0
659.5
304.1
284.0
590.1
480.1
269.2
540.5
392.2
583.8
492.8
575.5
657.1
547.1
673.9
284.6
776.0
312.7
580.0
NOTE: Cases reported with unknown sex are not included in this table.
Chlamydia Tables
89
Table 5.
State/Area
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
U.S. TOTAL
Northeast
Midwest
South
West
Guam
Puerto Rico
Virgin Islands
OUTLYING AREAS
TOTAL
2004
1,603
1,283
3,884
1,612
33,323
3,855
2,168
814
529
8,117
6,411
1,288
617
11,187
4,080
1,743
1,298
1,433
4,016
581
3,841
3,449
8,622
3,081
3,766
5,013
685
1,391
1,821
471
2,945
2,151
14,031
5,051
601
8,189
2,129
2,600
10,282
936
2,456
708
6,278
12,619
1,137
276
5,024
4,800
649
5,290
262
210,396
35,139
51,203
66,348
57,706
140
348
71
559
210,955
2005
2,507
1,447
5,058
1,684
36,449
4,213
2,656
899
681
8,522
6,793
1,396
616
12,886
4,703
1,990
1,365
2,285
3,583
606
3,627
3,809
8,525
3,369
4,584
5,791
619
1,378
1,955
499
3,323
2,121
18,547
5,481
574
9,139
2,799
2,824
10,128
868
2,572
774
6,619
13,138
1,521
232
5,823
5,145
671
5,688
299
232,781
40,668
56,182
72,268
63,663
140
348
46
534
233,315
Cases
2006
4,985
1,458
5,588
1,655
38,003
4,276
2,741
990
819
10,410
8,089
1,384
895
13,881
4,849
2,233
1,543
2,580
3,372
634
4,439
4,193
8,724
3,692
4,149
6,044
709
1,401
2,211
513
3,606
2,368
20,148
6,314
588
9,039
3,314
2,992
10,981
962
3,272
709
6,968
15,178
1,635
294
6,384
4,798
698
5,551
371
252,630
44,072
58,254
83,616
66,688
140
1,007
55
1,202
253,832
2007
5,955
1,616
6,055
2,060
40,213
4,479
2,877
925
2,034
15,376
10,808
1,431
1,030
13,736
5,032
2,333
1,551
2,605
3,758
708
4,907
4,457
8,845
3,732
4,968
6,228
716
1,363
2,460
522
4,169
2,415
24,045
5,493
594
10,852
3,399
2,959
11,934
892
5,549
725
7,262
17,687
1,795
245
6,433
4,991
744
5,090
284
280,337
49,849
60,081
99,963
70,444
153
1,125
81
1,359
281,696
2008
6,007
1,608
6,401
3,491
44,060
5,319
3,264
1,079
2,438
18,593
10,690
1,560
1,133
16,052
5,572
2,490
1,807
3,508
5,226
761
5,307
4,839
11,007
4,085
4,930
6,701
865
1,441
2,539
561
4,390
2,272
27,056
6,656
629
10,847
3,606
3,311
11,722
915
5,723
767
7,559
21,812
2,039
294
7,985
5,767
825
5,707
563
313,779
53,802
67,105
115,435
77,437
113
1,034
139
1,286
315,065
2004
73.0
378.6
135.2
119.5
186.0
166.1
127.5
201.1
202.1
95.2
146.9
204.4
88.3
179.2
132.9
119.9
95.6
70.5
183.0
90.3
142.7
111.0
173.5
121.7
267.3
178.3
148.2
161.1
153.2
73.5
69.5
229.8
150.8
120.3
189.8
146.7
122.3
145.5
171.0
179.6
120.1
184.7
217.5
112.7
94.8
90.3
136.8
155.1
73.1
194.0
102.7
145.6
132.7
158.5
127.4
171.2
165.3
18.6
136.8
27.8
144.0
2006
223.6
420.9
181.1
120.1
208.5
178.7
160.7
239.0
300.4
117.2
175.4
215.1
121.2
219.7
155.9
151.6
112.5
125.2
161.7
98.1
163.4
134.5
175.5
143.7
294.4
211.7
150.0
159.8
174.2
79.1
84.6
245.4
215.4
145.4
184.1
161.5
187.8
162.6
181.6
186.4
155.5
181.5
236.1
129.6
127.5
95.8
169.9
150.4
78.4
201.1
142.1
171.3
165.6
178.6
156.0
192.1
160.7
53.4
106.1
59.3
169.7
2007
265.6
455.4
190.8
148.3
220.0
182.8
168.5
220.6
731.4
171.4
230.3
221.6
136.5
216.9
160.9
158.2
112.7
125.3
180.2
110.1
180.5
142.6
178.3
144.2
351.4
216.9
149.3
155.0
188.3
80.4
98.1
248.5
256.9
124.1
185.0
194.1
190.2
158.9
197.3
174.3
258.4
182.7
241.6
148.3
134.4
80.1
170.0
154.9
83.9
182.8
107.2
188.6
187.4
183.7
184.3
200.7
173.1
59.4
155.5
66.8
186.9
2008
267.9
453.2
201.7
251.3
241.1
217.1
191.2
257.3
876.6
207.3
227.8
241.6
150.2
253.4
178.2
168.9
131.3
168.8
250.6
118.4
195.2
154.8
221.9
157.8
348.7
233.4
180.3
163.9
194.3
86.4
103.3
233.8
289.0
150.3
195.9
194.0
201.7
177.8
193.8
178.8
266.5
193.3
251.5
182.9
152.6
96.1
211.0
178.9
93.0
205.0
212.4
211.1
202.2
205.2
212.8
220.6
127.9
54.6
266.9
63.3
209.1
NOTE: Cases reported with unknown sex are not included in this table.
90
Chlamydia Tables
Table 6.
Atlanta-Sandy Springs-Marietta, GA
Austin-Round Rock, TX
Baltimore-Towson, MD
Birmingham-Hoover, AL
Boston-Cambridge-Quincy, MA-NH
Buffalo-Cheektowaga-Tonawanda, NY
Charlotte-Gastonia-Concord, NC-SC
Chicago-Naperville-Joliet, IL-IN-WI
Cincinnati-Middletown, OH-KY-IN
Cleveland-Elyria-Mentor, OH
Columbus, OH
Dallas-Fort Worth-Arlington, TX
Denver-Aurora, CO
Detroit-Warren-Livonia, MI
Hartford-WestHartford-East Hartford, CT
Houston-Baytown-Sugar Land, TX
Indianapolis, IN
Jacksonville, FL
Kansas City, MO-KS
Las Vegas-Paradise, NV
Los Angeles-Long Beach-Santa Ana, CA
Louisville, KY-IN
Memphis, TN-MS-AR
Miami-Fort Lauderdale-Miami Beach, FL
Milwaukee-Waukesha-West Allis, WI
Minneapolis-St. Paul-Bloomington, MN-WI
Nashville-Davidson-Murfreesboro, TN
New Orleans-Metairie-Kenner, LA
New York-Newark-Edison, NY-NJ-PA
Oklahoma City, OK
Orlando, FL
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD
Phoenix-Mesa-Scottsdale, AZ
Pittsburgh, PA
Portland-Vancouver-Beaverton, OR-WA
Providence-New Bedford-Fall River, RI-MA
Richmond, VA
Riverside-San Bernardino-Ontario, CA
Rochester, NY
Sacramento-Arden-Arcade-Roseville, CA
Salt Lake City, UT
San Antonio, TX
San Diego-Carlsbad-San Marcos, CA
San Francisco-Oakland-Fremont, CA
San Jose-Sunnyvale-Santa Clara, CA
Seattle-Tacoma-Bellevue, WA
St. Louis, MO-IL
Tampa-St. Petersburg-Clearwater, FL
Virginia Beach-Norfolk-Newport News, VA-NC
Washington-Arlington-Alexandria, DC-VA-MD-WV
U.S. MSA TOTAL
Cases
2004
2005
2006
2007
2008
17,068 16,748 20,979 21,609 20,722
4,580
5,103
7,325
6,814
8,413
10,959 11,071 11,617 13,053 13,537
3,905
4,720
5,338
6,913
6,690
9,006
9,368
9,918 10,697 11,854
4,865
5,013
4,992
5,078
5,561
4,832
5,830
5,076
4,216
7,046
35,953 38,966 41,521 41,403 45,803
6,438
8,516
8,616 10,080 10,016
7,867
8,181
7,462
9,351
8,731
5,167
5,902
5,843
7,157
8,314
15,744 18,005 17,035 22,292 26,090
7,774
8,534
7,934
9,539 10,996
21,378 20,497 17,201 17,934 24,987
3,040
3,815
3,799
4,300
4,781
14,796 13,476 14,641 17,196 21,100
6,922
8,226
7,780
8,173
8,814
5,017
5,246
5,582
6,501
7,318
8,003
7,900
7,825
8,358
9,559
5,065
5,623
6,592
7,333
7,753
46,202 50,703 50,913 52,352 55,276
2,396
3,143
3,319
3,493
4,953
8,927
9,457 10,224 11,349 11,896
11,781 10,403 12,142 13,761 18,128
10,070 10,368 10,498 10,150
1,441
8,139
8,513
9,271
9,514 10,093
4,243
4,538
4,910
4,972
5,574
6,858
4,761
3,401
4,573
5,109
52,266 58,134 62,334 74,071 80,306
3,939
4,798
4,627
4,646
5,650
4,888
5,862
6,579
6,825
8,287
25,285 24,913 27,417 28,116 28,749
11,078 11,984 15,278 15,245 14,314
5,539
5,880
5,789
6,616
6,920
5,256
5,636
5,654
5,970
6,499
4,269
4,316
4,197
4,297
4,551
4,923
4,710
5,044
5,294
6,783
10,913 12,179 12,472 14,316 13,557
4,040
3,850
4,168
4,833
5,294
7,294
8,175
9,094
8,770
8,395
2,223
2,642
2,910
3,395
3,562
7,645
8,049
8,338
8,727
9,734
10,876 11,520 11,980 12,693 14,373
13,580 13,988 15,565 16,710 17,555
5,697
5,374
5,898
5,892
5,796
9,655 10,588
9,778 10,397 11,532
11,856 13,328 13,509 13,710 14,092
5,996
6,315
7,475
9,501 11,230
7,601
8,414
9,139
9,383 11,867
14,046 12,827 15,456 18,069 20,943
525,860 556,108 584,455 635,637 690,544
2004
362.5
324.3
415.2
360.8
203.5
421.4
327.7
382.8
312.8
368.1
305.0
276.2
333.6
475.8
256.6
285.6
426.9
409.4
415.7
306.8
357.5
199.5
714.0
219.7
664.4
261.2
304.0
519.7
279.4
344.2
262.6
435.9
298.2
230.6
254.6
262.1
426.5
287.7
387.9
361.7
218.2
412.3
371.0
326.9
327.1
304.9
428.9
231.7
462.3
273.3
333.0
2005
340.6
351.3
416.9
433.0
212.3
436.8
383.2
412.6
411.3
384.7
345.4
309.4
361.6
456.7
321.1
255.2
501.4
420.2
405.6
328.7
392.3
260.1
750.0
191.9
685.3
270.9
319.0
360.9
310.1
414.8
303.2
427.8
310.1
246.4
268.9
266.0
400.6
311.5
370.5
400.3
255.4
425.9
392.7
336.8
306.2
330.5
479.7
238.5
510.8
246.0
348.7
2006
408.3
484.0
437.0
485.3
222.6
438.8
320.7
436.8
409.5
353.0
338.6
283.7
329.4
384.9
319.6
264.3
467.0
436.8
397.7
370.8
393.1
271.6
802.1
222.2
695.2
292.0
337.4
331.9
331.2
394.7
331.5
470.5
378.2
244.2
264.5
260.2
422.4
309.8
402.5
439.9
272.5
429.3
407.3
372.4
330.0
299.6
483.1
277.1
554.1
292.2
362.3
2007
409.3
426.4
489.2
623.8
238.6
450.1
255.3
434.7
472.4
446.0
408.0
362.8
387.0
401.4
361.6
305.5
482.2
499.8
421.0
399.3
406.6
283.1
886.3
254.2
657.2
296.6
326.8
443.8
393.7
389.4
335.8
482.4
364.8
280.8
274.5
268.4
436.4
350.8
469.0
419.4
308.6
438.4
426.7
397.5
326.7
314.2
489.0
348.8
565.7
340.5
390.6
2008
392.5
526.4
507.4
603.7
264.4
492.9
426.6
480.9
469.4
416.5
473.9
424.6
446.1
559.3
402.1
374.9
520.0
562.6
481.5
422.2
429.3
401.5
929.0
334.9
93.3
314.6
366.4
495.8
426.8
473.6
407.7
493.3
342.5
293.8
298.8
284.3
559.2
332.2
513.7
401.5
323.8
489.0
483.1
417.6
321.3
348.5
502.6
412.3
715.4
394.7
424.4
Chlamydia Tables
91
Table 7.
Cases
2004
2005
2006
2007
2008
Atlanta-Sandy Springs-Marietta, GA
13,756
12,995
16,165
15,553
14,898
Austin-Round Rock, TX
3,405
3,720
5,170
4,753
5,933
Baltimore-Towson, MD
9,051
8,927
9,344
10,416
10,774
Birmingham-Hoover, AL
3,095
3,709
4,277
5,165
4,948
Boston-Cambridge-Quincy, MA-NH
6,549
6,663
7,140
7,721
8,458
Buffalo-Cheektowaga-Tonawanda, NY
3,698
3,849
3,762
3,818
4,076
Charlotte-Gastonia-Concord, NC-SC
4,059
4,878
4,189
3,430
5,469
Chicago-Naperville-Joliet, IL-IN-WI
27,271
28,860
30,600
31,134
33,220
Cincinnati-Middletown, OH-KY-IN
5,108
6,580
6,871
8,082
8,031
Cleveland-Elyria-Mentor, OH
5,909
6,066
5,458
7,023
6,487
Columbus, OH
4,058
4,445
4,549
5,428
6,027
Dallas-Fort Worth-Arlington, TX
12,536
14,641
13,466
17,251
20,125
Denver-Aurora, CO
5,558
6,122
5,827
7,020
7,824
Detroit-Warren-Livonia, MI
17,145
16,172
13,096
13,580
18,826
Hartford-WestHartford-East Hartford, CT
2,331
2,842
2,786
3,122
3,474
Houston-Baytown-Sugar Land, TX
12,258
11,539
12,178
14,170
17,287
Indianapolis, IN
5,167
5,949
5,596
5,808
6,352
Jacksonville, FL
3,759
4,021
4,273
4,627
5,392
Kansas City, MO-KS
5,993
5,930
5,791
6,231
7,115
Las Vegas-Paradise, NV
3,820
4,319
5,014
5,620
5,842
Los Angeles-Long Beach-Santa Ana, CA
32,903
36,044
35,826
36,520
38,100
Louisville, KY-IN
1,817
2,232
2,344
2,482
3,504
Memphis, TN-MS-AR
6,816
7,150
7,935
8,846
9,199
Miami-Fort Lauderdale-Miami Beach, FL
9,610
8,492
9,553
9,985
13,144
Milwaukee-Waukesha-West Allis, WI
7,358
7,558
7,761
7,653
1,116
Minneapolis-St. Paul-Bloomington, MN-WI
5,892
6,022
6,462
6,727
7,037
Nashville-Davidson-Murfreesboro, TN
3,018
3,122
3,413
3,445
3,916
New Orleans-Metairie-Kenner, LA
5,433
3,563
2,673
3,503
3,722
New York-Newark-Edison, NY-NJ-PA
41,039
42,214
45,007
52,815
56,829
Oklahoma City, OK
3,057
3,744
3,394
3,262
4,119
Orlando, FL
3,993
4,667
5,326
5,203
6,160
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD
18,369
18,236
19,813
20,132
20,708
Phoenix-Mesa-Scottsdale, AZ
8,555
9,338
11,859
11,675
10,725
Pittsburgh, PA
4,185
4,398
4,267
4,870
5,092
Portland-Vancouver-Beaverton, OR-WA
3,555
3,816
3,769
4,109
4,468
Providence-New Bedford-Fall River, RI-MA
3,138
3,225
2,967
3,116
3,327
Richmond, VA
3,573
3,425
3,617
3,778
4,981
Riverside-San Bernardino-Ontario, CA
8,252
9,257
9,426
10,773
10,009
Rochester, NY
2,869
2,670
2,890
3,337
3,594
Sacramento-Arden-Arcade-Roseville, CA
5,326
5,890
6,614
6,310
5,997
Salt Lake City, UT
1,501
1,709
1,941
2,299
2,254
San Antonio, TX
6,182
6,105
6,232
6,567
7,206
San Diego-Carlsbad-San Marcos, CA
7,908
8,210
8,620
9,187
10,257
San Francisco-Oakland-Fremont, CA
9,151
9,217
10,418
11,118
11,514
San Jose-Sunnyvale-Santa Clara, CA
4,038
3,752
4,128
4,232
4,218
Seattle-Tacoma-Bellevue, WA
6,775
7,411
6,915
7,412
7,975
St. Louis, MO-IL
9,086
9,804
9,952
10,012
10,166
Tampa-St. Petersburg-Clearwater, FL
4,920
5,184
5,936
6,841
8,099
Virginia Beach-Norfolk-Newport News, VA-NC
5,862
6,016
6,651
6,884
8,789
Washington-Arlington-Alexandria, DC-VA-MD-WV
11,170
10,086
11,722
13,194
14,967
U.S. MSA TOTAL
399,877 414,784 432,983 466,239 501,750
2004
580.4
492.5
662.1
552.6
287.6
616.7
541.9
570.2
484.6
531.6
472.8
440.7
479.3
744.1
381.9
473.1
625.9
600.4
611.3
471.0
504.6
295.1
1,053.0
347.8
945.2
374.8
426.5
791.6
423.4
527.5
424.0
611.6
464.3
334.6
343.2
372.1
601.2
435.4
536.9
519.5
298.1
653.1
542.6
436.4
471.7
427.2
636.1
369.1
704.2
424.8
497.5
2005
524.8
522.7
649.4
657.7
293.8
646.3
631.9
600.4
621.4
548.7
513.4
504.7
521.7
703.4
464.3
437.0
712.5
630.6
598.8
513.8
552.9
360.6
1,098.1
304.2
973.0
380.0
433.4
519.8
435.0
638.7
477.4
605.3
487.7
354.2
363.1
384.3
566.7
474.3
501.5
567.4
334.4
633.1
565.1
439.6
435.6
462.5
683.2
380.8
720.5
378.3
511.3
2006
622.2
699.1
677.9
751.3
311.7
637.8
520.7
633.8
638.2
497.2
520.7
450.4
485.8
572.9
456.5
439.8
660.3
654.9
578.2
573.3
549.2
374.3
1,202.2
340.1
1,004.8
404.3
462.7
503.2
462.7
570.1
531.7
658.0
592.7
346.5
351.7
355.8
590.0
468.5
544.7
629.1
368.8
628.0
590.4
495.3
472.4
423.6
689.2
428.6
789.6
432.7
528.1
2007
582.4
609.2
753.5
900.4
335.2
653.5
407.4
644.2
740.4
645.2
611.1
564.5
572.1
594.5
511.7
504.4
673.8
695.7
616.2
623.0
563.3
392.6
1,332.7
359.0
968.8
417.2
446.5
653.5
543.6
539.5
507.6
668.7
564.2
398.4
376.7
376.8
605.1
528.4
632.2
594.0
425.3
646.8
620.4
525.7
480.4
447.2
691.6
489.4
811.7
485.5
564.1
2008
557.9
760.4
779.4
862.6
367.2
697.6
649.6
687.3
735.7
595.9
678.5
658.5
637.6
824.1
569.4
615.4
736.9
810.8
703.7
647.7
587.7
554.3
1,385.9
472.6
141.3
436.5
507.5
694.3
584.9
681.3
600.9
687.8
518.3
416.6
409.6
402.3
797.8
490.9
680.9
564.5
417.0
709.7
692.7
544.5
478.8
481.2
702.3
579.4
1,036.3
550.7
607.0
92
Chlamydia Tables
Table 8.
Atlanta-Sandy Springs-Marietta, GA
Austin-Round Rock, TX
Baltimore-Towson, MD
Birmingham-Hoover, AL
Boston-Cambridge-Quincy, MA-NH
Buffalo-Cheektowaga-Tonawanda, NY
Charlotte-Gastonia-Concord, NC-SC
Chicago-Naperville-Joliet, IL-IN-WI
Cincinnati-Middletown, OH-KY-IN
Cleveland-Elyria-Mentor, OH
Columbus, OH
Dallas-Fort Worth-Arlington, TX
Denver-Aurora, CO
Detroit-Warren-Livonia, MI
Hartford-WestHartford-East Hartford, CT
Houston-Baytown-Sugar Land, TX
Indianapolis, IN
Jacksonville, FL
Kansas City, MO-KS
Las Vegas-Paradise, NV
Los Angeles-Long Beach-Santa Ana, CA
Louisville, KY-IN
Memphis, TN-MS-AR
Miami-Fort Lauderdale-Miami Beach, FL
Milwaukee-Waukesha-West Allis, WI
Minneapolis-St. Paul-Bloomington, MN-WI
Nashville-Davidson-Murfreesboro, TN
New Orleans-Metairie-Kenner, LA
New York-Newark-Edison, NY-NJ-PA
Oklahoma City, OK
Orlando, FL
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD
Phoenix-Mesa-Scottsdale, AZ
Pittsburgh, PA
Portland-Vancouver-Beaverton, OR-WA
Providence-New Bedford-Fall River, RI-MA
Richmond, VA
Riverside-San Bernardino-Ontario, CA
Rochester, NY
Sacramento-Arden-Arcade-Roseville, CA
Salt Lake City, UT
San Antonio, TX
San Diego-Carlsbad-San Marcos, CA
San Francisco-Oakland-Fremont, CA
San Jose-Sunnyvale-Santa Clara, CA
Seattle-Tacoma-Bellevue, WA
St. Louis, MO-IL
Tampa-St. Petersburg-Clearwater, FL
Virginia Beach-Norfolk-Newport News, VA-NC
Washington-Arlington-Alexandria, DC-VA-MD-WV
U.S. MSA TOTAL
Cases
2004
2005
2006
2007
2008
3,187
3,463
4,574
5,896
5,585
1,093
1,357
2,147
2,053
2,472
1,908
2,139
2,250
2,624
2,754
810
1,005
1,058
1,745
1,740
2,449
2,697
2,762
2,966
3,383
1,167
1,164
1,229
1,260
1,485
770
951
887
786
1,549
8,602 10,075 10,905 10,259
12,578
1,239
1,746
1,691
1,935
1,963
1,904
1,986
1,953
2,285
2,216
1,058
1,377
1,272
1,706
2,275
3,192
3,346
3,558
4,987
5,962
2,210
2,412
2,107
2,519
3,161
4,233
4,256
4,027
4,220
5,996
708
973
1,013
1,178
1,303
2,504
1,930
2,449
2,963
3,776
1,744
2,242
2,167
2,340
2,451
1,258
1,225
1,309
1,873
1,912
2,010
1,970
2,034
2,127
2,444
1,233
1,301
1,576
1,704
1,911
13,208 14,585 14,921 15,639
16,886
572
909
961
1,011
1,436
2,111
2,307
2,289
2,503
2,697
2,171
1,911
2,588
3,771
4,934
2,711
2,804
2,720
2,473
321
2,247
2,491
2,809
2,787
3,056
1,225
1,415
1,497
1,527
1,658
1,327
1,100
676
985
1,349
11,125 15,890 17,301 21,165
23,441
882
1,054
1,233
1,384
1,473
895
1,195
1,252
1,620
2,117
6,915
6,677
7,600
7,972
8,040
2,521
2,646
3,410
3,569
3,586
1,353
1,482
1,522
1,745
1,828
1,701
1,820
1,885
1,861
2,029
1,126
1,085
1,223
1,178
1,222
1,348
1,281
1,423
1,514
1,793
2,654
2,913
3,029
3,532
3,548
1,171
1,180
1,278
1,496
1,700
1,901
2,220
2,431
2,387
2,346
722
933
969
1,096
1,308
1,460
1,942
2,104
2,160
2,527
2,844
3,022
3,134
3,457
4,078
4,370
4,686
5,058
5,465
5,968
1,628
1,575
1,723
1,633
1,558
2,880
3,177
2,863
2,985
3,538
2,770
3,524
3,557
3,698
3,925
1,076
1,131
1,535
2,652
3,050
1,724
2,375
2,481
2,494
3,064
2,848
2,706
3,637
4,849
5,897
124,765 139,651 150,077 168,034 187,289
2004
136.3
151.6
150.0
155.1
114.0
210.4
106.1
186.7
123.4
185.7
126.6
111.8
188.8
193.4
123.3
96.7
219.1
209.9
212.7
146.9
206.2
97.8
350.1
83.5
367.7
145.5
178.0
209.6
123.4
156.2
97.3
247.2
134.6
117.6
165.4
143.3
240.7
139.8
230.9
191.7
140.1
160.9
192.9
212.4
183.9
182.2
207.4
85.7
212.4
113.5
160.9
2005
141.8
183.2
167.0
191.0
125.8
210.8
126.9
217.3
172.6
194.6
163.4
114.6
203.3
194.4
168.9
73.1
278.3
200.6
205.8
149.6
227.7
154.2
378.3
72.6
380.9
159.9
201.5
173.5
175.7
184.7
125.0
237.6
135.7
129.5
174.2
138.5
224.2
148.8
232.9
221.1
178.2
209.8
204.1
227.9
176.2
198.5
262.3
87.9
292.4
106.2
178.2
2006
180.1
277.4
175.8
199.4
127.6
224.4
113.9
233.1
164.6
192.2
149.3
118.0
174.2
184.5
175.1
88.4
264.7
209.3
210.6
174.5
232.2
161.3
372.4
97.5
368.8
178.2
208.6
137.0
190.3
213.7
127.3
269.9
167.3
133.6
176.9
157.0
244.9
150.4
253.1
239.3
179.0
221.5
211.6
243.6
188.7
175.5
263.0
116.9
307.4
140.9
189.2
2007
226.0
251.0
204.1
326.4
136.1
231.7
97.1
218.7
185.7
226.7
197.0
161.5
203.5
193.3
203.5
105.1
280.9
294.6
218.3
182.4
244.7
168.1
405.8
143.3
327.8
174.6
203.7
199.3
232.6
235.2
160.8
283.0
169.1
154.0
171.6
152.2
257.2
172.9
297.6
232.0
195.9
221.5
231.4
261.6
177.0
180.7
272.7
200.0
307.7
187.3
209.9
2008
214.1
302.2
214.2
325.5
155.2
273.0
191.3
268.1
188.4
219.9
262.7
193.0
255.4
274.6
225.0
133.9
294.2
300.7
250.8
204.5
264.2
238.7
437.3
187.5
42.5
191.5
221.1
272.9
257.6
250.3
210.1
285.4
169.9
161.3
187.1
157.9
304.6
173.7
338.2
228.0
233.8
259.1
272.9
285.7
168.8
214.2
289.4
230.0
378.0
227.8
233.9
Chlamydia Tables
93
Table 9.
Rank
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
Cases
46,707
34,257
19,218
17,012
16,983
16,896
15,931
14,373
13,699
13,407
11,682
10,887
9,804
8,964
8,569
8,547
8,421
7,923
7,753
7,572
7,564
7,460
7,360
7,132
7,030
6,982
6,958
6,924
6,264
6,136
6,057
5,837
5,822
5,814
5,764
5,650
5,576
5,567
5,363
5,239
5,203
5,139
5,010
5,002
4,960
4,919
4,883
4,790
4,769
4,722
4,666
4,366
4,298
4,286
Cumulative Percent
3
6
8
9
11
12
13
14
16
17
18
19
19
20
21
22
22
23
24
24
25
25
26
27
27
28
28
29
29
30
30
31
31
32
32
33
33
34
34
35
35
35
36
36
37
37
38
38
38
39
39
39
40
40
94
Chlamydia Tables
Table 10.
Age
Group
Cases
Rates
Male
10.8
453.3
735.1
393.9
187.1
100.7
55.8
22.5
7.1
2.2
145.9
11.2
498.0
800.7
435.4
207.8
110.8
61.0
24.9
8.0
2.6
160.0
11.7
537.9
852.7
466.4
226.0
119.8
66.2
27.3
8.8
2.7
171.7
12.0
611.0
937.8
509.4
248.7
129.9
72.9
31.9
9.7
2.6
189.0
13.9
701.6
1,056.1
565.9
271.7
140.8
78.3
34.4
10.4
2.7
211.7
Female
132.3
2,724.6
2,603.7
1,021.0
369.3
151.1
62.4
22.0
5.9
2.0
481.9
127.0
2,754.5
2,687.8
1,054.8
392.6
161.0
64.9
22.7
6.5
2.3
493.9
122.8
2,824.0
2,791.5
1,104.3
424.1
172.6
70.2
25.2
6.6
2.2
512.0
124.8
2,982.5
2,955.1
1,166.5
465.2
188.3
78.3
28.1
7.7
1.8
540.9
129.9
3,275.8
3,179.9
1,240.6
498.9
205.6
85.8
30.9
8.4
2.1
585.6
2008
Total
70.1
1,559.3
1,641.1
700.6
277.3
125.8
59.1
22.2
6.5
2.1
316.5
67.7
1,597.2
1,713.9
737.9
299.2
135.7
63.0
23.8
7.2
2.4
329.4
65.9
1,651.7
1,789.6
778.3
323.8
146.1
68.2
26.2
7.6
2.4
344.3
67.1
1,766.9
1,914.2
830.2
355.4
158.9
75.6
30.0
8.7
2.1
367.5
70.6
1,956.4
2,084.0
895.3
383.6
173.0
82.1
32.6
9.4
2.3
401.3
2007
Female
13,646
275,036
264,749
97,667
37,406
15,839
7,229
4,649
892
420
718,527
12,924
282,302
273,643
103,347
38,964
16,809
7,458
4,902
1,021
483
742,892
12,364
293,392
284,763
111,809
41,252
18,184
7,919
5,533
1,077
469
777,675
12,378
312,169
300,815
119,938
44,785
19,816
8,625
6,261
1,311
395
827,443
12,883
342,875
323,696
127,550
48,027
21,633
9,457
6,874
1,430
458
895,771
2006
Male
1,172
48,209
79,410
39,374
19,353
10,647
6,397
4,602
993
335
210,935
1,200
53,734
86,931
44,712
21,102
11,700
6,940
5,203
1,169
402
233,553
1,238
58,820
93,035
49,369
22,558
12,763
7,410
5,818
1,334
424
253,236
1,251
67,247
101,782
54,889
24,633
13,838
7,992
6,881
1,531
417
280,931
1,450
77,226
114,615
60,985
26,911
15,004
8,585
7,437
1,642
432
314,752
2005
Total
14,817
323,246
344,159
137,041
56,759
26,486
13,626
9,251
1,885
755
929,462
14,124
336,036
360,574
148,059
60,065
28,509
14,397
10,105
2,191
885
976,445
13,601
352,212
377,798
161,178
63,810
30,947
15,329
11,351
2,411
894
1,030,911
13,629
379,416
402,597
174,826
69,417
33,654
16,617
13,141
2,842
812
1,108,374
14,333
420,101
438,311
188,535
74,939
36,637
18,041
14,311
3,073
889
1,210,523
2004
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
ChlamydiaReported cases and rates per 100,000 population by age group and sex:
United States, 20042008
NOTE: This table should be used only for age comparisons. If age was not specified, cases were prorated according to the distribution of cases for which age
was known. Differences between total cases from this table and others in the report are due to different reporting formats. The 0 to 9 year age group is not shown
because some of these cases may not be due to sexual transmission; however, they are included in the totals.
Chlamydia Tables
95
2004
African-American,
Non-Hispanic
Age White, Non-Hispanic
Group Total Male Female Total Male Female
1014
1519
2024
2529
3034
3539
4044
4554
5564
2005
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
2006
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
2007
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
2008
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
3,199
95,195
109,590
37,871
13,869
6,553
3,815
2,543
593
253
273,854
2,986
93,876
114,066
40,477
14,600
7,143
3,986
2,875
657
253
281,268
2,732
97,442
120,835
46,643
16,327
8,102
4,253
3,296
796
285
301,064
2,586
102,471
127,025
50,642
17,687
9,118
4,626
3,916
924
279
319,675
2,686
110,221
135,198
54,253
19,540
9,742
5,016
4,245
1,007
303
342,555
122
9,468
22,268
10,560
4,596
2,748
1,947
1,360
363
116
53,669
126
9,636
24,303
11,580
4,739
3,024
2,045
1,639
408
123
57,709
84
10,379
26,260
13,506
5,518
3,265
2,131
1,792
474
147
63,675
96
11,768
27,910
14,958
5,926
3,531
2,243
2,225
574
171
69,524
143
13,270
30,684
16,559
6,668
3,833
2,464
2,362
606
181
76,880
3,076
85,727
87,322
27,311
9,273
3,806
1,868
1,182
231
137
220,186
2,860
84,240
89,763
28,897
9,861
4,119
1,941
1,236
250
130
223,559
2,648
87,063
94,575
33,137
10,809
4,837
2,122
1,504
322
139
237,389
2,490
90,703
99,114
35,684
11,761
5,587
2,383
1,691
350
108
250,151
2,543
96,951
104,514
37,694
12,872
5,910
2,552
1,883
401
122
265,675
8,504
157,398
149,743
58,590
24,171
11,323
5,900
4,190
790
281
421,608
7,355
153,777
142,156
57,704
23,142
10,768
5,662
4,032
791
345
406,423
8,187
180,893
164,045
67,691
26,296
12,686
6,436
5,049
943
337
473,235
8,301
199,686
181,659
75,660
29,957
14,181
7,190
5,955
1,196
318
524,817
8,714
223,088
199,298
81,611
31,778
15,044
7,619
6,374
1,277
331
575,822
759
28,143
38,420
18,657
9,671
5,277
3,148
2,322
444
140
107,202
723
30,214
39,355
19,824
9,740
5,300
3,148
2,338
467
168
111,513
891
36,692
45,448
23,107
11,044
6,367
3,639
2,901
588
177
131,077
894
42,634
52,169
26,692
12,456
7,024
3,983
3,440
688
157
150,384
1,020
49,101
58,689
29,326
13,256
7,438
4,128
3,655
743
155
167,755
7,745
129,255
111,322
39,933
14,499
6,047
2,753
1,868
346
140
314,407
6,631
123,563
102,801
37,879
13,402
5,468
2,515
1,693
324
177
294,910
7,296
144,201
118,597
44,584
15,253
6,319
2,797
2,148
355
161
342,159
7,407
157,052
129,490
48,967
17,501
7,158
3,207
2,515
508
162
374,433
7,694
173,987
140,609
52,286
18,522
7,607
3,491
2,718
534
175
408,067
Total
Hispanic
2,152
49,457
59,885
29,424
13,326
5,927
2,532
1,416
292
118
164,762
2,069
52,224
64,259
31,795
14,349
6,539
2,656
1,674
334
141
176,271
2,088
58,312
71,991
36,568
16,281
7,570
3,211
1,938
392
176
198,783
2,139
60,919
73,166
37,779
16,772
7,721
3,366
2,183
430
145
204,855
2,380
68,593
80,714
40,786
18,211
8,912
3,923
2,427
457
161
226,793
Asian/Pacific
Islander
Male
Female Total
222
7,769
13,482
7,409
3,572
1,777
829
501
118
37
35,786
183
8,526
14,772
8,528
4,132
2,001
908
575
123
53
39,885
233
9,483
16,675
9,968
4,596
2,319
1,157
695
157
56
45,432
214
10,273
17,063
10,367
4,754
2,438
1,214
800
138
56
47,389
235
12,020
19,741
11,731
5,355
2,765
1,418
915
175
54
54,487
1,929
41,688
46,403
22,014
9,754
4,150
1,703
915
174
81
128,976
1,886
43,698
49,487
23,267
10,217
4,538
1,748
1,100
211
87
136,386
1,856
48,829
55,316
26,600
11,685
5,251
2,054
1,242
234
119
153,351
1,925
50,647
56,103
27,412
12,018
5,283
2,152
1,383
292
89
157,467
2,144
56,573
60,973
29,056
12,855
6,147
2,505
1,513
282
108
172,306
135
3,900
6,232
3,159
1,863
967
499
471
88
27
17,358
112
3,761
6,315
3,107
1,849
1,057
559
443
148
35
17,408
98
3,387
5,836
3,206
1,876
998
633
486
133
26
16,701
125
3,919
6,127
3,661
1,948
1,144
649
510
181
31
18,310
94
4,187
6,888
4,073
2,191
1,306
633
614
210
53
20,274
American Indian/
Alaska Native
130
3,415
4,941
2,357
1,361
643
335
294
62
17
13,568
98
3,115
4,899
2,211
1,211
720
346
286
101
17
13,020
95
2,974
4,707
2,381
1,354
706
437
296
86
12
13,061
119
3,364
4,895
2,720
1,368
775
395
317
105
17
14,087
86
3,643
5,419
2,997
1,525
873
394
365
142
31
15,493
266
5,551
5,820
2,614
1,209
646
332
265
40
19
16,787
332
5,964
6,148
2,829
1,177
625
345
240
50
15
17,762
309
6,259
6,646
3,103
1,421
709
413
271
64
28
19,267
249
5,801
6,212
2,992
1,299
638
371
249
30
12
17,872
215
6,397
6,912
3,434
1,436
708
392
328
51
20
19,917
Male Female
31
776
1,176
549
287
161
90
82
8
7
3,174
24
882
1,295
715
270
181
92
82
21
4
3,571
18
1,016
1,309
708
329
171
106
82
16
6
3,773
17
909
1,281
651
319
152
108
71
8
5
3,525
14
1,003
1,443
790
344
169
124
83
11
9
3,997
236
4,774
4,644
2,065
922
486
242
183
33
12
13,613
309
5,082
4,853
2,114
906
444
254
158
30
12
14,191
290
5,243
5,337
2,395
1,092
538
307
189
48
22
15,493
232
4,893
4,930
2,342
979
486
263
178
22
7
14,348
201
5,394
5,468
2,643
1,093
539
268
245
40
11
15,920
NOTE: These tables should be used only for race/ethnicity comparisons. See Table 10 for age-specific cases and rates and Tables 35 for total and sex-specific
cases and rates. If age or race/ethnicity was not specified, cases were prorated according to the distribution of cases for which these variables were specified. For
the following years the states listed did not report age and/or race/ethnicity for most cases and their case data and population denominators were excluded: 2004
(CO, DC, NJ); 2005 (CO, DC, GA, HI, NJ); 2006 (CO, HI); 2007 (CO, HI); 2008 (CO, HI). Differences between total cases from this table and others in the report are due to
different reporting formats and above listed exclusions. The 0 to 9 year age group is not shown because some of these cases may not be due to sexual transmission;
however they are included in the totals.
96
Chlamydia Tables
Table 11 B. ChlamydiaRates per 100,000 population by race/ethnicity, age group and sex:
United States, 20042008
White, NonAfrican-American,
Asian/Pacific
American Indian/
Hispanic
Non-Hispanic
Hispanic
Islander
Alaska Native
Age
Group Total Male Female Total Male Female Total Male Female Total Male Female Total Male Female
65+
TOTAL
65+
TOTAL
65+
TOTAL
65+
TOTAL
65+
TOTAL
46.3
1,840.6
2,673.0
1,553.3
813.6
442.3
249.9
110.6
37.3
12.9
638.4
48.7
2,073.2
2,927.8
1,722.3
911.8
487.3
272.4
116.9
39.8
16.0
709.9
54.7
2,195.4
2,980.0
1,705.6
926.6
514.6
280.4
126.3
42.5
14.8
733.3
56.4
2,509.0
3,400.4
1,905.9
1,049.4
565.5
312.6
146.7
47.6
12.9
832.6
64.3
2,889.5
3,825.4
2,093.9
1,116.9
598.8
323.9
155.9
51.4
12.8
928.8
487.3
8,687.4
7,762.9
3,093.3
1,098.2
452.0
192.0
76.4
23.4
8.0
1,704.8
460.9
8,716.3
7,754.4
3,101.1
1,133.5
450.1
191.5
72.8
22.3
10.5
1,712.6
462.2
8,858.2
7,942.6
3,105.1
1,153.6
453.7
189.1
80.1
20.6
8.4
1,741.8
482.4
9,490.0
8,632.6
3,343.1
1,332.9
512.7
220.8
91.9
28.2
8.3
1,887.3
501.0
10513.4
9,373.9
3,569.7
1,410.6
544.8
240.3
99.3
29.7
9.0
2,056.9
59.8
12.1
109.8
1,562.2
474.9 2,725.0
1,677.8
686.3 2,891.6
794.8
361.4 1,332.5
381.1
189.7
604.4
191.9
108.1
287.2
93.0
58.5
130.3
37.3
26.3
48.4
14.0
11.8
15.9
5.8
4.3
6.8
421.4 177.1 682.4
57.2
9.9
106.8
1,613.2
511.2 2,784.1
1,854.2
782.9 3,134.6
855.5
414.0 1,404.5
409.4
219.0
631.4
208.5
119.9
309.5
95.5
62.6
131.2
42.2
28.7
55.9
15.1
11.7
18.2
6.6
5.9
7.1
444.5 194.9 710.5
54.2
11.8
98.6
1,646.6
519.5 2,845.8
1,964.5
838.3 3,301.5
900.9
440.4 1,481.2
424.6
220.7
666.9
219.1
125.8
325.9
105.0
72.1
141.3
43.9
31.1
57.0
15.8
13.2
18.1
7.5
5.6
8.8
459.2 203.0 733.6
55.2
10.8
101.7
1,664.0
544.9 2,852.4
2,030.1
882.8 3,356.8
928.1
457.4 1,519.3
430.7
223.9
678.4
216.9
128.2
318.6
107.5
73.8
145.0
47.0
33.9
60.6
16.3
10.9
21.4
5.9
5.4
6.3
461.0 206.4 733.3
61.4
11.9
113.3
1,873.6
637.5 3,186.2
2,239.5 1,021.4 3,648.2
1,002.0
517.6 1,610.3
467.6
252.3
725.6
250.3
145.4
370.8
125.3
86.2
168.8
52.3
38.8
66.2
17.4
13.8
20.7
6.6
5.1
7.6
510.4 237.3 802.5
16.6
475.0
658.5
294.5
153.2
89.7
49.4
27.7
8.3
2.5
139.8
14.8
492.4
727.6
307.6
159.6
100.7
58.6
27.5
14.4
3.6
148.4
11.7
402.3
627.9
288.6
146.1
82.5
58.7
26.8
11.2
2.4
127.2
14.8
461.4
681.1
334.4
155.0
90.7
59.2
27.4
14.5
2.7
137.1
11.1
493.0
765.7
372.0
174.4
103.6
57.8
33.1
16.8
4.6
151.9
1.2
114.9
269.6
152.1
84.3
61.7
33.7
22.3
5.2
2.1
62.9
3.6
164.2
321.8
180.5
112.7
65.9
46.1
20.9
10.0
4.4
77.0
0.7
95.2
238.5
151.1
83.3
49.5
37.5
22.3
8.6
3.0
57.0
1.5
126.7
268.5
174.1
94.5
60.0
47.7
21.9
13.2
2.8
65.0
2.0
124.2
319.9
199.0
108.6
70.3
45.0
28.4
11.8
4.5
73.6
32.9
856.3
1,056.5
432.4
219.2
116.4
64.1
32.4
11.0
2.9
212.3
26.7
840.9
1,144.8
430.5
204.4
133.7
70.2
33.4
18.2
3.0
215.9
23.2
729.3
1,032.1
421.5
206.2
113.9
78.8
30.8
13.5
2.0
193.6
28.5
817.8
1,111.3
490.9
212.8
120.0
70.2
32.4
15.6
2.7
205.4
20.6
885.7
1,230.4
541.0
237.2
135.3
70.0
37.3
21.1
4.7
225.9
119.7
2,467.3
2,790.5
1,541.8
734.2
389.7
180.0
83.8
20.5
11.1
699.9
157.4
2,665.3
2,920.5
1,635.7
738.5
390.9
193.8
75.5
24.8
8.8
747.0
149.4
2,748.8
3,066.6
1,696.7
889.7
434.9
232.5
81.9
29.7
14.9
790.1
125.3
2,547.7
2,843.3
1,579.4
809.4
390.0
214.6
73.7
13.1
6.0
725.7
108.3
2,809.3
3,163.6
1,812.3
895.0
432.9
227.0
97.0
22.3
9.9
808.8
27.2
677.8
1,113.2
641.3
350.3
196.4
100.9
54.0
8.0
9.9
268.8
22.1
775.9
1,215.3
817.9
340.3
229.4
106.0
54.2
21.2
4.8
305.3
17.6
879.6
1,187.9
767.3
411.4
211.8
121.8
52.3
15.5
7.4
314.5
17.1
789.2
1,153.4
680.4
397.4
187.6
127.7
43.8
7.4
6.1
291.0
14.1
870.6
1,299.2
826.5
427.6
208.3
146.9
51.7
9.7
9.9
330.0
214.2
4,323.7
4,512.3
2,459.7
1,115.4
578.0
254.4
111.0
31.9
11.9
1,117.9
295.9
4,617.5
4,669.1
2,472.6
1,135.0
548.5
276.6
94.9
28.1
11.8
1,174.6
284.7
4,672.9
5,008.6
2,642.2
1,368.0
653.6
338.0
108.8
42.6
20.7
1,250.8
236.6
4,346.9
4,592.0
2,495.6
1,222.6
589.3
297.5
100.7
18.2
5.8
1,146.4
205.2
4,792.6
5,092.9
2,817.1
1,364.0
654.2
303.3
138.1
33.8
9.8
1,272.1
2008
1014
1519
2024
2529
3034
3539
4044
4554
5564
263.3
5,217.4
5,215.0
2,351.1
963.4
447.4
219.1
92.2
29.6
9.9
1,196.6
251.4
5,348.8
5,324.4
2,432.2
1,028.3
467.7
229.3
93.1
30.1
12.6
1,234.3
255.3
5,483.0
5,435.0
2,425.6
1,046.0
482.4
231.8
101.4
30.3
10.9
1,261.3
266.0
5,953.3
5,987.0
2,640.6
1,198.3
537.5
263.7
117.2
36.8
10.1
1,384.7
279.2
6,651.0
6,568.4
2,848.3
1,271.2
570.2
279.4
125.4
39.3
10.4
1,519.3
2007
1014
1519
2024
2529
3034
3539
4044
4554
5564
51.5
1,402.3
1,425.4
491.8
154.7
58.2
24.4
8.0
2.1
0.8
226.7
50.5
1,412.8
1,508.7
524.5
176.8
66.2
26.7
8.5
2.2
0.8
236.7
44.9
1,374.9
1,508.7
550.9
189.4
73.1
28.4
9.7
2.6
0.8
236.6
43.1
1,435.6
1,583.1
581.4
209.6
85.7
33.0
10.8
2.8
0.6
248.9
44.0
1,534.5
1,669.3
614.1
229.4
90.6
35.4
12.0
3.2
0.7
264.4
2006
1014
1519
2024
2529
3034
3539
4044
4554
5564
1.9
146.7
350.5
186.4
75.6
41.7
25.5
9.4
3.4
1.0
57.4
2.1
153.2
391.5
206.5
83.9
48.1
28.2
11.5
3.8
1.0
63.4
1.4
155.4
398.9
221.9
95.6
49.0
28.6
11.7
4.1
1.2
65.9
1.6
176.7
423.8
240.4
104.4
53.7
31.2
14.5
4.8
1.3
71.8
2.3
199.3
465.9
266.2
117.5
58.3
34.2
15.3
5.0
1.4
79.4
2005
1014
1519
2024
2529
3034
3539
4044
4554
5564
26.0
757.4
878.2
337.6
114.9
49.9
24.9
8.7
2.7
0.9
143.6
25.6
766.1
938.3
364.1
130.1
57.1
27.4
10.0
3.0
0.9
151.7
22.5
748.9
940.2
385.5
142.2
61.0
28.5
10.7
3.3
1.0
152.8
21.8
789.6
988.8
409.8
156.7
69.6
32.1
12.6
3.7
0.9
162.0
22.6
849.3
1,052.4
439.0
173.1
74.4
34.8
13.7
4.1
1.0
173.6
2004
1014
1519
2024
2529
3034
3539
4044
4554
5564
NOTE: These tables should be used only for race/ethnicity comparisons. See Table 10 for age-specific cases and rates and Tables 35 for total and sex-specific
cases and rates. If age or race/ethnicity was not specified, cases were prorated according to the distribution of cases for which these variables were specified. For
the following years the states listed did not report age and/or race/ethnicity for most cases and their case data and population denominators were excluded: 2004
(CO, DC, NJ); 2005 (CO, DC, GA, HI, NJ); 2006 (CO, HI); 2007 (CO, HI); 2008 (CO, HI). Differences between total rates from this table and others in the report are due to
different reporting formats and above listed exclusions. The 0 to 9 year age group is not shown because some of these cases may not be due to sexual transmission;
however they are included in the totals.
Chlamydia Tables
97
Table 12.
GonorrheaReported cases and rates by state, ranked by rates: United States, 2008
Rank*
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
State
Mississippi
Louisiana
South Carolina
Alabama
North Carolina
Georgia
Michigan
Illinois
Arkansas
Ohio
Oklahoma
Tennessee
Indiana
Missouri
Texas
Virginia
Florida
Delaware
Maryland
U.S. TOTAL
Wisconsin
Kentucky
Pennsylvania
New York
Nevada
Alaska
Nebraska
Kansas
Connecticut
Colorado
New Mexico
California
New Jersey
Minnesota
Iowa
Arizona
Washington
Hawaii
South Dakota
West Virginia
Massachusetts
Oregon
Rhode Island
Wyoming
North Dakota
YEAR 2010 TARGET
Utah
Montana
Idaho
New Hampshire
Maine
Vermont
Cases
7,494
9,455
9,442
9,740
15,972
16,272
17,064
20,674
4,514
16,803
5,185
8,780
8,769
8,014
32,199
10,337
23,326
1,045
6,666
336,742
6,087
4,548
11,071
17,108
2,172
578
1,460
2,274
2,801
3,757
1,403
25,787
5,298
3,037
1,700
3,449
3,127
610
375
746
2,129
1,225
307
124
143
477
122
187
100
96
37
* States were ranked in descending order by rate, number of cases, and alphabetically by state.
Total includes cases reported by the District of Columbia with 2,656 cases and a rate of 451.5, but excludes outlying areas (Guam with 109 cases and rate of 62.8,
Puerto Rico with 273 cases and rate of 6.9, and Virgin Islands with 120 cases and rate of 109.3).
98
Gonorrhea Tables
Table 13.
State/Area
2004
Alabama
8,206
Alaska
567
Arizona
4,065
Arkansas
4,137
30,155
California
Colorado
3,054
Connecticut
2,862
Delaware
894
District of Columbia
2,568
18,580
Florida
Georgia
15,783
Hawaii
1,193
Idaho
103
Illinois
20,597
6,851
Indiana
Iowa
1,249
Kansas
2,542
Kentucky
2,758
Louisiana
10,538
Maine
210
Maryland
8,297
Massachusetts
3,057
Michigan
17,376
Minnesota
2,957
Mississippi
7,163
Missouri
9,218
Montana
88
Nebraska
1,147
Nevada
3,078
New Hampshire
133
New Jersey
6,696
New Mexico
1,306
New York
18,737
North Carolina
15,194
North Dakota
110
Ohio
20,467
Oklahoma
4,453
Oregon
1,302
Pennsylvania
11,236
Rhode Island
816
South Carolina
9,171
South Dakota
304
Tennessee
8,475
Texas
24,371
Utah
603
Vermont
86
Virginia
8,565
Washington
2,810
West Virginia
892
Wisconsin
5,053
Wyoming
59
U.S. TOTAL
330,132
Northeast
43,833
Midwest
87,871
South
150,045
West
48,383
Guam
114
Puerto Rico
267
Virgin Islands
75
OUTLYING AREAS
456
TOTAL
330,588
2005
9,406
600
4,951
4,476
34,338
3,224
2,750
913
2,146
20,225
15,860
1,024
119
20,019
8,094
1,606
2,605
2,935
9,572
142
7,035
2,537
17,684
3,482
7,171
9,455
158
1,158
2,880
177
5,722
1,552
17,717
15,072
128
20,985
5,228
1,562
11,222
438
8,561
351
8,605
26,110
727
60
8,346
3,739
770
5,869
87
339,593
40,765
91,436
152,431
54,961
106
328
30
464
340,057
Cases
2006
10,665
630
5,949
4,306
33,740
3,695
2,610
1,485
1,887
23,976
19,669
885
206
20,186
8,732
1,966
2,210
3,277
10,883
137
7,328
2,429
15,677
3,303
7,511
10,204
194
1,433
2,791
180
5,492
1,733
17,459
17,312
153
19,190
4,951
1,461
11,466
508
10,320
367
9,694
30,449
888
72
6,476
4,231
953
6,927
120
358,366
40,353
90,348
171,142
56,523
98
302
34
434
358,800
2007
10,885
579
5,062
4,168
31,294
3,376
2,327
1,293
2,373
23,327
17,835
659
269
20,813
8,790
1,928
2,282
3,449
11,137
118
6,768
2,695
15,482
3,459
8,314
9,876
122
1,434
2,357
138
6,076
1,796
17,697
16,666
116
21,066
4,827
1,236
12,706
402
10,326
261
9,564
32,073
821
64
6,269
3,653
930
6,752
81
355,991
42,223
92,259
170,204
51,305
141
323
69
533
356,524
2008
9,740
578
3,449
4,514
25,787
3,757
2,801
1,045
2,656
23,326
16,272
610
187
20,674
8,769
1,700
2,274
4,548
9,455
96
6,666
2,129
17,064
3,037
7,494
8,014
122
1,460
2,172
100
5,298
1,403
17,108
15,972
143
16,803
5,185
1,225
11,071
307
9,442
375
8,780
32,199
477
37
10,337
3,127
746
6,087
124
336,742
38,947
86,400
168,377
43,018
109
273
120
502
337,244
Gonorrhea Tables
2004
181.1
86.5
70.8
150.3
84.0
66.4
81.7
107.7
463.9
106.8
178.8
94.5
7.4
162.0
109.8
42.3
92.9
66.5
233.4
15.9
149.3
47.6
171.8
58.0
246.7
160.2
9.5
65.6
131.8
10.2
77.0
68.6
97.5
177.9
17.3
178.6
126.4
36.2
90.6
75.5
218.5
39.4
143.6
108.4
25.2
13.8
114.8
45.3
49.1
91.7
11.6
112.4
80.3
133.7
141.6
71.8
68.6
6.9
68.9
10.9
111.0
2006
231.9
94.0
96.5
153.2
92.5
77.7
74.5
174.0
324.5
132.5
210.1
68.8
14.0
157.3
138.3
65.9
80.0
77.9
253.8
10.4
130.5
37.7
155.3
63.9
258.1
174.6
20.5
81.0
111.8
13.7
62.9
88.7
90.4
195.5
24.1
167.2
138.3
39.5
92.2
47.6
238.8
46.9
160.5
129.5
34.8
11.5
84.7
66.2
52.4
124.7
23.3
119.7
73.7
136.4
156.9
81.5
57.3
7.7
31.3
10.3
118.2
2007
235.2
84.7
79.9
147.0
85.6
69.4
66.4
149.5
403.4
127.8
186.9
51.3
17.9
161.9
138.5
64.5
82.2
81.3
259.4
9.0
120.5
41.8
153.7
66.5
284.8
168.0
12.7
80.8
91.9
10.5
70.0
91.2
91.7
183.9
18.1
183.7
133.4
33.0
102.2
38.0
234.3
32.8
155.3
134.2
31.0
10.3
81.3
56.5
51.3
120.5
15.5
118.0
77.2
139.0
154.1
73.2
81.2
8.2
62.8
12.6
116.6
2008
210.5
84.6
54.4
159.2
70.5
77.3
80.0
120.8
451.5
127.8
170.5
47.5
12.5
160.9
138.2
56.9
81.9
107.2
220.2
7.3
118.6
33.0
169.4
58.4
256.8
136.3
12.7
82.3
84.7
7.6
61.0
71.2
88.7
176.3
22.4
146.5
143.3
32.7
89.0
29.0
214.2
47.1
142.6
134.7
18.0
6.0
134.0
48.3
41.2
108.7
23.7
111.6
71.2
130.1
152.4
61.4
62.8
6.9
109.3
11.9
110.3
99
Table 14.
State/Area
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
U.S. TOTAL
Northeast
Midwest
South
West
Guam
Puerto Rico
Virgin Islands
OUTLYING AREAS
TOTAL
2004
3,673
337
1,787
2,032
13,620
1,656
1,756
508
1,293
9,371
8,119
680
42
11,510
3,550
736
1,565
1,415
5,450
84
4,327
1,531
9,614
1,712
4,362
5,139
54
656
1,417
54
3,607
749
9,720
7,384
72
11,144
2,471
567
6,295
478
5,007
178
4,327
12,433
266
53
4,650
1,229
470
2,953
39
172,142
23,578
48,829
77,292
22,443
70
150
48
268
172,410
2005
4,494
349
2,338
2,252
15,827
1,619
1,590
515
1,029
10,204
7,819
619
57
10,998
4,453
885
1,645
1,530
4,761
61
3,620
1,320
10,161
1,909
4,234
5,334
102
688
1,343
97
3,077
884
9,031
7,545
76
11,592
3,018
661
6,271
227
4,601
196
4,395
13,827
319
26
4,402
1,622
427
3,433
54
177,537
21,700
51,370
78,673
25,794
71
194
18
283
177,820
Cases
2006
5,983
356
2,847
2,182
15,688
1,879
1,478
829
808
12,427
10,002
476
113
10,926
4,806
1,179
1,327
1,709
5,605
54
3,850
1,214
8,900
1,814
4,400
5,752
123
865
1,257
97
2,829
1,003
8,479
8,718
86
10,508
2,780
609
6,219
273
5,406
215
5,104
15,619
369
39
3,287
1,938
488
4,047
71
187,033
20,682
50,425
89,197
26,729
49
152
23
224
187,257
2007
6,095
326
2,342
2,275
14,533
1,807
1,372
699
1,077
11,793
9,334
295
152
11,312
4,884
1,121
1,401
1,887
5,822
45
3,529
1,282
8,984
1,930
4,901
5,481
75
847
1,066
63
3,059
974
8,324
8,941
66
11,771
2,606
564
6,945
169
5,640
153
5,247
16,192
345
30
3,369
1,858
504
4,066
41
187,594
21,289
52,016
89,911
24,378
66
165
51
282
187,876
2008
5,582
321
1,577
2,520
11,625
1,978
1,686
606
1,259
12,279
8,687
298
90
11,342
5,056
1,024
1,459
2,511
5,177
43
3,604
1,100
10,047
1,657
4,357
4,542
92
891
1,012
49
2,813
783
8,349
8,876
93
9,784
2,964
553
6,210
135
5,704
247
4,801
17,029
137
19
5,847
1,522
425
3,744
71
182,577
20,404
49,886
92,228
20,059
58
128
86
272
182,849
2004
157.4
106.5
62.3
144.7
75.8
72.6
97.4
119.3
443.1
105.6
181.9
107.5
6.0
177.9
112.0
49.1
113.6
67.0
234.7
12.5
150.9
46.3
186.9
66.6
291.9
174.6
11.6
74.2
123.7
8.2
80.8
77.4
98.0
170.0
22.7
189.6
138.6
31.4
98.5
85.4
232.6
45.9
143.5
110.1
22.4
16.8
122.7
39.5
50.6
106.1
15.5
115.4
83.9
146.1
143.4
66.6
86.0
7.4
84.4
12.4
114.0
2006
252.5
110.0
92.4
152.3
86.0
79.6
82.2
188.7
261.6
135.0
210.4
74.1
15.5
167.7
150.0
78.1
95.3
79.7
254.5
8.0
132.8
36.6
173.6
69.8
293.1
192.5
26.1
97.0
102.5
14.6
63.4
101.3
85.2
193.1
27.2
178.7
153.2
32.7
97.3
49.5
243.8
54.9
165.3
132.4
29.1
12.3
84.6
60.4
52.6
144.8
28.0
123.1
73.5
150.0
160.7
77.2
58.4
7.4
40.5
10.3
121.5
2007
255.5
99.2
74.0
157.4
79.5
75.0
76.4
156.9
347.2
127.0
192.4
46.3
20.4
173.5
151.7
74.1
100.1
87.2
263.7
6.7
121.7
38.6
175.7
74.0
325.6
182.3
15.7
94.6
84.7
9.5
68.9
97.6
83.8
193.0
20.7
200.3
142.4
29.9
108.8
31.0
249.5
38.3
166.5
135.2
26.3
9.5
85.8
57.2
54.5
144.3
15.9
122.6
75.8
154.4
160.0
69.7
77.5
8.0
88.3
12.9
121.1
2008
234.0
97.7
49.8
174.3
63.6
82.0
93.9
136.0
405.9
132.3
179.1
46.7
12.1
174.0
157.1
67.7
104.2
116.1
234.5
6.4
124.3
33.1
196.5
63.5
289.5
151.0
19.2
99.5
80.4
7.4
63.4
78.4
84.0
191.6
29.2
166.5
162.0
29.3
97.3
24.7
252.3
61.8
152.4
142.2
10.5
6.0
148.9
46.9
46.0
132.9
27.5
119.4
72.7
148.1
164.1
57.3
68.1
6.2
149.0
12.4
117.8
NOTE: Cases reported with unknown sex are not included in this table.
100
Gonorrhea Tables
Table 15.
State/Area
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
U.S. TOTAL
Northeast
Midwest
South
West
Guam
Puerto Rico
Virgin Islands
OUTLYING AREAS
TOTAL
2004
4,526
230
2,274
2,104
16,440
1,398
1,106
386
1,269
9,209
7,596
513
60
9,087
3,270
511
977
1,338
5,029
126
3,969
1,524
7,762
1,245
2,801
4,079
33
488
1,658
79
3,089
557
8,985
7,810
38
9,046
1,982
735
4,941
338
4,136
126
4,148
11,902
337
33
3,904
1,581
421
2,087
20
157,303
20,221
38,716
72,530
25,836
44
117
27
188
157,491
2005
4,892
251
2,610
2,223
18,348
1,605
1,160
398
1,113
10,021
7,885
405
60
9,020
3,616
721
960
1,399
4,744
81
3,410
1,216
7,468
1,573
2,937
4,121
56
467
1,535
80
2,645
668
8,680
7,527
52
9,035
2,210
901
4,950
211
3,925
155
4,209
12,269
408
34
3,939
2,117
343
2,431
33
161,117
19,057
39,619
73,444
28,997
35
134
12
181
161,298
Cases
2006
4,678
274
3,097
2,122
17,856
1,816
1,132
656
1,072
11,546
9,510
409
92
9,260
3,895
787
883
1,561
5,186
83
3,461
1,212
6,738
1,489
3,111
4,452
71
552
1,533
83
2,657
730
8,976
8,594
67
8,493
2,171
852
5,247
235
4,899
152
4,590
14,812
519
33
3,187
2,293
465
2,870
49
170,508
19,658
39,638
81,621
29,591
49
150
11
210
170,718
2007
4,786
253
2,718
1,890
16,632
1,569
955
594
1,284
11,527
8,401
364
112
9,501
3,880
807
881
1,559
5,201
73
3,238
1,412
6,447
1,529
3,413
4,395
47
583
1,291
75
3,014
822
9,363
7,725
50
9,164
2,221
672
5,758
232
4,665
107
4,317
15,819
476
34
2,895
1,795
426
2,673
40
167,685
20,916
40,017
79,961
26,791
75
158
18
251
167,936
2008
4,151
257
1,869
1,993
14,025
1,777
1,113
439
1,383
10,995
7,465
312
97
9,331
3,693
676
815
2,030
4,233
53
3,054
1,026
6,876
1,380
3,135
3,472
29
568
1,160
51
2,483
619
8,751
7,023
50
6,693
2,212
672
4,860
172
3,712
128
3,979
15,150
340
18
4,477
1,600
321
2,332
53
153,103
18,527
36,014
75,752
22,810
51
145
34
230
153,333
2004
206.1
67.9
79.1
156.0
91.8
60.2
65.1
95.4
484.9
108.0
174.0
81.4
8.6
145.5
106.6
35.1
71.9
65.8
229.2
19.6
147.5
49.1
156.2
49.2
198.8
145.1
7.1
56.5
139.5
12.3
72.9
59.5
96.6
186.0
12.0
162.1
113.9
41.1
82.2
64.8
202.2
32.9
143.7
106.3
28.1
10.8
106.3
51.1
47.4
76.5
7.8
108.8
76.4
119.8
139.3
76.7
51.9
6.3
52.0
9.4
107.5
2006
209.8
79.1
100.4
154.0
98.0
75.9
66.3
158.4
393.2
130.0
206.2
63.6
12.5
146.6
125.2
53.4
64.4
75.7
248.6
12.8
127.4
38.9
135.6
58.0
220.7
156.0
15.0
63.0
120.8
12.8
62.3
75.7
95.9
198.0
21.0
151.7
123.0
46.3
86.8
45.5
232.9
38.9
155.5
126.4
40.5
10.7
84.8
71.9
52.2
104.0
18.8
115.6
73.9
121.5
152.3
85.3
56.2
8.0
21.2
10.4
114.2
2007
213.5
71.3
85.7
136.0
91.0
64.0
55.9
141.7
461.7
128.5
179.0
56.4
14.8
150.0
124.1
54.7
64.0
75.0
249.4
11.4
119.1
45.2
130.0
59.1
241.4
153.1
9.8
66.3
98.8
11.6
70.9
84.6
100.0
174.5
15.6
163.9
124.3
36.1
95.2
45.3
217.3
27.0
143.6
132.6
35.6
11.1
76.5
55.7
48.0
96.0
15.1
112.8
78.6
122.4
147.4
76.3
84.9
8.3
34.6
12.3
111.4
2008
185.1
72.4
58.9
143.5
76.7
72.5
65.2
104.7
497.3
122.6
159.0
48.3
12.9
147.3
118.1
45.8
59.2
97.7
203.0
8.2
112.3
32.8
138.6
53.3
221.8
120.9
6.0
64.6
88.8
7.9
58.4
63.7
93.5
158.6
15.6
119.7
123.7
36.1
80.3
33.6
172.9
32.3
132.4
127.0
25.5
5.9
118.3
49.6
36.2
83.8
20.0
103.0
69.6
110.1
139.6
65.0
57.7
7.7
65.3
11.3
101.8
NOTE: Cases reported with unknown sex are not included in this table.
Gonorrhea Tables
101
Table 16.
Atlanta-Sandy Springs-Marietta, GA
Austin-Round Rock, TX
Baltimore-Towson, MD
Birmingham-Hoover, AL
Boston-Cambridge-Quincy, MA-NH
Buffalo-Cheektowaga-Tonawanda, NY
Charlotte-Gastonia-Concord, NC-SC
Chicago-Naperville-Joliet, IL-IN-WI
Cincinnati-Middletown, OH-KY-IN
Cleveland-Elyria-Mentor, OH
Columbus, OH
Dallas-Fort Worth-Arlington, TX
Denver-Aurora, CO
Detroit-Warren-Livonia, MI
Hartford-WestHartford-East Hartford, CT
Houston-Baytown-Sugar Land, TX
Indianapolis, IN
Jacksonville, FL
Kansas City, MO-KS
Las Vegas-Paradise, NV
Los Angeles-Long Beach-Santa Ana, CA
Louisville, KY-IN
Memphis, TN-MS-AR
Miami-Fort Lauderdale-Miami Beach, FL
Milwaukee-Waukesha-West Allis, WI
Minneapolis-St. Paul-Bloomington, MN-WI
Nashville-Davidson-Murfreesboro, TN
New Orleans-Metairie-Kenner, LA
New York-Newark-Edison, NY-NJ-PA
Oklahoma City, OK
Orlando, FL
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD
Phoenix-Mesa-Scottsdale, AZ
Pittsburgh, PA
Portland-Vancouver-Beaverton, OR-WA
Providence-New Bedford-Fall River, RI-MA
Richmond, VA
Riverside-San Bernardino-Ontario, CA
Rochester, NY
Sacramento-Arden-Arcade-Roseville, CA
Salt Lake City, UT
San Antonio, TX
San Diego-Carlsbad-San Marcos, CA
San Francisco-Oakland-Fremont, CA
San Jose-Sunnyvale-Santa Clara, CA
Seattle-Tacoma-Bellevue, WA
St. Louis, MO-IL
Tampa-St. Petersburg-Clearwater, FL
Virginia Beach-Norfolk-Newport News, VA-NC
Washington-Arlington-Alexandria, DC-VA-MD-WV
U.S. MSA TOTAL
Cases
2004
2005
2006
2007
2008
7,355
7,838
10,223
9,060
8,084
1,472
1,706
2,446
2,075
2,388
5,256
4,779
4,653
4,156
4,146
2,377
2,381
2,444
3,129
2,891
1,998
1,684
1,542
1,770
1,464
1,670
1,926
2,068
2,289
1,898
2,998
3,330
3,388
2,388
3,249
15,684
14,857
15,127
14,979
16,181
3,455
3,927
3,862
4,583
3,926
4,472
4,641
4,663
4,286
2,770
3,004
3,445
3,303
4,136
3,853
7,119
8,416
8,365
10,064
9,197
2,232
2,147
2,253
2,238
2,625
9,299
10,766
8,535
8,554
10,850
933
993
988
920
1,029
5,525
5,213
7,318
7,757
7,290
3,510
4,142
4,410
4,543
4,194
2,197
2,578
2,954
3,113
2,979
3,832
3,769
3,822
3,683
3,268
2,645
2,487
2,478
2,112
1,918
11,103
12,697
12,210
11,059
9,832
1,484
1,551
1,749
1,908
2,300
3,832
3,782
4,665
4,756
4,475
4,622
4,497
5,356
5,152
5,471
3,311
4,031
5,006
4,960
446
2,439
2,920
2,780
2,834
2,345
1,602
1,474
1,734
1,692
1,541
3,316
2,609
1,962
2,713
2,045
16,915
15,533
14,949
15,396
15,116
2,153
2,548
2,315
2,373
2,403
2,285
2,848
3,393
2,743
2,704
7,818
7,719
8,163
8,669
7,724
3,161
3,133
4,260
3,333
2,211
1,799
2,157
2,057
2,599
2,569
1,173
1,393
1,128
1,053
1,033
1,048
650
693
621
455
2,160
2,361
1,778
2,199
2,698
2,631
3,012
2,994
3,166
2,199
1,900
1,899
1,457
1,207
1,345
2,066
2,450
2,235
2,315
1,771
371
460
623
573
346
2,183
2,300
2,701
2,601
3,113
2,379
2,695
2,767
2,385
2,066
4,967
5,713
6,029
5,695
5,065
1,084
1,055
1,065
893
712
1,883
2,704
3,079
2,572
2,182
5,719
6,391
6,547
6,483
5,003
2,801
2,910
3,667
3,819
3,852
3,812
3,355
2,544
2,504
4,935
5,803
4,497
4,358
4,665
5,557
194,853 202,369 209,106 208,773 197,714
2004
156.2
104.2
199.2
219.6
45.2
144.7
203.3
167.0
167.9
209.3
177.3
124.9
95.8
207.0
78.8
106.7
216.5
179.3
199.0
160.2
85.9
123.6
306.5
86.2
218.4
78.3
114.8
251.3
90.4
188.1
122.7
134.8
85.1
74.9
56.8
64.3
187.1
69.4
182.4
102.4
36.4
117.7
81.1
119.6
62.2
59.5
206.9
108.2
231.8
112.9
123.4
2005
159.4
117.5
180.0
218.4
38.2
167.8
218.9
157.3
189.7
218.3
201.6
144.6
91.0
239.9
83.6
98.7
252.5
206.5
193.5
145.4
98.2
128.3
299.9
82.9
266.4
92.9
103.6
197.7
82.9
220.3
147.3
132.6
81.1
90.4
66.5
40.1
200.8
77.0
182.8
120.0
44.5
121.7
91.9
137.6
60.1
84.4
230.0
109.9
203.7
86.2
126.9
2006
199.0
161.6
175.0
222.2
34.6
181.8
214.0
159.1
183.5
220.6
191.4
139.3
93.5
191.0
83.1
132.1
264.7
231.1
194.3
139.4
94.3
143.1
366.0
98.0
331.5
87.6
119.2
191.5
79.4
197.5
170.9
140.1
105.5
86.8
52.8
43.0
148.9
74.4
140.7
108.1
58.3
139.1
94.1
144.2
59.6
94.3
234.1
135.9
154.2
82.4
129.6
2007
171.6
129.8
155.8
282.3
39.5
202.9
144.6
157.3
214.8
204.4
235.8
163.8
90.8
191.5
77.4
137.8
268.0
239.3
185.5
115.0
85.9
154.7
371.4
95.2
321.2
88.3
111.2
263.3
81.8
198.9
135.0
148.7
79.7
110.3
48.4
38.8
181.3
77.6
117.1
110.7
52.1
130.7
80.2
135.5
49.5
77.7
231.2
140.2
151.0
87.9
128.3
2008
153.1
149.4
155.4
260.9
32.7
168.2
196.7
169.9
184.0
132.1
219.6
149.7
106.5
242.9
86.5
129.5
247.4
229.0
164.6
104.4
76.4
186.4
349.5
101.1
28.9
73.1
101.3
198.5
80.3
201.4
133.0
132.5
52.9
109.1
47.5
28.4
222.4
53.9
130.5
84.7
31.5
156.4
69.4
120.5
39.5
65.9
178.4
141.4
297.5
104.7
121.5
102
Gonorrhea Tables
Table 17.
Atlanta-Sandy Springs-Marietta, GA
Austin-Round Rock, TX
Baltimore-Towson, MD
Birmingham-Hoover, AL
Boston-Cambridge-Quincy, MA-NH
Buffalo-Cheektowaga-Tonawanda, NY
Charlotte-Gastonia-Concord, NC-SC
Chicago-Naperville-Joliet, IL-IN-WI
Cincinnati-Middletown, OH-KY-IN
Cleveland-Elyria-Mentor, OH
Columbus, OH
Dallas-Fort Worth-Arlington, TX
Denver-Aurora, CO
Detroit-Warren-Livonia, MI
Hartford-WestHartford-East Hartford, CT
Houston-Baytown-Sugar Land, TX
Indianapolis, IN
Jacksonville, FL
Kansas City, MO-KS
Las Vegas-Paradise, NV
Los Angeles-Long Beach-Santa Ana, CA
Louisville, KY-IN
Memphis, TN-MS-AR
Miami-Fort Lauderdale-Miami Beach, FL
Milwaukee-Waukesha-West Allis, WI
Minneapolis-St. Paul-Bloomington, MN-WI
Nashville-Davidson-Murfreesboro, TN
New Orleans-Metairie-Kenner, LA
New York-Newark-Edison, NY-NJ-PA
Oklahoma City, OK
Orlando, FL
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD
Phoenix-Mesa-Scottsdale, AZ
Pittsburgh, PA
Portland-Vancouver-Beaverton, OR-WA
Providence-New Bedford-Fall River, RI-MA
Richmond, VA
Riverside-San Bernardino-Ontario, CA
Rochester, NY
Sacramento-Arden-Arcade-Roseville, CA
Salt Lake City, UT
San Antonio, TX
San Diego-Carlsbad-San Marcos, CA
San Francisco-Oakland-Fremont, CA
San Jose-Sunnyvale-Santa Clara, CA
Seattle-Tacoma-Bellevue, WA
St. Louis, MO-IL
Tampa-St. Petersburg-Clearwater, FL
Virginia Beach-Norfolk-Newport News, VA-NC
Washington-Arlington-Alexandria, DC-VA-MD-WV
U.S. MSA TOTAL
Cases
2004
2005
2006
2007
2008
3,563
3,567
5,026
4,515
3,967
692
830
1,134
992
1,177
2,710
2,426
2,470
2,179
2,302
1,060
1,133
1,511
1,761
1,655
937
793
728
773
720
920
1,079
1,153
1,258
1,059
1,413
1,604
1,584
1,188
1,697
8,546
7,948
7,853
7,813
8,594
2,038
2,274
2,465
2,884
2,696
2,192
2,264
2,277
2,180
1,469
1,475
1,896
1,758
2,142
2,062
3,547
4,135
4,129
4,905
4,953
1,144
996
1,044
1,128
1,345
4,850
6,079
4,613
4,721
6,226
533
520
521
522
609
2,813
3,016
3,806
3,805
3,749
1,698
2,163
2,297
2,385
2,290
1,083
1,240
1,506
1,532
1,587
2,027
2,035
2,099
2,040
1,888
1,206
1,163
1,123
954
880
4,997
5,687
5,657
5,001
4,214
720
740
887
1,026
1,228
1,926
1,990
2,548
2,789
2,472
2,307
2,317
2,708
2,444
2,661
1,906
2,298
2,923
2,972
300
1,373
1,548
1,486
1,500
1,210
742
661
794
800
783
1,606
1,287
965
1,322
984
8,821
7,784
7,015
6,979
7,089
1,181
1,486
1,275
1,202
1,294
1,063
1,286
1,688
1,377
1,424
4,189
4,219
4,257
4,416
4,098
1,373
1,456
2,014
1,497
988
1,063
1,216
1,174
1,530
1,524
491
551
436
446
420
607
365
374
282
209
1,187
1,256
824
1,122
1,436
1,323
1,572
1,602
1,705
1,237
919
1,006
748
608
744
1,049
1,307
1,164
1,190
917
143
183
246
229
88
1,109
1,155
1,412
1,279
1,557
936
1,108
1,158
961
803
1,580
2,052
2,122
2,174
1,863
467
457
488
385
312
717
1,060
1,300
1,205
965
3,213
3,638
3,718
3,539
2,756
1,474
1,542
2,064
1,973
2,006
1,990
1,717
1,305
1,355
2,875
2,973
2,269
2,048
2,268
2,711
97,892 102,374 105,497 105,253 102,093
2005
144.1
116.6
176.5
200.9
35.0
181.2
207.8
165.3
214.8
204.8
219.0
142.6
84.9
264.4
85.0
114.2
259.1
194.5
205.5
138.4
87.2
119.6
305.6
83.0
295.8
97.7
91.8
187.8
80.2
253.5
131.6
140.0
76.0
97.9
52.4
43.5
207.8
80.5
188.9
125.9
35.8
119.8
76.3
97.9
53.1
66.1
253.5
113.3
205.6
85.1
126.2
2006
193.5
153.3
179.2
265.4
31.8
195.5
196.9
162.7
229.0
207.4
201.2
138.1
87.0
201.8
85.4
137.5
271.1
230.8
209.6
128.4
86.7
141.6
386.0
96.4
378.4
93.0
107.6
181.7
72.1
214.2
168.5
141.4
100.7
95.3
40.7
44.9
134.4
79.6
141.0
110.7
46.7
142.3
79.3
100.9
55.8
79.6
257.5
149.0
154.9
75.6
128.7
2007
169.1
127.1
157.6
307.0
33.6
215.3
141.1
161.7
264.2
200.3
241.1
160.5
91.9
206.7
85.6
135.5
276.7
230.4
201.8
105.8
77.1
162.3
420.2
87.9
376.2
93.0
103.7
246.6
71.8
198.8
134.3
146.7
72.3
125.2
40.9
34.1
179.7
83.6
115.2
112.0
42.4
126.0
64.9
102.8
43.7
72.7
244.5
141.1
159.8
83.5
127.3
2008
148.5
150.8
166.5
288.5
31.3
181.3
201.6
177.8
247.0
135.0
232.1
162.1
109.6
272.5
99.8
133.5
265.7
238.6
186.7
97.6
65.0
194.2
372.4
95.7
38.0
75.0
101.5
183.6
73.0
214.0
138.9
136.1
47.7
124.7
38.5
25.3
230.0
60.7
141.0
86.3
16.3
153.3
54.2
88.1
35.4
58.2
190.4
143.5
339.0
99.8
123.5
Gonorrhea Tables
103
Table 18.
Atlanta-Sandy Springs-Marietta, GA
Austin-Round Rock, TX
Baltimore-Towson, MD
Birmingham-Hoover, AL
Boston-Cambridge-Quincy, MA-NH
Buffalo-Cheektowaga-Tonawanda, NY
Charlotte-Gastonia-Concord, NC-SC
Chicago-Naperville-Joliet, IL-IN-WI
Cincinnati-Middletown, OH-KY-IN
Cleveland-Elyria-Mentor, OH
Columbus, OH
Dallas-Fort Worth-Arlington, TX
Denver-Aurora, CO
Detroit-Warren-Livonia, MI
Hartford-WestHartford-East Hartford, CT
Houston-Baytown-Sugar Land, TX
Indianapolis, IN
Jacksonville, FL
Kansas City, MO-KS
Las Vegas-Paradise, NV
Los Angeles-Long Beach-Santa Ana, CA
Louisville, KY-IN
Memphis, TN-MS-AR
Miami-Fort Lauderdale-Miami Beach, FL
Milwaukee-Waukesha-West Allis, WI
Minneapolis-St. Paul-Bloomington, MN-WI
Nashville-Davidson-Murfreesboro, TN
New Orleans-Metairie-Kenner, LA
New York-Newark-Edison, NY-NJ-PA
Oklahoma City, OK
Orlando, FL
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD
Phoenix-Mesa-Scottsdale, AZ
Pittsburgh, PA
Portland-Vancouver-Beaverton, OR-WA
Providence-New Bedford-Fall River, RI-MA
Richmond, VA
Riverside-San Bernardino-Ontario, CA
Rochester, NY
Sacramento-Arden-Arcade-Roseville, CA
Salt Lake City, UT
San Antonio, TX
San Diego-Carlsbad-San Marcos, CA
San Francisco-Oakland-Fremont, CA
San Jose-Sunnyvale-Santa Clara, CA
Seattle-Tacoma-Bellevue, WA
St. Louis, MO-IL
Tampa-St. Petersburg-Clearwater, FL
Virginia Beach-Norfolk-Newport News, VA-NC
Washington-Arlington-Alexandria, DC-VA-MD-WV
U.S. MSA TOTAL
2004
3,750
768
2,546
1,316
1,060
750
1,583
7,122
1,375
2,236
1,509
3,560
1,088
4,449
400
2,707
1,808
1,114
1,805
1,436
6,084
761
1,906
2,315
1,405
1,066
860
1,684
8,063
972
1,222
3,629
1,787
736
682
441
971
1,308
981
1,002
228
1,073
1,417
3,367
617
1,166
2,506
1,327
1,816
2,822
96,596
2005
4,183
870
2,352
1,243
890
847
1,726
6,900
1,616
2,329
1,531
4,276
1,151
4,657
473
2,194
1,972
1,338
1,734
1,322
6,985
811
1,792
2,180
1,731
1,372
813
1,299
7,744
1,062
1,562
3,500
1,676
941
842
285
1,105
1,440
893
1,123
277
1,145
1,500
3,644
597
1,644
2,753
1,368
1,636
2,220
99,544
Cases
2006
2007
2008
5,083
4,484
4,054
1,310
1,081
1,208
2,180
1,976
1,841
932
1,367
1,235
812
996
742
913
1,031
839
1,804
1,199
1,542
7,267
7,161
7,586
1,373
1,674
1,224
2,366
2,091
1,295
1,537
1,985
1,788
4,230
5,123
4,243
1,209
1,110
1,278
3,890
3,786
4,502
467
398
418
3,504
3,930
3,525
2,106
2,150
1,902
1,448
1,581
1,392
1,723
1,643
1,380
1,354
1,158
1,038
6,505
6,023
5,543
858
881
1,070
2,117
1,967
2,003
2,648
2,706
2,801
2,080
1,975
145
1,294
1,334
1,135
940
892
758
981
1,352
1,050
7,929
8,406
8,017
1,040
1,171
1,103
1,704
1,366
1,277
3,904
4,250
3,626
2,242
1,834
1,222
883
1,069
1,045
692
607
611
318
338
246
954
1,074
1,261
1,390
1,450
961
709
599
601
1,046
1,098
835
377
344
258
1,289
1,322
1,556
1,531
1,415
1,254
3,882
3,493
3,179
570
506
398
1,779
1,367
1,216
2,829
2,944
2,247
1,602
1,842
1,822
1,237
1,148
2,058
2,291
2,385
2,823
103,129 103,082 95,153
2005
171.3
117.4
183.6
236.2
41.5
153.4
230.4
148.8
159.7
228.2
181.6
146.5
97.0
212.7
82.1
83.1
244.8
219.1
181.1
152.0
109.1
137.6
293.9
82.9
235.2
88.1
115.8
204.9
85.6
186.1
163.4
124.5
85.9
82.2
80.6
36.4
193.4
73.5
176.3
111.8
52.9
123.7
101.3
177.2
66.8
102.7
204.9
106.3
201.4
87.1
127.0
2006
200.1
169.2
170.3
175.6
37.5
166.7
231.7
155.4
133.6
232.8
180.4
140.3
100.0
178.2
80.7
126.4
257.3
231.5
178.4
149.9
101.2
144.0
344.4
99.7
282.0
82.1
131.0
198.8
87.2
180.2
173.3
138.6
110.0
77.5
64.9
40.8
164.2
69.0
140.4
103.0
69.6
135.7
103.4
186.9
62.4
109.1
209.2
122.0
153.3
88.8
130.0
2007
171.9
132.2
153.7
255.7
45.7
189.6
148.1
152.6
160.6
207.4
229.2
165.9
89.7
173.4
68.7
139.4
258.1
248.7
168.6
123.9
94.2
146.5
318.9
102.8
261.8
83.6
119.0
273.5
92.4
199.0
135.6
150.9
86.9
94.3
56.0
43.7
182.4
71.0
119.2
106.7
61.5
135.5
94.7
167.2
54.8
82.7
217.1
138.9
141.6
92.1
128.8
2008
155.4
147.7
143.2
231.0
34.0
154.3
190.4
161.7
117.5
128.5
206.5
137.4
103.2
206.2
72.2
125.0
228.3
218.9
141.6
111.1
86.7
177.9
324.8
106.4
19.2
71.1
101.1
212.4
88.1
187.5
126.8
128.7
57.9
92.2
56.4
31.8
214.2
47.0
119.6
81.2
46.1
159.5
83.9
152.2
43.1
73.6
165.7
137.4
253.9
109.0
118.8
104
Gonorrhea Tables
Table 19.
Rank
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
Cases
13,227
9,081
8,959
6,164
5,137
4,950
3,971
3,849
3,666
3,313
3,185
3,181
2,944
2,940
2,932
2,661
2,656
2,629
2,604
2,478
2,472
2,345
2,323
2,158
2,128
2,121
2,120
2,116
2,099
2,092
2,075
2,066
2,043
2,023
1,952
1,918
1,890
1,884
1,873
1,731
1,662
1,642
1,569
1,505
1,500
1,480
1,471
1,448
1,370
1,315
1,309
1,299
1,298
1,279
1,264
1,232
1,222
1,222
1,210
1,164
1,155
1,154
1,146
1,130
1,091
1,068
1,057
1,056
1,054
1,046
1,028
Cumulative Percent
3
6
9
11
12
14
15
16
17
18
19
20
21
22
23
23
24
25
26
26
27
28
29
29
30
30
31
32
32
33
34
34
35
35
36
36
37
38
38
39
39
40
40
41
41
41
42
42
43
43
44
44
44
45
45
45
46
46
46
47
47
48
48
48
49
49
49
49
50
50
50
Counties and independent cities were ranked in descending order by number of cases reported in 2008.
NOTE: Milwaukee County was not ranked by case count or rate due to misclassification of 2008 Milwaukee County STD morbidity data.
Gonorrhea Tables
105
Table 20.
2008
2007
2006
2005
2004
Age
Group
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
GonorrheaReported cases and rates per 100,000 population by age group and sex:
United States, 20042008
Total
4,447
87,454
103,187
54,857
30,372
19,793
14,026
12,078
2,653
745
330,132
4,278
90,840
106,280
57,195
30,044
19,948
14,346
12,636
2,777
763
339,593
4,250
96,524
110,969
61,843
31,313
20,674
14,534
13,847
3,137
800
358,366
3,958
98,579
111,788
61,364
30,294
19,094
13,184
13,346
3,179
710
355,991
3,668
97,293
109,005
56,791
27,629
16,419
11,048
11,152
2,629
657
336,742
Cases
Male
630
26,607
45,917
29,520
18,664
13,350
10,220
9,645
2,286
615
157,623
646
27,781
47,187
30,631
18,244
13,413
10,406
10,063
2,399
631
161,557
675
30,119
49,304
32,946
18,858
13,813
10,636
11,064
2,686
648
170,902
623
31,270
49,101
32,296
18,114
12,724
9,704
10,690
2,692
620
168,012
598
30,637
47,053
29,089
16,177
10,615
7,859
8,659
2,203
552
153,599
Female
3,817
60,847
57,269
25,337
11,708
6,443
3,806
2,433
367
130
172,509
3,631
63,060
59,093
26,565
11,800
6,535
3,940
2,573
378
132
178,036
3,574
66,405
61,665
28,897
12,455
6,861
3,898
2,782
451
152
187,464
3,335
67,309
62,687
29,068
12,180
6,370
3,480
2,656
487
89
187,979
3,070
66,656
61,951
27,701
11,452
5,804
3,189
2,493
426
104
183,143
Total
21.0
421.9
492.0
280.4
148.4
94.0
60.8
29.0
9.1
2.1
112.4
20.5
431.8
505.2
285.0
149.6
95.0
62.8
29.7
9.1
2.1
114.6
20.6
452.6
525.6
298.6
158.9
97.6
64.6
32.0
9.9
2.1
119.7
19.5
459.1
531.5
291.4
155.1
90.2
60.0
30.4
9.7
1.9
118.0
18.1
453.1
518.3
269.7
141.4
77.5
50.3
25.4
8.0
1.7
111.6
Rates
Male
5.8
250.2
425.0
295.4
180.5
126.3
89.2
47.2
16.3
4.1
109.1
6.0
257.5
434.6
298.3
179.7
127.0
91.5
48.2
16.4
4.1
110.7
6.4
275.4
451.9
311.3
188.9
129.7
95.0
52.0
17.6
4.1
115.9
6.0
284.1
452.4
299.7
182.9
119.4
88.5
49.5
17.1
3.9
113.0
5.8
278.3
433.6
269.9
163.3
99.6
71.7
40.1
14.0
3.5
103.3
Female
37.0
602.8
563.2
264.9
115.6
61.5
32.8
11.5
2.4
0.6
115.7
35.7
615.3
580.4
271.1
118.9
62.6
34.3
11.9
2.4
0.6
118.4
35.5
639.2
604.5
285.4
128.1
65.1
34.6
12.7
2.8
0.7
123.4
33.6
643.1
615.8
282.7
126.5
60.5
31.6
11.9
2.9
0.4
122.9
31.0
636.8
608.6
269.4
119.0
55.2
28.9
11.2
2.5
0.5
119.7
NOTE: This table should be used only for age comparisons. If age was not specified, cases were prorated according to the distribution of cases for which
age was known. Differences between total cases from this table and others in the report are due to different reporting formats. The 0 to 9 year age group is
not shown because some of these cases may not be due to sexual transmission; however, they are included in the totals.
106
Gonorrhea Tables
107
2008
2007
2006
2005
2004
African-American,
Non-Hispanic
Age White, Non-Hispanic
Male Female
Group Total Male Female Total
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
678
15,369
19,129
10,539
6,751
5,276
4,021
3,341
831
219
66,250
691
15,758
20,892
11,681
6,790
5,384
4,255
3,535
853
242
70,209
596
16,038
21,590
12,907
6,948
5,570
4,231
3,952
1,019
269
73,200
477
15,620
20,828
12,481
6,516
4,984
3,680
3,786
1,010
275
69,753
448
14,141
19,542
11,213
5,692
3,967
2,987
3,158
804
270
62,306
44
2,546
5,909
4,237
3,459
3,277
2,713
2,487
695
174
25,585
35
2,679
6,509
4,667
3,405
3,256
2,863
2,668
721
203
27,050
53
2,612
6,684
5,147
3,313
3,281
2,800
2,875
836
226
27,848
20
2,700
6,344
4,997
3,006
2,778
2,451
2,808
833
244
26,209
37
2,484
5,774
4,326
2,575
2,165
1,946
2,288
671
224
22,518
634
12,822
13,220
6,301
3,293
1,998
1,307
855
136
45
40,665
655
13,079
14,383
7,013
3,385
2,127
1,392
867
132
39
43,159
543
13,426
14,906
7,760
3,636
2,289
1,432
1,077
183
44
45,353
457
12,920
14,485
7,484
3,510
2,206
1,228
979
177
31
43,544
411
11,657
13,768
6,887
3,117
1,802
1,041
870
133
46
39,788
3,336
63,917
73,374
38,013
20,027
12,243
8,710
7,777
1,615
472
229,843
3,154
66,165
73,365
38,213
19,172
12,004
8,606
7,993
1,653
452
231,076
3,227
70,992
77,200
41,339
20,334
12,565
8,798
8,744
1,886
450
245,855
3,066
74,252
79,557
42,001
20,077
11,915
8,238
8,540
1,908
367
250,260
2,847
74,285
78,084
38,706
18,355
10,258
6,725
6,933
1,588
317
238,410
526
21,682
35,351
21,985
13,180
8,667
6,653
6,523
1,457
404
116,537
549
22,563
35,373
22,200
12,540
8,570
6,593
6,667
1,490
386
117,025
549
24,675
37,200
23,863
13,363
9,018
6,831
7,427
1,699
370
125,102
537
25,860
37,666
23,643
12,995
8,578
6,433
7,176
1,680
318
125,010
507
25,450
36,182
21,221
11,619
7,093
5,017
5,642
1,372
281
114,496
2,811
42,234
38,023
16,028
6,847
3,576
2,058
1,253
158
68
113,306
2,604
43,602
37,991
16,013
6,632
3,433
2,012
1,325
163
66
114,050
2,678
46,317
40,000
17,477
6,971
3,547
1,967
1,317
187
80
120,753
2,529
48,392
41,891
18,358
7,082
3,337
1,805
1,364
228
49
125,250
2,340
48,835
41,902
17,486
6,736
3,165
1,708
1,290
215
35
123,915
Hispanic
Total
366
6,908
8,891
5,387
2,956
1,883
1,060
746
159
42
28,455
355
7,299
9,742
5,915
3,248
2,009
1,153
831
191
55
30,845
367
8,055
10,340
6,408
3,340
2,097
1,241
896
172
65
33,044
364
7,536
9,761
5,880
3,120
1,843
1,048
824
196
50
30,676
312
7,651
9,637
5,814
3,016
1,834
1,096
796
168
45
30,412
Male Female
48
318
2,101 4,807
4,017 4,874
2,882 2,505
1,726 1,230
1,178
706
736
324
511
235
116
43
29
14
13,360 15,096
52
304
2,134 5,165
4,438 5,303
3,126 2,790
1,830 1,418
1,270
739
776
377
561
270
134
57
36
19
14,374 16,471
70
297
2,451 5,603
4,739 5,601
3,424 2,985
1,861 1,478
1,270
827
843
398
619
277
116
55
44
21
15,460 17,584
64
300
2,439 5,097
4,544 5,217
3,188 2,692
1,822 1,298
1,170
673
710
339
594
230
133
63
44
6
14,729 15,947
44
268
2,410 5,240
4,454 5,183
3,086 2,727
1,725 1,291
1,149
685
751
345
562
233
112
56
32
13
14,339 16,073
Asian/Pacific
Islander
Total
28
475
868
497
384
214
116
103
35
3
2,726
25
606
960
633
405
268
146
118
44
8
3,214
23
556
809
558
365
246
144
125
32
8
2,869
22
498
767
519
354
187
119
114
49
13
2,643
27
529
842
552
322
211
134
162
47
14
2,849
Male
5
115
329
262
200
143
75
61
12
1
1,205
1
176
418
341
281
180
93
79
28
4
1,602
1
125
335
278
207
154
102
69
14
3
1,290
0
122
297
285
207
120
82
64
33
10
1,221
4
130
349
279
169
144
100
111
29
6
1,327
Female
23
359
538
234
184
72
40
42
23
2
1,521
23
430
542
293
124
88
53
39
16
4
1,612
21
431
474
280
157
93
42
56
18
5
1,579
22
376
470
234
146
67
37
50
16
3
1,422
23
399
493
273
153
67
34
51
18
7
1,522
American Indian/
Alaska Native
NOTE: These tables should be used only for race/ethnicity comparisons. See Table 20 for age-specific cases and rates and Tables 1315 for total and sexspecific cases and rates. If age or race/ethnicity was not specified, cases were prorated according to the distribution of cases for which these variables were
specified. In 2005, Hawaii did not report age and/or race/ethnicity for most cases and its case data and population denominators were excluded. Differences
between total cases from this table and others in the report are due to different reporting formats. The 0 to 9 year age group is not shown because some of these
cases may not be due to sexual transmission; however they are included in the totals.
108
Gonorrhea Tables
Table 21 B. GonorrheaRates per 100,000 population by race/ethnicity, age group and sex: United
States, 20042008
African-American,
Asian/Pacific
American Indian/
Non-Hispanic
Hispanic
Islander
Alaska Native
Age White, Non-Hispanic
Group Total Male Female Total Male Female Total Male Female Total Male Female Total Male Female
30.7
1,360.8
2,357.1
1,748.9
1,056.8
690.9
502.7
296.5
116.2
35.1
662.5
32.8
1,376.4
2,333.5
1,692.4
1,024.0
688.7
500.6
294.9
112.7
32.8
658.0
33.5
1,467.6
2,421.0
1,748.0
1,111.7
722.8
522.4
321.3
122.1
30.8
695.1
33.6
1,512.6
2,436.3
1,674.3
1,085.4
684.5
500.9
303.9
115.6
26.0
687.1
31.8
1,488.6
2,340.3
1,502.8
970.5
566.0
390.7
239.0
94.4
23.0
629.4
169.2
2,723.6
2,542.6
1,187.0
494.6
254.4
136.7
48.9
10.1
3.7
586.2
160.2
2,730.3
2,542.0
1,148.5
488.3
246.6
134.3
50.3
9.9
3.5
584.2
168.6
2,829.6
2,663.3
1,209.6
524.0
253.2
132.3
48.8
10.8
4.2
611.3
163.6
2,907.9
2,776.2
1,245.4
536.1
237.6
123.6
49.6
12.6
2.5
627.7
151.4
2,934.6
2,777.0
1,186.2
509.9
225.3
116.9
46.9
11.9
1.8
621.0
9.7
207.3
236.2
137.6
79.9
57.6
36.7
18.5
7.2
2.0
68.9
9.2
211.5
261.7
147.1
85.7
59.4
38.5
19.5
8.1
2.4
72.4
9.3
222.3
275.6
153.9
85.0
59.4
39.7
19.8
6.8
2.7
74.6
9.2
201.2
264.5
140.8
78.1
50.6
32.8
17.3
7.3
2.0
67.4
7.9
204.2
261.2
139.2
75.5
50.4
34.2
16.7
6.2
1.8
66.8
2.5
122.0
193.8
132.9
86.6
67.7
49.1
25.3
11.0
3.1
62.6
2.6
119.9
218.3
139.7
89.3
70.3
49.6
26.1
11.9
3.7
65.3
3.5
131.3
232.6
147.5
87.2
67.3
51.4
27.1
9.6
4.3
67.4
3.1
126.4
229.4
137.1
83.7
60.1
42.2
24.6
10.3
4.1
62.6
2.2
124.9
224.9
132.7
79.2
59.0
44.6
23.3
8.6
3.0
61.0
17.2
298.4
288.0
143.4
72.0
46.1
23.3
11.7
3.7
1.1
75.6
16.1
308.9
314.0
156.5
81.4
46.9
26.3
12.8
4.6
1.5
80.1
15.4
319.2
326.7
162.1
82.4
50.2
26.8
12.4
4.2
1.5
82.2
15.5
280.5
305.1
145.6
71.5
39.7
22.3
9.8
4.5
0.4
72.6
13.8
288.4
303.2
147.5
71.1
40.4
22.7
10.0
4.0
0.9
73.1
3.3
54.7
87.2
43.7
29.5
18.6
10.7
5.7
3.1
0.3
20.7
3.0
73.1
102.5
57.7
31.8
23.2
13.9
6.7
3.9
0.8
25.2
2.6
61.8
82.1
47.5
27.0
19.3
12.5
6.4
2.5
0.6
20.4
2.4
54.8
80.4
44.9
26.8
14.0
10.2
5.7
3.6
1.0
18.5
3.0
58.2
88.3
47.8
24.4
15.9
11.6
8.1
3.5
1.0
20.0
1.2
25.8
65.4
47.0
31.4
25.4
14.5
7.2
2.3
0.3
18.8
0.3
41.2
88.0
63.1
45.1
31.9
18.3
9.6
5.4
1.0
25.8
0.3
27.0
66.8
48.1
31.5
24.7
18.3
7.5
2.3
0.6
18.9
0.0
26.1
61.1
50.0
32.2
18.4
14.4
6.8
5.2
1.8
17.6
0.9
27.7
71.7
48.9
26.3
22.2
17.7
11.8
4.7
1.1
19.1
5.5
85.3
109.4
40.5
27.7
12.1
7.2
4.3
3.9
0.3
22.4
5.8
107.1
117.4
52.4
19.0
14.9
9.9
4.2
2.6
0.7
24.6
4.9
98.7
97.9
46.9
22.8
14.2
7.1
5.5
2.6
0.7
21.9
4.9
85.4
100.5
40.0
21.7
9.8
6.2
4.7
2.2
0.4
19.4
5.2
90.7
105.6
46.7
22.6
9.8
5.7
4.9
2.4
1.0
20.8
16.6
342.3
440.7
243.5
147.4
101.3
61.5
33.8
5.7
4.4
116.5
20.9
367.8
466.7
317.6
189.8
116.5
64.6
28.2
11.3
1.9
131.5
17.1
379.0
473.3
339.5
199.1
115.7
64.7
38.0
12.4
4.3
136.9
14.7
288.5
396.9
250.4
138.6
98.0
55.4
23.6
6.5
2.2
106.0
16.2
294.1
406.7
262.8
148.2
88.8
59.7
29.9
9.4
5.5
110.2
5.8
136.3
295.1
180.3
117.7
100.0
44.2
40.8
6.8
7.6
78.3
7.4
167.5
312.9
238.4
165.9
117.7
49.5
29.5
17.2
1.8
92.1
1.4
214.1
317.3
252.5
139.7
108.4
66.2
45.9
18.2
7.2
98.9
2.7
125.4
226.0
190.3
103.3
93.8
32.1
29.4
11.9
5.0
68.8
5.6
135.5
264.8
183.6
108.9
78.1
52.0
33.5
16.9
10.4
75.0
27.7
556.1
590.4
308.0
177.0
102.5
77.7
27.3
4.7
2.0
153.6
34.7
575.2
625.0
398.8
213.7
115.3
79.0
26.9
5.8
1.9
169.7
33.2
548.9
634.8
428.2
258.6
123.0
63.3
30.9
7.0
2.1
173.7
27.1
455.4
574.3
311.8
174.1
102.2
77.6
18.3
1.5
0.0
142.0
27.2
456.5
554.0
343.7
187.8
99.3
67.0
26.7
2.6
1.6
144.2
2008
98.8
2,032.9
2,449.7
1,457.9
761.0
460.3
308.0
163.2
57.4
15.7
622.5
95.5
2,044.5
2,437.0
1,412.1
742.3
455.3
305.6
163.3
55.7
14.7
619.4
100.0
2,139.5
2,540.8
1,471.2
803.0
474.4
314.8
174.6
60.4
14.4
651.2
97.6
2,200.9
2,604.2
1,455.2
797.3
448.3
300.2
167.0
58.5
11.5
656.0
90.6
2,201.9
2,556.0
1,341.1
728.9
386.0
245.0
135.6
48.6
10.0
625.0
2007
10.1
200.4
207.1
108.6
52.3
29.1
16.2
5.5
1.2
0.3
40.0
10.7
203.6
225.1
118.1
55.9
31.5
17.7
5.5
1.1
0.2
42.4
9.0
208.3
233.2
126.2
62.4
33.9
18.8
6.8
1.5
0.2
44.4
7.8
200.9
226.9
119.2
61.2
33.1
16.7
6.1
1.4
0.2
42.5
7.0
181.3
215.7
109.7
54.4
27.1
14.1
5.4
1.0
0.3
38.8
2006
0.7
37.7
89.3
71.6
54.2
47.3
33.8
16.3
6.3
1.4
26.1
0.5
39.5
97.6
77.2
55.5
47.7
36.5
17.3
6.3
1.6
27.6
0.8
38.4
99.4
82.7
56.1
48.2
36.8
18.4
7.0
1.8
28.3
0.3
39.8
94.3
78.5
51.8
41.3
33.4
17.9
6.8
1.9
26.5
0.6
36.6
85.8
67.9
44.4
32.2
26.5
14.6
5.5
1.7
22.8
2005
5.3
116.8
147.1
89.9
53.3
38.2
25.0
10.9
3.7
0.7
33.2
5.5
119.3
160.0
97.5
55.7
39.7
27.1
11.4
3.6
0.8
35.1
4.8
121.0
164.6
104.3
59.2
41.1
27.8
12.6
4.2
0.9
36.5
3.9
118.2
158.9
98.7
56.5
37.3
25.0
12.0
4.0
0.9
34.7
3.7
107.0
149.1
88.7
49.3
29.6
20.3
10.0
3.2
0.9
31.0
2004
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
NOTE: These tables should be used only for race/ethnicity comparisons. See Table 20 for age-specific cases and rates and Tables 1315 for total and sexspecific cases and rates. If age or race/ethnicity was not specified, cases were prorated according to the distribution of cases for which these variables were
specified. In 2005, Hawaii did not report age and/or race/ethnicity for most cases and its case data and population denominators were excluded. Differences
between total cases from this table and others in the report are due to different reporting formats. The 0 to 9 year age group is not shown because some of these
cases may not be due to sexual transmission; however they are included in the totals.
Gonorrhea Tables
109
Table 22.
All Stages of Syphilis*Reported cases and rates by state/area and region listed in
alphabetical order: United States and outlying areas, 20042008
State/Area
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
U.S. TOTAL
Northeast
Midwest
South
West
Guam
Puerto Rico
Virgin Islands
OUTLYING AREAS
TOTAL
2004
639
15
974
249
4,590
179
169
61
357
2,964
1,589
36
78
1,348
273
36
87
151
1,646
7
1,002
517
806
145
404
269
4
15
254
26
826
251
4,472
747
0
571
168
108
574
104
524
0
804
4,205
78
3
610
336
18
128
6
33,423
6,698
3,678
16,138
6,909
13
1,154
17
1,184
34,607
2005
551
22
792
231
5,340
144
166
35
365
2,888
1,924
57
54
1,608
288
28
88
129
1,239
6
1,005
398
488
208
371
372
7
18
343
33
813
183
3,853
713
1
502
159
109
712
64
549
4
917
4,289
50
1
655
359
18
138
1
33,288
6,046
3,743
16,038
7,461
19
1,223
13
1,255
34,543
Cases
2006
931
25
926
246
6,046
182
197
74
314
2,945
1,933
66
12
1,473
250
68
87
188
1,390
22
1,038
378
384
189
520
430
2
34
389
35
799
237
4,586
962
3
491
251
99
888
71
397
29
1,015
4,956
68
7
701
423
30
170
1
36,958
6,983
3,608
17,891
8,476
13
1,068
5
1,086
38,044
2007
1,006
16
1,245
371
6,323
157
148
63
416
3,918
2,254
58
14
1,220
216
65
97
153
1,808
21
1,170
399
473
186
707
484
8
30
396
52
926
180
4,999
1,093
2
549
216
59
844
76
411
12
1,212
5,506
45
11
736
367
27
170
6
40,921
7,476
3,504
21,067
8,874
37
1,269
5
1,311
42,232
2008
1,187
9
1,394
508
6,909
352
173
59
370
4,585
2,833
68
26
1,565
351
75
125
218
2,024
27
1,088
479
546
265
736
542
10
36
325
41
1,009
189
5,515
998
4
763
257
97
902
55
412
6
1,283
6,336
40
18
789
438
44
187
9
46,277
8,219
4,465
23,727
9,866
45
797
1
843
47,120
2004
14.1
2.3
17.0
9.0
12.8
3.9
4.8
7.3
64.5
17.0
18.0
2.9
5.6
10.6
4.4
1.2
3.2
3.6
36.5
0.5
18.0
8.1
8.0
2.8
13.9
4.7
0.4
0.9
10.9
2.0
9.5
13.2
23.3
8.7
0.0
5.0
4.8
3.0
4.6
9.6
12.5
0.0
13.6
18.7
3.3
0.5
8.2
5.4
1.0
2.3
1.2
11.4
12.3
5.6
15.2
10.2
7.8
29.6
15.6
28.4
11.6
2006
20.2
3.7
15.0
8.8
16.6
3.8
5.6
8.7
54.0
16.3
20.6
5.1
0.8
11.5
4.0
2.3
3.1
4.5
32.4
1.7
18.5
5.9
3.8
3.7
17.9
7.4
0.2
1.9
15.6
2.7
9.2
12.1
23.8
10.9
0.5
4.3
7.0
2.7
7.1
6.7
9.2
3.7
16.8
21.1
2.7
1.1
9.2
6.6
1.6
3.1
0.2
12.3
12.8
5.4
16.4
12.2
7.6
27.2
4.6
25.8
12.5
2007
21.7
2.3
19.6
13.1
17.3
3.2
4.2
7.3
70.7
21.5
23.6
4.5
0.9
9.5
3.4
2.2
3.5
3.6
42.1
1.6
20.8
6.2
4.7
3.6
24.2
8.2
0.8
1.7
15.4
4.0
10.7
9.1
25.9
12.1
0.3
4.8
6.0
1.6
6.8
7.2
9.3
1.5
19.7
23.0
1.7
1.8
9.5
5.7
1.5
3.0
1.1
13.6
13.7
5.3
19.1
12.7
21.3
32.2
4.6
31.0
13.8
2008
25.6
1.3
22.0
17.9
18.9
7.2
4.9
6.8
62.9
25.1
29.7
5.3
1.7
12.2
5.5
2.5
4.5
5.1
47.1
2.0
19.4
7.4
5.4
5.1
25.2
9.2
1.0
2.0
12.7
3.1
11.6
9.6
28.6
11.0
0.6
6.7
7.1
2.6
7.3
5.2
9.3
0.8
20.8
26.5
1.5
2.9
10.2
6.8
2.4
3.3
1.7
15.3
15.0
6.7
21.5
14.1
25.9
20.2
0.9
19.9
15.4
110
Syphilis Tables
Table 23.
Atlanta-Sandy Springs-Marietta, GA
Austin-Round Rock, TX
Baltimore-Towson, MD
Birmingham-Hoover, AL
Boston-Cambridge-Quincy, MA-NH
Buffalo-Cheektowaga-Tonawanda, NY
Charlotte-Gastonia-Concord, NC-SC
Chicago-Naperville-Joliet, IL-IN-WI
Cincinnati-Middletown, OH-KY-IN
Cleveland-Elyria-Mentor, OH
Columbus, OH
Dallas-Fort Worth-Arlington, TX
Denver-Aurora, CO
Detroit-Warren-Livonia, MI
Hartford-WestHartford-East Hartford, CT
Houston-Baytown-Sugar Land, TX
Indianapolis, IN
Jacksonville, FL
Kansas City, MO-KS
Las Vegas-Paradise, NV
Los Angeles-Long Beach-Santa Ana, CA
Louisville, KY-IN
Memphis, TN-MS-AR
Miami-Fort Lauderdale-Miami Beach, FL
Milwaukee-Waukesha-West Allis, WI
Minneapolis-St. Paul-Bloomington, MN-WI
Nashville-Davidson-Murfreesboro, TN
New Orleans-Metairie-Kenner, LA
New York-Newark-Edison, NY-NJ-PA
Oklahoma City, OK
Orlando, FL
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD
Phoenix-Mesa-Scottsdale, AZ
Pittsburgh, PA
Portland-Vancouver-Beaverton, OR-WA
Providence-New Bedford-Fall River, RI-MA
Richmond, VA
Riverside-San Bernardino-Ontario, CA
Rochester, NY
Sacramento-Arden-Arcade-Roseville, CA
Salt Lake City, UT
San Antonio, TX
San Diego-Carlsbad-San Marcos, CA
San Francisco-Oakland-Fremont, CA
San Jose-Sunnyvale-Santa Clara, CA
Seattle-Tacoma-Bellevue, WA
St. Louis, MO-IL
Tampa-St. Petersburg-Clearwater, FL
Virginia Beach-Norfolk-Newport News, VA-NC
Washington-Arlington-Alexandria, DC-VA-MD-WV
U.S. MSA TOTAL
Cases
2004
2005
2006
2007
2008
1,315
1,626
1,641
1,904
2,243
200
193
212
234
344
647
679
642
650
685
117
243
561
483
504
410
339
329
324
383
24
14
42
26
20
154
235
303
301
223
1,296
1,541
1,386
1,116
1,452
54
55
58
77
105
84
52
53
83
127
254
227
229
222
311
1,374
1,495
1,678
1,643
1,780
135
111
141
120
269
679
390
284
339
304
46
57
65
51
71
1,289
1,188
1,570
2,048
2,088
128
134
121
95
189
218
151
165
198
308
101
193
228
268
237
225
300
355
364
299
2,483
3,159
3,594
3,581
3,572
115
102
101
77
91
519
585
612
761
746
1,687
1,444
1,455
1,863
2,408
85
77
100
127
138
125
187
161
170
223
194
189
194
240
277
449
350
352
560
491
4,918
4,318
4,924
5,503
6,097
110
87
116
114
161
267
413
403
583
460
678
583
773
778
812
754
595
757
866
857
32
112
152
122
98
84
94
74
51
64
137
75
92
100
71
85
87
106
129
226
319
399
376
340
452
41
36
90
76
51
64
39
136
117
243
53
35
41
35
35
361
458
473
420
598
356
448
572
788
828
917
719
741
783
1,044
113
121
94
159
156
273
285
356
309
359
189
173
186
252
322
303
326
428
612
680
198
246
245
232
248
896
894
928
1,162
956
25,555 25,859 28,695 31,456 34,706
2004
27.9
14.2
24.5
10.8
9.3
2.1
10.4
13.8
2.6
3.9
15.0
24.1
5.8
15.1
3.9
24.9
7.9
17.8
5.2
13.6
19.2
9.6
41.5
31.5
5.6
4.0
13.9
34.0
26.3
9.6
14.3
11.7
20.3
1.3
4.1
8.4
7.4
8.4
3.9
3.2
5.2
19.5
12.1
22.1
6.5
8.6
6.8
11.7
12.0
17.4
16.2
2005
33.1
13.3
25.6
22.3
7.7
1.2
15.4
16.3
2.7
2.4
13.3
25.7
4.7
8.7
4.8
22.5
8.2
12.1
9.9
17.5
24.4
8.4
46.4
26.6
5.1
6.0
13.3
26.5
23.0
7.5
21.4
10.0
15.4
4.7
4.5
4.6
7.4
10.2
3.5
1.9
3.4
24.2
15.3
17.3
6.9
8.9
6.2
12.3
14.9
17.1
16.2
2006
31.9
14.0
24.1
51.0
7.4
3.7
19.1
14.6
2.8
2.5
13.3
27.9
5.9
6.4
5.5
28.3
7.3
12.9
11.6
20.0
27.8
8.3
48.0
26.6
6.6
5.1
13.3
34.4
26.2
9.9
20.3
13.3
18.7
6.4
3.5
5.7
8.9
9.3
8.7
6.6
3.8
24.4
19.4
17.7
5.3
10.9
6.7
15.9
14.9
17.5
17.8
2007
36.1
14.6
24.4
43.6
7.2
2.3
18.2
11.7
3.6
4.0
12.7
26.7
4.9
7.6
4.3
36.4
5.6
15.2
13.5
19.8
27.8
6.2
59.4
34.4
8.2
5.3
15.8
54.3
29.2
9.6
28.7
13.3
20.7
5.2
2.3
6.2
10.6
8.3
7.4
5.6
3.2
21.1
26.5
18.6
8.8
9.3
9.0
22.5
14.0
21.9
19.3
2008
42.5
21.5
25.7
45.5
8.5
1.8
13.5
15.2
4.9
6.1
17.7
29.0
10.9
6.8
6.0
37.1
11.2
23.7
11.9
16.3
27.7
7.4
58.3
44.5
8.9
7.0
18.2
47.7
32.4
13.5
22.6
13.9
20.5
4.2
2.9
4.4
18.6
11.1
4.9
11.6
3.2
30.0
27.8
24.8
8.6
10.8
11.5
25.0
15.0
18.0
21.3
Syphilis Tables
111
Table 24.
Primary and secondary syphilisReported cases and rates by state, ranked by rates:
United States, 2008
Rank*
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
State
Cases
Louisiana
Alabama
Georgia
Arkansas
Maryland
Tennessee
New York
Mississippi
California
Texas
Florida
Arizona
U.S. TOTAL
Illinois
Missouri
Virginia
Massachusetts
North Carolina
Ohio
Nevada
Washington
Colorado
New Jersey
Oklahoma
Hawaii
New Mexico
Minnesota
South Carolina
Indiana
Kentucky
Pennsylvania
Michigan
Delaware
Vermont
Rhode Island
New Hampshire
Wisconsin
Kansas
Connecticut
Utah
Nebraska
Maine
Montana
West Virginia
Oregon
Wyoming
Iowa
Idaho
YEAR 2010 TARGET
Alaska
South Dakota
North Dakota
707
449
914
206
378
413
1,217
184
2,204
1,405
1,044
317
13,500
554
224
266
216
287
351
77
181
128
226
86
29
44
116
98
140
93
272
210
16
11
18
20
65
30
34
25
15
10
7
13
26
3
16
7
1
1
0
* States were ranked in descending order by rate, number of cases, and alphabetically by state. States with no cases were not ranked.
Total includes cases reported by the District of Columbia with 146 cases and a rate of 24.8, but excludes outlying areas (Guam with 6 cases and rate of 3.5, Puerto
Rico with 167 cases and rate of 4.2, and Virgin Islands with 0 cases and rate of 0.0).
112
Syphilis Tables
Table 25.
Primary and secondary syphilisReported cases and rates by state/area and region
listed in alphabetical order: United States and outlying areas, 20042008
State/Area
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
U.S. TOTAL
Northeast
Midwest
South
West
Guam
Puerto Rico
Virgin Islands
OUTLYING AREAS
TOTAL
2004
165
8
157
47
1,356
63
45
9
69
728
549
8
24
386
60
5
24
47
332
2
380
114
192
27
59
94
4
7
40
5
150
82
727
192
0
237
25
29
118
26
116
0
130
827
13
1
116
150
3
29
3
7,980
1,188
1,061
3,794
1,937
0
182
5
187
8,167
2005
169
9
175
52
1,585
46
58
11
114
724
645
11
20
525
62
9
19
52
278
1
313
125
105
70
49
147
7
4
109
16
133
56
705
274
1
211
44
41
199
24
84
2
217
873
10
1
143
152
3
41
0
8,724
1,262
1,196
4,045
2,221
2
224
1
227
8,951
Cases
2006
319
11
203
77
1,835
69
64
20
116
719
581
18
3
431
93
19
27
73
342
9
300
124
118
47
86
168
1
7
137
13
173
79
736
309
1
184
70
29
264
14
66
13
249
1,064
21
3
190
182
11
68
0
9,756
1,400
1,176
4,592
2,588
3
150
1
154
9,910
2007
380
7
296
122
2,038
57
39
18
178
913
680
9
1
464
54
21
28
56
533
9
345
155
123
59
133
239
8
4
111
30
227
46
1,068
323
1
194
65
18
263
36
91
7
367
1,160
20
10
230
154
6
66
4
11,466
1,837
1,260
5,600
2,769
8
169
0
177
11,643
2008
449
1
317
206
2,204
128
34
16
146
1,044
914
29
7
554
140
16
30
93
707
10
378
216
210
116
184
224
7
15
77
20
226
44
1,217
287
0
351
86
26
272
18
98
1
413
1,405
25
11
266
181
13
65
3
13,500
2,024
1,722
6,705
3,049
6
167
0
173
13,673
Syphilis Tables
2004
3.6
1.2
2.7
1.7
3.8
1.4
1.3
1.1
12.5
4.2
6.2
0.6
1.7
3.0
1.0
0.2
0.9
1.1
7.4
0.2
6.8
1.8
1.9
0.5
2.0
1.6
0.4
0.4
1.7
0.4
1.7
4.3
3.8
2.2
0.0
2.1
0.7
0.8
1.0
2.4
2.8
0.0
2.2
3.7
0.5
0.2
1.6
2.4
0.2
0.5
0.6
2.7
2.2
1.6
3.6
2.9
0.0
4.7
4.6
4.5
2.7
2006
6.9
1.6
3.3
2.7
5.0
1.5
1.8
2.3
19.9
4.0
6.2
1.4
0.2
3.4
1.5
0.6
1.0
1.7
8.0
0.7
5.3
1.9
1.2
0.9
3.0
2.9
0.1
0.4
5.5
1.0
2.0
4.0
3.8
3.5
0.2
1.6
2.0
0.8
2.1
1.3
1.5
1.7
4.1
4.5
0.8
0.5
2.5
2.8
0.6
1.2
0.0
3.3
2.6
1.8
4.2
3.7
1.8
3.8
0.9
3.7
3.3
2007
8.2
1.0
4.7
4.3
5.6
1.2
1.1
2.1
30.3
5.0
7.1
0.7
0.1
3.6
0.9
0.7
1.0
1.3
12.4
0.7
6.1
2.4
1.2
1.1
4.6
4.1
0.8
0.2
4.3
2.3
2.6
2.3
5.5
3.6
0.2
1.7
1.8
0.5
2.1
3.4
2.1
0.9
6.0
4.9
0.8
1.6
3.0
2.4
0.3
1.2
0.8
3.8
3.4
1.9
5.1
4.0
4.6
4.3
0.0
4.2
3.8
2008
9.7
0.1
5.0
7.3
6.0
2.6
1.0
1.9
24.8
5.7
9.6
2.3
0.5
4.3
2.2
0.5
1.1
2.2
16.5
0.8
6.7
3.3
2.1
2.2
6.3
3.8
0.7
0.8
3.0
1.5
2.6
2.2
6.3
3.2
0.0
3.1
2.4
0.7
2.2
1.7
2.2
0.1
6.7
5.9
0.9
1.8
3.4
2.8
0.7
1.2
0.6
4.5
3.7
2.6
6.1
4.3
3.5
4.2
0.0
4.1
4.5
113
Table 26.
State/Area
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
U.S. TOTAL
Northeast
Midwest
South
West
Guam
Puerto Rico
Virgin Islands
OUTLYING AREAS
TOTAL
2004
52
0
42
18
63
7
3
1
4
98
45
0
11
55
6
1
7
6
123
0
92
5
61
3
19
12
1
4
8
0
38
36
32
48
0
61
9
1
16
10
25
0
34
179
3
0
6
6
1
2
1
1,255
104
212
760
179
0
62
3
65
1,320
2005
69
1
49
21
121
2
2
2
11
100
47
0
6
47
10
1
2
3
112
0
88
4
20
2
12
12
1
0
24
0
17
16
28
58
0
40
17
2
34
6
17
0
64
243
1
0
19
5
0
3
0
1,339
91
137
883
228
1
81
0
82
1,421
Cases
2006
116
2
33
35
128
5
2
4
6
98
41
1
2
37
10
6
2
7
123
2
61
7
26
4
36
19
0
1
34
0
12
22
29
67
0
43
19
0
34
0
11
5
73
261
3
0
23
4
1
3
0
1,458
86
156
982
234
1
46
0
47
1,505
2007
143
1
64
50
115
2
2
1
5
153
53
1
1
39
8
3
6
9
209
0
47
10
27
1
35
27
2
0
12
0
16
15
32
60
0
28
24
2
34
2
10
2
113
297
0
0
16
6
2
6
1
1,692
96
147
1,227
222
4
56
0
60
1,752
2008
171
0
56
81
110
3
0
6
7
193
96
7
1
38
16
3
5
14
307
0
77
6
60
5
66
29
1
3
14
0
21
6
52
44
0
63
25
2
21
0
12
1
119
450
1
0
25
5
4
14
2
2,242
100
237
1,697
208
1
29
0
30
2,272
2004
2.2
0.0
1.5
1.3
0.4
0.3
0.2
0.2
1.4
1.1
1.0
0.0
1.6
0.9
0.2
0.1
0.5
0.3
5.3
0.0
3.2
0.2
1.2
0.1
1.3
0.4
0.2
0.5
0.7
0.0
0.9
3.7
0.3
1.1
0.0
1.0
0.5
0.1
0.3
1.8
1.2
0.0
1.1
1.6
0.3
0.0
0.2
0.2
0.1
0.1
0.4
0.8
0.4
0.6
1.4
0.5
0.0
3.1
5.3
3.0
0.9
2006
4.9
0.6
1.1
2.4
0.7
0.2
0.1
0.9
1.9
1.1
0.9
0.2
0.3
0.6
0.3
0.4
0.1
0.3
5.6
0.3
2.1
0.2
0.5
0.2
2.4
0.6
0.0
0.1
2.8
0.0
0.3
2.2
0.3
1.5
0.0
0.7
1.0
0.0
0.5
0.0
0.5
1.3
2.4
2.2
0.2
0.0
0.6
0.1
0.1
0.1
0.0
1.0
0.3
0.5
1.8
0.7
1.2
2.3
0.0
2.2
1.0
2007
6.0
0.3
2.0
3.5
0.6
0.1
0.1
0.2
1.6
1.6
1.1
0.2
0.1
0.6
0.2
0.2
0.4
0.4
9.5
0.0
1.6
0.3
0.5
0.0
2.3
0.9
0.4
0.0
1.0
0.0
0.4
1.5
0.3
1.3
0.0
0.5
1.3
0.1
0.5
0.4
0.4
0.5
3.6
2.5
0.0
0.0
0.4
0.2
0.2
0.2
0.4
1.1
0.3
0.4
2.2
0.6
4.7
2.7
0.0
2.7
1.1
2008
7.2
0.0
1.8
5.6
0.6
0.1
0.0
1.3
2.3
2.1
2.0
1.1
0.1
0.6
0.5
0.2
0.4
0.6
13.9
0.0
2.7
0.2
1.2
0.2
4.4
1.0
0.2
0.3
1.1
0.0
0.5
0.6
0.5
0.9
0.0
1.1
1.4
0.1
0.3
0.0
0.5
0.3
3.8
3.8
0.1
0.0
0.6
0.2
0.4
0.5
0.8
1.5
0.4
0.7
3.0
0.6
1.2
1.4
0.0
1.4
1.5
NOTE: Cases reported with unknown sex are not included in this table.
114
Syphilis Tables
Table 27.
State/Area
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
U.S. TOTAL
Northeast
Midwest
South
West
Guam
Puerto Rico
Virgin Islands
OUTLYING AREAS
TOTAL
2004
113
8
115
29
1,291
56
42
8
65
630
504
8
13
331
54
3
17
41
209
2
288
109
131
24
40
82
3
3
32
5
112
46
695
144
0
176
16
28
102
16
91
0
96
648
10
1
110
144
2
27
2
6,722
1,084
848
3,034
1,756
0
120
2
122
6,844
2005
100
8
125
31
1,463
44
56
9
103
624
598
11
14
478
52
8
17
49
166
1
225
121
85
68
37
135
6
4
85
16
116
40
677
216
1
171
27
39
165
18
67
2
153
630
9
1
124
147
3
38
0
7,383
1,171
1,059
3,162
1,991
1
143
1
145
7,528
Cases
2006
203
9
166
42
1,706
64
62
16
110
621
540
17
1
394
83
13
25
66
219
7
239
117
92
43
50
149
1
6
103
13
161
57
707
242
1
141
51
29
230
14
55
8
176
803
18
3
167
178
10
65
0
8,293
1,314
1,020
3,610
2,349
2
104
1
107
8,400
2007
237
6
230
72
1,921
55
37
17
173
760
626
8
0
425
46
18
22
47
324
9
298
145
96
58
98
212
6
4
99
30
211
31
1,036
263
1
166
41
16
229
34
81
5
254
863
20
10
214
148
4
60
3
9,769
1,741
1,113
4,372
2,543
4
113
0
117
9,886
2008
278
1
261
125
2,092
125
34
10
139
850
818
22
6
516
124
13
25
79
400
10
301
210
150
111
118
195
6
12
63
20
205
38
1,165
243
0
288
61
24
251
18
86
0
294
955
24
11
241
176
9
51
1
11,255
1,924
1,485
5,007
2,839
5
138
0
143
11,398
2004
5.1
2.4
4.0
2.2
7.2
2.4
2.5
2.0
24.8
7.4
11.5
1.3
1.9
5.3
1.8
0.2
1.3
2.0
9.5
0.3
10.7
3.5
2.6
0.9
2.8
2.9
0.6
0.3
2.7
0.8
2.6
4.9
7.5
3.4
0.0
3.2
0.9
1.6
1.7
3.1
4.4
0.0
3.3
5.8
0.8
0.3
3.0
4.7
0.2
1.0
0.8
4.7
4.1
2.6
5.8
5.2
0.0
6.4
3.9
6.1
4.7
2006
9.1
2.6
5.4
3.0
9.4
2.7
3.6
3.9
40.3
7.0
11.7
2.6
0.1
6.2
2.7
0.9
1.8
3.2
10.5
1.1
8.8
3.8
1.9
1.7
3.5
5.2
0.2
0.7
8.1
2.0
3.8
5.9
7.6
5.6
0.3
2.5
2.9
1.6
3.8
2.7
2.6
2.0
6.0
6.9
1.4
1.0
4.4
5.6
1.1
2.4
0.0
5.6
4.9
3.1
6.7
6.8
2.3
5.5
1.9
5.3
5.6
2007
10.6
1.7
7.2
5.2
10.5
2.2
2.2
4.1
62.2
8.5
13.3
1.2
0.0
6.7
1.5
1.2
1.6
2.3
15.5
1.4
11.0
4.6
1.9
2.2
6.9
7.4
1.3
0.5
7.6
4.6
5.0
3.2
11.1
5.9
0.3
3.0
2.3
0.9
3.8
6.6
3.8
1.3
8.4
7.2
1.5
3.3
5.7
4.6
0.5
2.2
1.1
6.6
6.5
3.4
8.1
7.2
4.5
6.0
0.0
5.8
6.6
2008
12.4
0.3
8.2
9.0
11.4
5.1
2.0
2.4
50.0
9.5
17.4
3.4
0.8
8.1
4.0
0.9
1.8
3.8
19.2
1.6
11.1
6.7
3.0
4.3
8.3
6.8
1.3
1.4
4.8
3.1
4.8
3.9
12.4
5.5
0.0
5.2
3.4
1.3
4.1
3.5
4.0
0.0
9.8
8.0
1.8
3.6
6.4
5.5
1.0
1.8
0.4
7.6
7.2
4.5
9.2
8.1
5.7
7.3
0.0
7.0
7.6
NOTE: Cases reported with unknown sex are not included in this table.
Syphilis Tables
115
Table 28.
Atlanta-Sandy Springs-Marietta, GA
Austin-Round Rock, TX
Baltimore-Towson, MD
Birmingham-Hoover, AL
Boston-Cambridge-Quincy, MA-NH
Buffalo-Cheektowaga-Tonawanda, NY
Charlotte-Gastonia-Concord, NC-SC
Chicago-Naperville-Joliet, IL-IN-WI
Cincinnati-Middletown, OH-KY-IN
Cleveland-Elyria-Mentor, OH
Columbus, OH
Dallas-Fort Worth-Arlington, TX
Denver-Aurora, CO
Detroit-Warren-Livonia, MI
Hartford-WestHartford-East Hartford, CT
Houston-Baytown-Sugar Land, TX
Indianapolis, IN
Jacksonville, FL
Kansas City, MO-KS
Las Vegas-Paradise, NV
Los Angeles-Long Beach-Santa Ana, CA
Louisville, KY-IN
Memphis, TN-MS-AR
Miami-Fort Lauderdale-Miami Beach, FL
Milwaukee-Waukesha-West Allis, WI
Minneapolis-St. Paul-Bloomington, MN-WI
Nashville-Davidson-Murfreesboro, TN
New Orleans-Metairie-Kenner, LA
New York-Newark-Edison, NY-NJ-PA
Oklahoma City, OK
Orlando, FL
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD
Phoenix-Mesa-Scottsdale, AZ
Pittsburgh, PA
Portland-Vancouver-Beaverton, OR-WA
Providence-New Bedford-Fall River, RI-MA
Richmond, VA
Riverside-San Bernardino-Ontario, CA
Rochester, NY
Sacramento-Arden-Arcade-Roseville, CA
Salt Lake City, UT
San Antonio, TX
San Diego-Carlsbad-San Marcos, CA
San Francisco-Oakland-Fremont, CA
San Jose-Sunnyvale-Santa Clara, CA
Seattle-Tacoma-Bellevue, WA
St. Louis, MO-IL
Tampa-St. Petersburg-Clearwater, FL
Virginia Beach-Norfolk-Newport News, VA-NC
Washington-Arlington-Alexandria, DC-VA-MD-WV
U.S. MSA TOTAL
2004
508
56
276
33
84
9
46
373
22
40
109
279
55
153
13
235
34
72
35
38
551
38
99
434
19
26
17
101
816
20
69
95
106
22
26
30
11
103
12
19
5
116
138
422
56
138
71
89
50
199
6,368
2005
598
44
244
101
106
7
103
510
24
22
109
305
38
77
14
279
35
50
89
103
806
46
138
395
22
68
34
88
773
23
106
127
113
69
39
28
13
121
6
16
9
129
194
331
44
125
50
85
60
233
7,149
Cases
2006
529
84
213
244
117
18
121
416
13
18
107
320
56
82
23
396
47
41
112
132
945
41
145
369
38
43
40
90
811
24
94
173
157
91
25
18
28
108
14
32
15
136
235
363
52
160
65
110
84
250
7,845
2007 2008
608
765
74
107
211
270
189
188
131
173
11
3
103
58
427
535
34
62
29
64
76
135
265
328
46
103
91
100
15
8
501
456
26
80
44
67
149
102
102
72
1,061
920
32
36
208
234
414
509
53
45
57
105
84
85
168
170
1,208 1,353
36
61
145
126
205
214
193
211
60
38
11
21
44
25
38
92
95
157
16
9
59
102
19
23
157
195
347
345
308
478
56
42
138
153
112
121
195
191
88
98
377
297
9,116 10,132
2004
10.8
4.0
10.5
3.0
1.9
0.8
3.1
4.0
1.1
1.9
6.4
4.9
2.4
3.4
1.1
4.5
2.1
5.9
1.8
2.3
4.3
3.2
7.9
8.1
1.3
0.8
1.2
7.7
4.4
1.7
3.7
1.6
2.9
0.9
1.3
1.8
1.0
2.7
1.2
0.9
0.5
6.3
4.7
10.2
3.2
4.4
2.6
3.4
3.0
3.9
4.0
2005
12.2
3.0
9.2
9.3
2.4
0.6
6.8
5.4
1.2
1.0
6.4
5.2
1.6
1.7
1.2
5.3
2.1
4.0
4.6
6.0
6.2
3.8
10.9
7.3
1.5
2.2
2.4
6.7
4.1
2.0
5.5
2.2
2.9
2.9
1.9
1.7
1.1
3.1
0.6
0.8
0.9
6.8
6.6
8.0
2.5
3.9
1.8
3.2
3.6
4.5
4.5
2006
10.3
5.5
8.0
22.2
2.6
1.6
7.6
4.4
0.6
0.9
6.2
5.3
2.3
1.8
1.9
7.1
2.8
3.2
5.7
7.4
7.3
3.4
11.4
6.8
2.5
1.4
2.7
8.8
4.3
2.0
4.7
3.0
3.9
3.8
1.2
1.1
2.3
2.7
1.4
1.5
1.4
7.0
8.0
8.7
2.9
4.9
2.3
4.1
5.1
4.7
4.9
2007
11.5
4.6
7.9
17.1
2.9
1.0
6.2
4.5
1.6
1.4
4.3
4.3
1.9
2.0
1.3
8.9
1.5
3.4
7.5
5.6
8.2
2.6
16.2
7.6
3.4
1.8
5.5
16.3
6.4
3.0
7.1
3.5
4.6
2.5
0.5
2.7
3.1
2.3
1.6
2.8
1.7
7.9
11.7
7.3
3.1
4.2
4.0
7.2
5.3
7.1
5.6
2008
14.5
6.7
10.1
17.0
3.9
0.3
3.5
5.6
2.9
3.1
7.7
5.3
4.2
2.2
0.7
8.1
4.7
5.2
5.1
3.9
7.1
2.9
18.3
9.4
2.9
3.3
5.6
16.5
7.2
5.1
6.2
3.7
5.0
1.6
1.0
1.6
7.6
3.8
0.9
4.9
2.1
9.8
11.6
11.4
2.3
4.6
4.3
7.0
5.9
5.6
6.2
116
Syphilis Tables
Table 29.
Atlanta-Sandy Springs-Marietta, GA
Austin-Round Rock, TX
Baltimore-Towson, MD
Birmingham-Hoover, AL
Boston-Cambridge-Quincy, MA-NH
Buffalo-Cheektowaga-Tonawanda, NY
Charlotte-Gastonia-Concord, NC-SC
Chicago-Naperville-Joliet, IL-IN-WI
Cincinnati-Middletown, OH-KY-IN
Cleveland-Elyria-Mentor, OH
Columbus, OH
Dallas-Fort Worth-Arlington, TX
Denver-Aurora, CO
Detroit-Warren-Livonia, MI
Hartford-WestHartford-East Hartford, CT
Houston-Baytown-Sugar Land, TX
Indianapolis, IN
Jacksonville, FL
Kansas City, MO-KS
Las Vegas-Paradise, NV
Los Angeles-Long Beach-Santa Ana, CA
Louisville, KY-IN
Memphis, TN-MS-AR
Miami-Fort Lauderdale-Miami Beach, FL
Milwaukee-Waukesha-West Allis, WI
Minneapolis-St. Paul-Bloomington, MN-WI
Nashville-Davidson-Murfreesboro, TN
New Orleans-Metairie-Kenner, LA
New York-Newark-Edison, NY-NJ-PA
Oklahoma City, OK
Orlando, FL
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD
Phoenix-Mesa-Scottsdale, AZ
Pittsburgh, PA
Portland-Vancouver-Beaverton, OR-WA
Providence-New Bedford-Fall River, RI-MA
Richmond, VA
Riverside-San Bernardino-Ontario, CA
Rochester, NY
Sacramento-Arden-Arcade-Roseville, CA
Salt Lake City, UT
San Antonio, TX
San Diego-Carlsbad-San Marcos, CA
San Francisco-Oakland-Fremont, CA
San Jose-Sunnyvale-Santa Clara, CA
Seattle-Tacoma-Bellevue, WA
St. Louis, MO-IL
Tampa-St. Petersburg-Clearwater, FL
Virginia Beach-Norfolk-Newport News, VA-NC
Washington-Arlington-Alexandria, DC-VA-MD-WV
U.S. MSA TOTAL
2004
36
3
70
11
5
1
12
55
2
3
31
73
6
49
0
39
2
32
5
8
40
6
33
41
1
3
2
27
58
7
10
16
25
7
0
10
1
1
0
0
1
20
10
2
4
6
9
3
4
16
806
2005
36
3
84
35
1
0
20
50
0
1
22
100
1
17
0
61
4
20
5
21
63
3
50
43
1
3
2
23
37
9
14
13
23
25
0
7
1
12
1
0
1
34
25
8
2
4
5
8
15
13
926
Cases
2005
1.5
0.4
6.1
6.2
0.0
0.0
2.6
1.0
0.0
0.1
2.5
3.4
0.1
0.7
0.0
2.3
0.5
3.1
0.5
2.5
1.0
0.5
7.7
1.5
0.1
0.2
0.3
3.4
0.4
1.5
1.4
0.4
1.2
2.0
0.0
0.8
0.2
0.6
0.2
0.0
0.2
3.5
1.7
0.4
0.2
0.2
0.3
0.6
1.8
0.5
1.1
2006
1.3
1.5
3.8
16.5
0.3
0.3
3.5
0.9
0.5
0.2
3.4
3.7
0.3
0.9
0.2
2.3
0.1
1.7
1.7
3.7
1.1
0.5
7.9
1.4
0.3
0.2
0.3
4.7
0.3
1.0
1.4
0.2
0.9
2.3
0.0
0.0
0.2
0.5
0.0
0.3
0.2
3.2
0.8
0.3
0.8
0.1
0.2
1.1
2.1
0.4
1.2
2007
1.5
1.5
2.9
13.9
0.4
0.0
2.4
0.6
0.5
0.5
1.2
3.0
0.1
1.0
0.2
3.8
0.3
1.7
2.5
1.2
0.9
0.3
13.1
2.2
0.6
0.1
1.7
9.5
0.4
2.2
1.3
0.5
1.4
2.0
0.1
0.2
0.5
0.2
0.2
0.2
0.0
3.4
0.8
0.6
0.5
0.2
0.6
3.7
1.2
0.4
1.3
2008
1.9
2.1
5.1
13.4
0.2
0.0
1.1
0.8
1.3
1.2
2.1
3.8
0.1
1.2
0.0
4.1
0.9
2.4
2.0
1.2
0.5
0.5
10.7
2.7
1.4
0.3
1.8
9.9
0.6
2.6
2.0
0.6
1.2
0.5
0.0
0.0
1.0
0.2
0.0
1.7
0.2
5.7
0.8
0.6
0.3
0.1
1.1
3.9
1.4
0.6
1.5
Syphilis Tables
117
Table 30.
Atlanta-Sandy Springs-Marietta, GA
Austin-Round Rock, TX
Baltimore-Towson, MD
Birmingham-Hoover, AL
Boston-Cambridge-Quincy, MA-NH
Buffalo-Cheektowaga-Tonawanda, NY
Charlotte-Gastonia-Concord, NC-SC
Chicago-Naperville-Joliet, IL-IN-WI
Cincinnati-Middletown, OH-KY-IN
Cleveland-Elyria-Mentor, OH
Columbus, OH
Dallas-Fort Worth-Arlington, TX
Denver-Aurora, CO
Detroit-Warren-Livonia, MI
Hartford-WestHartford-East Hartford, CT
Houston-Baytown-Sugar Land, TX
Indianapolis, IN
Jacksonville, FL
Kansas City, MO-KS
Las Vegas-Paradise, NV
Los Angeles-Long Beach-Santa Ana, CA
Louisville, KY-IN
Memphis, TN-MS-AR
Miami-Fort Lauderdale-Miami Beach, FL
Milwaukee-Waukesha-West Allis, WI
Minneapolis-St. Paul-Bloomington, MN-WI
Nashville-Davidson-Murfreesboro, TN
New Orleans-Metairie-Kenner, LA
New York-Newark-Edison, NY-NJ-PA
Oklahoma City, OK
Orlando, FL
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD
Phoenix-Mesa-Scottsdale, AZ
Pittsburgh, PA
Portland-Vancouver-Beaverton, OR-WA
Providence-New Bedford-Fall River, RI-MA
Richmond, VA
Riverside-San Bernardino-Ontario, CA
Rochester, NY
Sacramento-Arden-Arcade-Roseville, CA
Salt Lake City, UT
San Antonio, TX
San Diego-Carlsbad-San Marcos, CA
San Francisco-Oakland-Fremont, CA
San Jose-Sunnyvale-Santa Clara, CA
Seattle-Tacoma-Bellevue, WA
St. Louis, MO-IL
Tampa-St. Petersburg-Clearwater, FL
Virginia Beach-Norfolk-Newport News, VA-NC
Washington-Arlington-Alexandria, DC-VA-MD-WV
U.S. MSA TOTAL
2004
472
53
206
22
79
8
34
318
20
37
78
206
49
104
13
196
32
40
30
30
511
32
66
393
18
23
15
74
758
13
59
79
81
15
26
20
10
102
12
19
4
96
128
419
52
132
62
86
46
183
5,561
2005
562
41
160
66
105
7
83
460
24
21
87
205
37
60
14
218
31
30
84
82
743
43
88
352
21
65
32
65
736
14
92
114
89
44
39
21
12
108
5
16
8
95
169
323
42
121
45
77
45
220
6,221
Cases
2006
496
73
160
150
110
16
93
373
8
16
77
208
53
62
22
331
46
30
95
100
873
38
93
329
36
40
38
65
780
18
80
167
136
63
25
18
27
98
14
29
14
104
223
355
45
158
62
95
66
239
6,847
2007
567
62
171
109
121
11
83
396
28
24
65
172
45
69
14
393
23
33
124
91
1,002
30
121
354
48
56
71
117
1,166
23
132
191
162
35
10
42
35
90
15
57
19
122
335
296
52
134
103
143
78
365
8,005
2008
714
91
200
111
169
3
49
495
48
51
116
212
102
73
8
342
72
51
82
61
889
33
163
435
34
100
71
117
1,293
45
105
197
187
32
21
25
86
150
9
84
22
137
333
466
39
151
105
137
86
282
8,884
2004
20.2
7.4
16.2
4.2
3.7
1.4
4.7
6.9
2.0
3.6
9.3
7.2
4.2
4.8
2.3
7.6
4.0
6.7
3.2
3.6
8.0
5.5
10.9
15.1
2.4
1.5
2.2
11.7
8.4
2.3
6.4
2.8
4.3
1.3
2.5
2.5
1.8
5.4
2.4
1.9
0.8
10.6
8.7
20.4
5.9
8.3
4.6
6.9
5.7
7.3
7.2
2005
23.0
5.5
12.5
12.5
4.9
1.3
11.1
9.9
2.4
2.1
10.3
7.0
3.1
2.7
2.4
8.3
3.8
4.9
8.8
9.4
11.6
7.3
14.4
13.4
2.9
4.2
4.6
10.3
8.1
2.5
9.6
4.1
4.6
3.8
3.7
2.7
2.1
5.5
1.0
1.6
1.5
10.3
11.4
15.7
4.7
7.6
3.3
6.0
5.5
8.6
7.9
2006
19.5
9.4
12.5
28.3
5.1
2.9
11.9
8.0
0.8
1.6
9.0
6.9
4.4
2.8
3.8
11.9
5.6
4.8
9.8
11.1
13.6
6.4
15.1
12.4
4.9
2.5
5.3
13.2
8.6
3.1
8.1
5.9
6.7
5.5
2.3
2.3
4.6
4.9
2.8
2.9
2.6
10.9
15.1
17.1
4.9
9.7
4.6
7.2
8.2
9.3
8.6
2007
21.7
7.6
13.3
20.4
5.6
2.0
10.3
8.4
2.7
2.4
7.5
5.6
3.6
3.2
2.4
13.9
2.8
5.2
12.7
9.7
15.7
5.0
19.6
13.5
6.4
3.5
9.5
23.7
12.8
3.9
13.1
6.8
7.7
3.1
0.9
5.4
5.9
4.4
3.0
5.5
3.4
12.5
22.4
14.2
5.6
8.1
7.6
10.8
9.6
14.1
10.0
2008
27.4
11.1
15.6
20.8
7.8
0.6
6.1
10.6
4.6
5.1
13.4
6.9
8.2
3.3
1.4
12.1
8.6
8.0
8.4
6.5
13.9
5.5
26.4
16.5
4.5
6.3
9.5
23.7
14.2
7.6
10.4
7.0
8.9
2.8
1.9
3.2
14.6
7.3
1.8
8.2
3.9
14.0
22.3
22.3
4.2
9.1
7.7
10.3
10.6
10.9
11.1
118
Syphilis Tables
Table 31.
Rank
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
Cases
822
491
488
386
380
345
344
275
254
215
213
207
198
198
184
183
182
174
150
146
141
130
129
128
122
118
117
103
101
98
96
94
94
93
91
86
86
81
79
76
76
75
74
73
72
66
63
62
60
60
60
60
59
58
57
57
57
56
49
49
48
48
45
44
42
40
40
39
37
36
Cumulative Percent
6
9
13
16
19
21
24
26
28
29
31
32
34
35
37
38
39
41
42
43
44
45
46
47
48
48
49
50
51
52
52
53
54
54
55
56
56
57
57
58
59
59
60
60
61
61
62
62
63
63
63
64
64
65
65
66
66
66
67
67
68
68
68
69
69
69
69
70
70
70
Syphilis Tables
119
Table 32.
City
Primary and secondary syphilisReported cases and rates* among men and women
and male-to-female rate ratios in the counties and independent cities ranked in the
top 30 for cases in 2008: United States, 20072008
Jefferson County, AL
Maricopa County, AZ
Los Angeles County, CA
Orange County, CA
Riverside County, CA
San Diego County, CA
San Francisco County, CA
Washington, D.C.
Broward County, FL
Hillsborough County, FL
Miami-Dade County, FL
DeKalb County, GA
Fulton County, GA
Cook County, IL
Caddo County, LA
Baltimore (City), MD
Suffolk County, MA
Bronx County, NY
Kings County, NY
New York County, NY
Queens County, NY
Franklin County, OH
Philadelphia County, PA
Shelby County, TN
Bexar County, TX
Dallas County, TX
Harris County, TX
Jefferson County, TX
Tarrant County, TX
King County, WA
Male
2007
2008
Case
Rate
Case
Rate
95
162
866
136
76
335
199
173
161
72
173
135
276
364
24
112
65
109
244
387
136
58
129
112
120
95
359
32
59
111
30.4
8.3
17.7
9.1
7.3
22.4
51.1
62.2
18.8
12.4
14.9
37.6
56.4
14.1
20.0
37.7
18.8
17.0
20.4
49.9
12.3
10.6
19.0
25.8
15.4
7.9
18.2
26.1
6.9
11.9
107
185
793
96
112
333
338
139
194
80
207
166
368
456
71
140
100
163
259
482
118
111
142
138
130
136
291
74
66
127
34.3
9.5
16.2
6.4
10.8
22.3
86.8
50.0
22.7
13.8
17.9
46.3
75.2
17.7
59.2
47.1
28.9
25.3
21.7
62.2
10.7
20.2
20.9
31.7
16.7
11.3
14.7
60.4
7.7
13.7
Female
2007
2008
Case
Rate
Case
Rate
71
26
52
6
3
12
3
5
17
43
37
6
17
27
9
28
8
7
11
7
2
10
7
79
35
57
95
7
28
1
20.5
1.3
1.0
0.4
0.3
0.8
0.8
1.6
1.9
7.2
3.0
1.6
3.4
1.0
6.8
8.2
2.2
1.0
0.8
0.8
0.2
1.8
0.9
16.6
4.3
4.9
4.8
5.9
3.3
0.1
76
22
29
2
4
12
6
7
21
37
47
16
18
32
59
58
1
11
16
9
4
18
8
60
54
77
89
67
37
1
21.9
1.1
0.6
0.1
0.4
0.8
1.6
2.3
2.3
6.2
3.8
4.2
3.6
1.2
44.5
17.1
0.3
1.5
1.2
1.1
0.3
3.2
1.0
12.6
6.6
6.6
4.5
56.1
4.3
0.1
Male-to-Female
Rate Ratio
2007
2008
1.5
6.4
17.7
22.8
24.3
28.0
63.9
38.9
9.9
1.7
5.0
23.5
16.6
14.1
2.9
4.6
8.5
17.0
25.5
62.4
61.5
5.9
21.1
1.6
3.6
1.6
3.8
4.4
2.1
119.0
1.6
8.6
27.0
64.0
27.0
27.9
54.3
21.7
9.9
2.2
4.7
11.0
20.9
14.8
1.3
2.8
96.3
16.9
18.1
56.5
35.7
6.3
20.9
2.5
2.5
1.7
3.3
1.1
1.8
137.0
120
Syphilis Tables
Table 33.
Age
Group
Cases
Rates
Male
0.0
1.8
6.8
9.4
10.8
12.4
10.5
4.5
1.8
0.4
4.7
0.0
2.3
8.1
9.8
11.6
13.2
11.0
5.2
1.9
0.4
5.1
0.0
3.0
9.9
12.6
10.6
13.4
12.2
6.0
2.2
0.5
5.6
0.0
3.8
13.5
14.6
13.2
14.4
14.2
6.8
2.4
0.5
6.6
0.1
5.3
17.3
17.2
15.0
14.7
14.4
8.3
2.6
0.6
7.6
Female
0.1
1.5
2.9
1.9
1.6
1.5
1.3
0.6
0.2
0.0
0.8
0.1
1.9
3.0
2.1
1.5
1.7
1.4
0.5
0.1
0.0
0.9
0.1
2.2
2.9
2.4
1.7
1.5
1.4
0.8
0.2
0.0
1.0
0.1
2.4
3.5
2.6
2.0
1.8
1.7
0.9
0.2
0.0
1.1
0.2
3.0
5.1
3.9
2.5
2.3
1.8
1.1
0.3
0.0
1.5
2008
Total
0.0
1.6
4.9
5.8
6.3
7.0
5.8
2.5
1.0
0.2
2.7
0.0
2.1
5.6
6.0
6.6
7.5
6.2
2.8
1.0
0.2
2.9
0.1
2.7
6.5
7.6
6.2
7.5
6.7
3.3
1.2
0.2
3.3
0.1
3.1
8.6
8.7
7.7
8.1
7.9
3.8
1.3
0.2
3.8
0.1
4.2
11.4
10.7
8.9
8.5
8.1
4.6
1.4
0.3
4.5
2007
Female
7
148
294
182
167
154
146
120
32
1
1,255
8
192
306
206
150
179
164
111
20
2
1,339
11
233
299
241
163
154
153
165
35
2
1,459
8
248
356
265
193
191
192
200
30
9
1,693
19
318
520
404
244
241
202
236
46
8
2,242
2006
Male
2
191
735
944
1,118
1,313
1,199
915
249
54
6,725
2
251
875
1,008
1,178
1,394
1,253
1,080
284
57
7,385
2
332
1,083
1,333
1,058
1,427
1,363
1,278
340
79
8,297
5
416
1,462
1,576
1,306
1,530
1,553
1,464
379
82
9,773
8
585
1,878
1,853
1,490
1,569
1,575
1,792
412
97
11,258
2005
Total
9
339
1,029
1,126
1,285
1,467
1,345
1,035
281
55
7,980
10
443
1,181
1,214
1,329
1,574
1,418
1,192
304
59
8,724
13
565
1,382
1,574
1,221
1,581
1,516
1,443
375
81
9,756
13
664
1,818
1,841
1,500
1,721
1,745
1,664
409
91
11,466
27
903
2,398
2,257
1,734
1,810
1,777
2,028
458
105
13,500
2004
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
Primary and secondary syphilisReported cases and rates per 100,000 population by age
group and sex: United States, 20042008
NOTE: This table should be used only for age comparisons. If age was not specified, cases were prorated according to the distribution of cases for which age
was known. Differences between total cases from this table and others in the report are due to different reporting formats. The 0 to 9 year age group is not shown
because some of these cases may not be due to sexual transmission; however, they are included in the totals.
Syphilis Tables
121
Table 34 A. Primary and secondary syphilisReported cases by race/ethnicity, age group and sex:
United States, 20042008
2008
2007
2006
2005
2004
White,
African-American,
Asian/Pacific
American Indian/
Non-Hispanic
Non-Hispanic
Hispanic
Islander
Alaska Native
Age
Group Total Male Female Total Male Female Total Male Female Total Male Female Total Male Female
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
0
56
242
317
512
675
684
525
155
36
3,203
0
67
281
331
491
761
741
660
167
26
3,524
1
71
291
431
433
720
802
766
194
34
3,744
0
95
338
486
506
699
841
824
213
47
4,049
2
123
453
583
552
688
781
996
229
62
4,469
0
33
185
281
470
640
655
503
145
35
2,947
0
36
230
299
456
712
700
631
162
26
3,254
0
39
247
381
395
676
756
729
186
34
3,443
0
49
271
431
455
650
783
773
210
45
3,668
1
72
366
500
499
615
718
935
219
59
3,983
0
23
57
36
41
35
29
23
10
1
256
0
30
51
32
35
49
40
29
5
0
270
1
33
44
50
38
44
46
38
8
0
301
0
46
67
54
51
49
58
51
3
2
381
1
50
87
83
53
73
63
61
9
3
486
8
211
573
534
496
489
455
379
101
16
3,266
9
304
660
612
554
518
446
385
102
23
3,615
11
419
853
795
497
532
443
500
139
25
4,215
13
470
1,124
954
612
683
605
620
154
38
5,274
23
645
1,543
1,203
772
742
684
779
185
30
6,607
2
113
375
421
402
392
353
295
83
16
2,452
1
173
459
480
455
415
350
320
90
21
2,764
2
246
630
641
398
447
356
394
115
23
3,253
5
299
883
784
504
559
486
489
130
31
4,170
7
411
1,161
926
617
607
562
624
151
25
5,093
6
98
198
113
95
98
102
84
18
0
814
8
131
201
132
99
103
97
65
13
2
850
9
173
223
154
99
85
87
107
24
2
962
8
171
240
170
108
125
119
132
24
7
1,104
16
235
381
277
155
134
122
155
33
5
1,514
1
55
188
237
238
249
179
110
20
3
1,280
1
62
216
236
230
268
193
126
30
8
1,370
0
74
218
304
243
282
227
143
35
17
1,543
0
91
328
352
325
293
265
187
41
5
1,887
2
126
357
412
349
345
282
225
36
11
2,146
0
33
156
213
215
235
169
98
20
3
1,142
1
36
167
198
216
244
172
111
28
8
1,182
0
46
187
271
223
263
213
129
33
17
1,381
0
66
289
319
298
280
254
171
38
5
1,720
0
98
308
375
317
317
267
206
34
11
1,931
1
22
32
24
23
14
9
12
0
0
138
0
26
49
38
14
24
21
14
2
0
188
0
28
31
34
20
18
14
14
2
0
162
0
26
40
33
27
12
11
16
3
0
167
2
29
49
37
33
28
15
19
2
0
214
0
11
19
28
29
36
18
11
2
0
153
0
5
15
27
43
19
26
15
4
2
156
0
1
12
37
34
33
30
24
2
0
173
0
0
15
35
38
31
27
24
2
1
171
0
7
34
45
49
30
24
22
7
2
220
0
9
16
25
28
35
18
11
1
0
142
0
4
11
25
42
19
24
14
4
2
145
0
1
11
35
31
32
29
22
2
0
163
0
0
12
34
35
31
26
24
2
1
164
0
5
34
41
49
27
23
22
7
2
211
0
2
3
3
1
1
0
0
1
0
11
0
1
4
2
1
0
2
1
0
0
11
0
0
1
2
3
1
1
2
0
0
10
0
0
2
1
3
0
1
0
0
0
7
0
2
0
4
0
2
1
0
0
0
9
0
6
8
11
10
18
10
10
4
0
77
0
5
8
8
12
8
12
6
0
0
60
1
0
8
7
14
14
15
9
5
5
80
0
7
13
15
19
15
6
10
0
0
85
0
2
11
15
12
5
5
5
2
0
58
0
3
4
5
3
12
4
9
1
0
42
0
1
7
6
10
4
7
4
0
0
40
0
0
7
6
11
9
10
5
4
5
57
0
2
6
7
15
10
4
7
0
0
52
0
0
8
11
8
2
4
4
1
0
40
0
3
4
5
6
6
5
1
3
0
35
0
4
1
2
2
4
4
2
0
0
20
1
0
1
1
3
5
5
4
1
0
24
0
5
7
7
4
5
2
2
0
0
33
0
2
3
3
3
3
1
1
1
0
18
NOTE: These tables should be used only for race/ethnicity comparisons. See Table 33 for age-specific cases and rates and Tables 2527 for total and sexspecific cases and rates. If age or race/ethnicity was not specified, cases were prorated according to the distribution of cases for which these variables were
specified. In 2007, Idaho did not report age and/or race/ethnicity for most cases and its case data and population denominators were excluded. Differences
between total cases from this table and others in the report are due to different reporting formats and above listed exclusions. The 0 to 9 year age group is not
shown because some of these cases may not be due to sexual transmission; however, they are included in the totals.
122
Syphilis Tables
Table 34 B. Primary and secondary syphilisRates per 100,000 population by race/ethnicity, age
group and sex: United States, 20042008
White,
African-American,
Asian/Pacific
American Indian/
Non-Hispanic
Non-Hispanic
Hispanic
Islander
Alaska Native
Age
Group Total Male Female Total Male Female Total Male Female Total Male Female Total Male Female
0.1
7.1
25.0
33.5
32.2
31.2
26.7
13.4
6.6
1.4
13.9
0.1
10.6
30.2
36.5
37.1
33.3
26.5
14.1
6.8
1.8
15.5
0.1
14.7
41.0
46.9
33.1
35.8
27.3
17.0
8.3
1.9
18.1
0.3
17.5
57.2
55.5
42.1
44.6
37.8
20.7
8.9
2.5
22.9
0.4
24.0
75.1
65.6
51.6
48.5
43.8
26.4
10.4
2.0
28.0
0.4
6.3
13.2
8.4
6.8
6.9
6.8
3.3
1.2
0.0
4.2
0.5
8.2
13.5
9.5
7.3
7.4
6.4
2.5
0.8
0.1
4.4
0.6
10.6
14.8
10.7
7.4
6.1
5.8
4.0
1.4
0.1
4.9
0.5
10.3
15.9
11.5
8.2
8.9
8.2
4.8
1.3
0.4
5.5
1.0
14.1
25.3
18.8
11.7
9.6
8.3
5.6
1.8
0.3
7.6
0.0
1.6
5.0
6.1
6.4
7.6
6.2
2.7
0.9
0.1
3.1
0.0
1.8
5.8
5.8
6.0
7.9
6.4
2.9
1.3
0.4
3.2
0.0
2.0
5.8
7.3
6.2
8.0
7.3
3.2
1.4
0.7
3.5
0.0
2.4
8.9
8.5
8.2
8.1
8.3
3.9
1.5
0.2
4.2
0.1
3.4
9.7
9.9
8.7
9.5
8.8
4.7
1.3
0.4
4.7
0.0
1.9
7.5
9.8
10.8
13.5
11.3
4.8
1.9
0.3
5.4
0.1
2.0
8.2
8.8
10.5
13.5
11.0
5.2
2.5
0.9
5.4
0.0
2.5
9.2
11.7
10.4
14.0
13.0
5.6
2.7
1.6
6.0
0.0
3.4
14.6
13.8
13.7
14.4
15.1
7.1
2.9
0.5
7.3
0.0
5.1
15.6
16.1
14.5
16.3
15.9
8.6
2.6
1.0
8.2
0.1
1.3
1.9
1.4
1.4
0.9
0.7
0.6
0.0
0.0
0.7
0.0
1.6
2.9
2.1
0.8
1.5
1.5
0.7
0.2
0.0
0.9
0.0
1.6
1.8
1.8
1.1
1.1
1.0
0.6
0.2
0.0
0.8
0.0
1.4
2.3
1.8
1.5
0.7
0.7
0.7
0.2
0.0
0.8
0.1
1.6
2.8
2.0
1.8
1.6
1.0
0.8
0.1
0.0
1.0
0.0
1.2
1.9
2.4
2.3
3.1
1.7
0.6
0.2
0.0
1.2
0.0
0.6
1.6
2.4
3.2
1.5
2.3
0.8
0.3
0.2
1.1
0.0
0.1
1.3
3.1
2.5
2.6
2.6
1.2
0.2
0.0
1.2
0.0
0.0
1.5
3.0
2.9
2.3
2.3
1.2
0.2
0.1
1.2
0.0
0.8
3.6
3.9
3.7
2.2
2.1
1.1
0.5
0.2
1.5
0.0
1.9
3.1
4.4
4.4
6.2
3.6
1.3
0.2
0.0
2.2
0.0
0.9
2.3
4.5
6.5
3.2
4.4
1.6
0.7
0.4
2.2
0.0
0.2
2.3
6.0
4.7
5.2
5.1
2.4
0.4
0.0
2.4
0.0
0.0
2.6
5.9
5.4
4.8
4.5
2.5
0.3
0.2
2.4
0.0
1.1
7.0
7.1
7.5
4.2
4.1
2.3
1.2
0.4
3.0
0.0
0.5
0.6
0.5
0.2
0.2
0.0
0.0
0.2
0.0
0.2
0.0
0.2
0.8
0.4
0.2
0.0
0.4
0.1
0.0
0.0
0.2
0.0
0.0
0.2
0.3
0.4
0.2
0.2
0.2
0.0
0.0
0.1
0.0
0.0
0.4
0.2
0.5
0.0
0.2
0.0
0.0
0.0
0.1
0.0
0.5
0.0
0.7
0.0
0.3
0.2
0.0
0.0
0.0
0.1
0.0
2.7
3.9
6.1
5.7
10.6
5.1
3.0
2.0
0.0
3.1
0.0
2.3
3.8
4.6
7.1
5.1
6.2
1.9
0.0
0.0
2.4
0.5
0.0
3.7
3.9
8.4
8.3
8.1
2.8
2.4
2.7
3.2
0.0
3.1
6.0
7.6
11.6
8.9
3.6
2.8
0.0
0.0
3.4
0.0
0.9
5.2
7.6
7.1
3.2
3.0
1.5
0.9
0.0
2.3
0.0
2.7
3.9
6.1
3.9
14.1
4.7
5.6
1.1
0.0
3.5
0.0
0.9
6.6
6.6
11.6
5.3
8.3
2.7
0.0
0.0
3.3
0.0
0.0
6.3
6.7
13.0
10.5
10.8
3.3
4.0
6.3
4.7
0.0
1.8
5.5
7.6
18.1
11.7
5.0
4.6
0.0
0.0
4.2
0.0
0.0
7.3
11.7
10.3
2.5
4.9
2.6
0.9
0.0
3.2
0.0
2.8
3.9
6.0
7.5
7.1
5.4
0.6
2.9
0.0
2.8
0.0
3.7
0.9
2.6
2.5
4.9
4.3
1.2
0.0
0.0
1.6
1.0
0.0
1.1
1.1
3.7
6.1
5.5
2.3
0.9
0.0
1.9
0.0
4.5
6.5
7.6
5.1
6.2
2.3
1.2
0.0
0.0
2.6
0.0
1.9
2.9
3.4
4.0
3.9
1.2
0.6
0.9
0.0
1.4
2008
0.2
6.7
19.1
20.5
18.9
18.4
16.1
8.0
3.6
0.5
8.8
0.3
9.4
21.9
22.6
21.4
19.6
15.8
7.9
3.5
0.7
9.7
0.3
12.6
28.1
28.3
19.6
20.1
15.9
10.0
4.5
0.8
11.2
0.4
13.9
36.8
33.1
24.3
25.7
22.0
12.1
4.7
1.2
13.8
0.7
19.1
50.5
41.7
30.7
27.9
24.9
15.2
5.7
0.9
17.3
2007
0.0
0.4
0.9
0.6
0.7
0.5
0.4
0.1
0.1
0.0
0.3
0.0
0.5
0.8
0.5
0.6
0.7
0.5
0.2
0.0
0.0
0.3
0.0
0.5
0.7
0.8
0.6
0.7
0.6
0.2
0.1
0.0
0.3
0.0
0.7
1.1
0.9
0.9
0.7
0.8
0.3
0.0
0.0
0.4
0.0
0.8
1.4
1.3
0.9
1.1
0.9
0.4
0.1
0.0
0.5
2006
0.0
0.5
2.8
4.7
7.4
9.2
8.2
3.3
1.3
0.3
3.0
0.0
0.5
3.4
4.9
7.4
10.4
8.9
4.1
1.4
0.2
3.3
0.0
0.6
3.7
6.1
6.7
9.9
9.9
4.7
1.6
0.3
3.5
0.0
0.7
4.1
6.8
7.9
9.7
10.7
4.9
1.7
0.3
3.7
0.0
1.1
5.4
7.8
8.6
9.1
9.8
5.9
1.8
0.5
4.0
2005
0.0
0.4
1.9
2.7
4.0
4.9
4.3
1.7
0.7
0.1
1.6
0.0
0.5
2.1
2.8
4.0
5.6
4.7
2.1
0.7
0.1
1.8
0.0
0.5
2.2
3.5
3.7
5.3
5.3
2.4
0.8
0.1
1.9
0.0
0.7
2.6
3.9
4.4
5.3
5.8
2.6
0.9
0.2
2.0
0.0
0.9
3.5
4.6
4.8
5.1
5.3
3.1
0.9
0.2
2.2
2004
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
1014
1519
2024
2529
3034
3539
4044
4554
5564
65+
TOTAL
NOTE: These tables should be used only for race/ethnicity comparisons. See Table 33 for age-specific cases and rates and Tables 2527 for total and sexspecific cases and rates. If age or race/ethnicity was not specified, cases were prorated according to the distribution of cases for which these variables were
specified. In 2007, Idaho did not report age and/or race/ethnicity for most cases and its case data and population denominators were excluded. Differences
between total cases from this table and others in the report are due to different reporting formats and above listed exclusions. The 0 to 9 year age group is not
shown because some of these cases may not be due to sexual transmission; however they are included in the totals.
Syphilis Tables
123
Table 35.
Early latent syphilisReported cases and rates by state/area and region listed in
alphabetical order: United States and outlying areas, 20042008
State/Area
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
U.S. TOTAL
Northeast
Midwest
South
West
Guam
Puerto Rico
Virgin Islands
OUTLYING AREAS
TOTAL
124
2004
231
1
219
56
873
24
16
25
113
856
333
3
26
322
45
12
12
24
316
0
213
96
121
21
130
58
0
0
24
0
344
69
744
261
0
184
62
29
183
15
204
0
206
1,069
5
0
108
51
9
55
0
7,768
1,398
830
4,216
1,324
0
353
8
361
8,129
2005
184
8
134
48
1,153
27
19
9
103
726
380
4
13
397
42
6
18
23
252
2
289
105
69
46
162
108
0
2
64
0
289
53
1,084
215
0
136
64
16
204
5
222
0
203
1,013
7
0
148
63
3
58
0
8,176
1,708
882
4,044
1,542
0
432
7
439
8,615
Cases
2006
341
6
186
67
1,369
38
27
16
77
760
366
2
3
267
46
6
18
36
481
7
193
82
43
58
197
93
0
1
119
2
314
85
993
294
0
115
121
19
286
6
174
6
233
1,312
7
2
165
81
6
60
0
9,186
1,719
713
4,839
1,915
3
368
0
371
9,557
2007
363
3
269
115
1,421
35
20
14
84
1,155
423
11
3
224
39
6
25
34
722
5
320
116
73
55
269
120
0
3
174
13
343
66
1,149
247
0
135
115
6
309
10
143
4
304
1,467
2
1
177
76
9
91
0
10,768
1,966
775
5,961
2,066
3
408
1
412
11,180
2008
440
2
258
144
1,648
91
28
23
77
1,252
563
9
6
271
83
11
54
47
809
10
313
149
99
47
232
145
1
0
168
4
415
45
1,372
221
2
224
117
18
309
7
192
3
312
1,733
10
6
238
98
16
78
1
12,401
2,300
1,017
6,729
2,355
2
241
0
243
12,644
Syphilis Tables
2004
5.1
0.2
3.8
2.0
2.4
0.5
0.5
3.0
20.4
4.9
3.8
0.2
1.9
2.5
0.7
0.4
0.4
0.6
7.0
0.0
3.8
1.5
1.2
0.4
4.5
1.0
0.0
0.0
1.0
0.0
4.0
3.6
3.9
3.1
0.0
1.6
1.8
0.8
1.5
1.4
4.9
0.0
3.5
4.8
0.2
0.0
1.4
0.8
0.5
1.0
0.0
2.6
2.6
1.3
4.0
2.0
0.0
9.1
7.4
8.7
2.7
2006
7.4
0.9
3.0
2.4
3.8
0.8
0.8
1.9
13.2
4.2
3.9
0.2
0.2
2.1
0.7
0.2
0.7
0.9
11.2
0.5
3.4
1.3
0.4
1.1
6.8
1.6
0.0
0.1
4.8
0.2
3.6
4.3
5.1
3.3
0.0
1.0
3.4
0.5
2.3
0.6
4.0
0.8
3.9
5.6
0.3
0.3
2.2
1.3
0.3
1.1
0.0
3.1
3.1
1.1
4.4
2.8
1.8
9.4
0.0
8.8
3.1
2007
7.8
0.4
4.2
4.1
3.9
0.7
0.6
1.6
14.3
6.3
4.4
0.9
0.2
1.7
0.6
0.2
0.9
0.8
16.8
0.4
5.7
1.8
0.7
1.1
9.2
2.0
0.0
0.2
6.8
1.0
3.9
3.4
6.0
2.7
0.0
1.2
3.2
0.2
2.5
0.9
3.2
0.5
4.9
6.1
0.1
0.2
2.3
1.2
0.5
1.6
0.0
3.6
3.6
1.2
5.4
2.9
1.7
10.3
0.9
9.7
3.7
2008
9.5
0.3
4.1
5.1
4.5
1.9
0.8
2.7
13.1
6.9
5.9
0.7
0.4
2.1
1.3
0.4
1.9
1.1
18.8
0.8
5.6
2.3
1.0
0.9
7.9
2.5
0.1
0.0
6.5
0.3
4.8
2.3
7.1
2.4
0.3
2.0
3.2
0.5
2.5
0.7
4.4
0.4
5.1
7.2
0.4
1.0
3.1
1.5
0.9
1.4
0.2
4.1
4.2
1.5
6.1
3.4
1.2
6.1
0.0
5.8
4.1
Table 36.
Atlanta-Sandy Springs-Marietta, GA
Austin-Round Rock, TX
Baltimore-Towson, MD
Birmingham-Hoover, AL
Boston-Cambridge-Quincy, MA-NH
Buffalo-Cheektowaga-Tonawanda, NY
Charlotte-Gastonia-Concord, NC-SC
Chicago-Naperville-Joliet, IL-IN-WI
Cincinnati-Middletown, OH-KY-IN
Cleveland-Elyria-Mentor, OH
Columbus, OH
Dallas-Fort Worth-Arlington, TX
Denver-Aurora, CO
Detroit-Warren-Livonia, MI
Hartford-WestHartford-East Hartford, CT
Houston-Baytown-Sugar Land, TX
Indianapolis, IN
Jacksonville, FL
Kansas City, MO-KS
Las Vegas-Paradise, NV
Los Angeles-Long Beach-Santa Ana, CA
Louisville, KY-IN
Memphis, TN-MS-AR
Miami-Fort Lauderdale-Miami Beach, FL
Milwaukee-Waukesha-West Allis, WI
Minneapolis-St. Paul-Bloomington, MN-WI
Nashville-Davidson-Murfreesboro, TN
New Orleans-Metairie-Kenner, LA
New York-Newark-Edison, NY-NJ-PA
Oklahoma City, OK
Orlando, FL
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD
Phoenix-Mesa-Scottsdale, AZ
Pittsburgh, PA
Portland-Vancouver-Beaverton, OR-WA
Providence-New Bedford-Fall River, RI-MA
Richmond, VA
Riverside-San Bernardino-Ontario, CA
Rochester, NY
Sacramento-Arden-Arcade-Roseville, CA
Salt Lake City, UT
San Antonio, TX
San Diego-Carlsbad-San Marcos, CA
San Francisco-Oakland-Fremont, CA
San Jose-Sunnyvale-Santa Clara, CA
Seattle-Tacoma-Bellevue, WA
St. Louis, MO-IL
Tampa-St. Petersburg-Clearwater, FL
Virginia Beach-Norfolk-Newport News, VA-NC
Washington-Arlington-Alexandria, DC-VA-MD-WV
U.S. MSA TOTAL
Cases
2004
6.0
4.2
6.3
3.9
1.6
0.3
3.9
3.4
0.4
1.5
4.3
6.7
0.9
2.3
0.4
4.7
1.5
6.1
1.2
1.2
3.4
1.3
13.6
8.9
2.4
0.6
2.1
6.4
5.4
4.1
4.8
3.8
4.4
0.3
1.1
1.5
1.6
1.1
0.4
0.5
0.5
4.3
2.9
5.7
0.7
1.3
1.1
4.0
2.7
3.5
3.7
2005
6.4
4.1
7.9
7.5
1.9
0.3
4.7
4.2
0.6
1.0
2.4
6.5
0.9
1.3
0.6
3.9
1.2
4.5
2.6
3.3
5.2
1.3
13.6
5.6
2.4
1.4
2.0
5.2
6.8
3.1
6.4
2.9
2.5
1.2
0.6
0.6
2.0
1.6
1.3
0.5
0.3
7.6
4.0
5.3
1.0
1.9
1.2
3.8
4.7
4.0
4.0
2006
5.7
3.4
5.1
20.0
1.5
1.2
6.2
2.8
0.3
0.5
3.2
8.9
1.3
0.8
0.8
5.3
1.1
4.4
2.1
6.3
6.6
1.5
13.7
5.6
3.0
1.6
2.9
12.4
6.3
6.3
4.6
4.8
4.1
1.8
0.4
0.6
2.4
1.6
0.8
1.1
0.5
8.9
4.2
5.3
1.0
2.3
1.1
6.6
4.5
3.2
4.3
2007
6.9
4.1
6.9
17.7
2.1
0.5
3.8
2.2
0.6
1.0
2.7
7.6
1.2
1.1
0.7
8.3
1.2
3.9
3.5
9.3
6.9
1.0
17.3
8.1
4.2
1.7
3.7
21.5
7.2
5.4
7.9
5.3
3.9
1.9
0.2
0.7
3.7
1.2
0.5
0.8
0.2
5.8
5.2
4.8
1.4
2.1
2.0
10.8
3.3
5.0
4.9
2008
7.6
6.8
8.0
18.0
2.8
0.9
3.8
2.6
1.1
2.3
5.1
8.1
2.8
1.0
0.8
9.9
3.3
6.6
4.0
9.0
7.1
1.6
15.5
10.4
3.9
1.3
3.5
23.2
8.7
6.0
7.3
5.2
3.8
1.8
0.5
0.8
6.7
2.2
0.5
1.9
0.9
10.2
6.0
6.7
1.4
2.7
2.5
10.1
4.2
4.2
5.7
Syphilis Tables
125
Table 37.
Late and late latent syphilis*Reported cases and rates by state/area and region listed
in alphabetical order: United States and outlying areas, 20042008
State/Area
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
U.S. TOTAL
Northeast
Midwest
South
West
Guam
Puerto Rico
Virgin Islands
OUTLYING AREAS
TOTAL
2004
232
6
572
142
2,293
90
108
26
174
1,364
701
25
25
614
164
19
49
79
979
5
399
307
470
96
212
114
0
8
189
21
319
97
2,979
285
0
148
79
50
273
62
194
0
459
2,244
59
2
380
135
6
43
3
17,300
4,076
1,725
7,955
3,544
13
608
4
625
17,925
2005
193
5
455
124
2,527
70
88
15
148
1,422
898
42
21
663
182
13
51
54
696
3
387
168
297
89
160
114
0
12
169
17
375
68
2,054
213
0
153
50
52
308
35
239
2
493
2,336
33
0
361
144
12
37
1
16,049
3,048
1,613
7,801
3,587
16
554
5
575
16,624
Cases
2006
262
8
521
92
2,773
73
106
38
120
1,445
977
46
6
760
111
43
41
78
551
6
526
172
210
83
237
166
1
26
117
20
297
66
2,833
352
2
192
58
51
335
51
155
10
527
2,501
38
2
343
160
13
42
1
17,644
3,822
1,686
8,275
3,861
7
535
4
546
18,190
2007
254
6
650
122
2,777
63
87
31
153
1,830
1,142
38
10
522
121
37
44
63
516
7
482
128
262
72
305
124
0
23
104
9
345
62
2,766
516
1
219
33
33
264
30
176
1
537
2,780
23
0
328
135
11
12
2
18,256
3,636
1,438
9,279
3,903
24
682
4
710
18,966
2008
286
6
789
149
2,995
133
109
20
147
2,272
1,345
30
13
720
128
48
41
77
485
7
374
114
227
102
320
171
2
21
71
17
364
96
2,903
480
2
185
51
53
313
30
120
2
548
3,071
5
1
281
159
14
43
5
19,945
3,858
1,690
10,040
4,357
37
381
1
419
20,364
2004
5.1
0.9
10.0
5.2
6.4
2.0
3.1
3.1
31.4
7.8
7.9
2.0
1.8
4.8
2.6
0.6
1.8
1.9
21.7
0.4
7.2
4.8
4.6
1.9
7.3
2.0
0.0
0.5
8.1
1.6
3.7
5.1
15.5
3.3
0.0
1.3
2.2
1.4
2.2
5.7
4.6
0.0
7.8
10.0
2.5
0.3
5.1
2.2
0.3
0.8
0.6
5.9
7.5
2.6
7.5
5.3
7.8
15.6
3.7
15.0
6.0
2006
5.7
1.2
8.4
3.3
7.6
1.5
3.0
4.5
20.6
8.0
10.4
3.6
0.4
5.9
1.8
1.4
1.5
1.9
12.9
0.5
9.4
2.7
2.1
1.6
8.1
2.8
0.1
1.5
4.7
1.5
3.4
3.4
14.7
4.0
0.3
1.7
1.6
1.4
2.7
4.8
3.6
1.3
8.7
10.6
1.5
0.3
4.5
2.5
0.7
0.8
0.2
5.9
7.0
2.5
7.6
5.6
4.1
13.6
3.7
13.0
6.0
2007
5.5
0.9
10.3
4.3
7.6
1.3
2.5
3.6
26.0
10.0
12.0
3.0
0.7
4.1
1.9
1.2
1.6
1.5
12.0
0.5
8.6
2.0
2.6
1.4
10.4
2.1
0.0
1.3
4.1
0.7
4.0
3.1
14.3
5.7
0.2
1.9
0.9
0.9
2.1
2.8
4.0
0.1
8.7
11.6
0.9
0.0
4.3
2.1
0.6
0.2
0.4
6.1
6.6
2.2
8.4
5.6
13.8
17.3
3.6
16.8
6.2
2008
6.2
0.9
12.4
5.3
8.2
2.7
3.1
2.3
25.0
12.4
14.1
2.3
0.9
5.6
2.0
1.6
1.5
1.8
11.3
0.5
6.7
1.8
2.3
2.0
11.0
2.9
0.2
1.2
2.8
1.3
4.2
4.9
15.0
5.3
0.3
1.6
1.4
1.4
2.5
2.8
2.7
0.3
8.9
12.8
0.2
0.2
3.6
2.5
0.8
0.8
1.0
6.6
7.1
2.5
9.1
6.2
21.3
9.7
0.9
9.9
6.7
* Late and late latent syphilis includes late latent syphilis, latent syphilis of unknown duration, neurosyphilis, and late syphilis with clinical manifestations other
than neurosyphilis.
126
Syphilis Tables
Table 38.
Late and late latent syphilis*Reported cases and rates in selected metropolitan
statistical areas (MSAs) listed in alphabetical order: United States, 20042008
Cases
2004
2005
2006
2007
2008
Atlanta-Sandy Springs-Marietta, GA
522
714
814
929
1,068
Austin-Round Rock, TX
85
89
74
94
127
Baltimore-Towson, MD
195
209
283
236
186
Birmingham-Hoover, AL
40
57
94
93
110
Boston-Cambridge-Quincy, MA-NH
256
149
147
98
86
Buffalo-Cheektowaga-Tonawanda, NY
11
4
7
9
7
Charlotte-Gastonia-Concord, NC-SC
45
61
83
133
100
Chicago-Naperville-Joliet, IL-IN-WI
576
611
687
469
650
Cincinnati-Middletown, OH-KY-IN
24
18
37
31
20
Cleveland-Elyria-Mentor, OH
11
9
24
33
15
Columbus, OH
72
76
67
99
84
Dallas-Fort Worth-Arlington, TX
701
792
809
881
934
Denver-Aurora, CO
56
51
51
43
98
Detroit-Warren-Livonia, MI
400
238
155
187
154
Hartford-WestHartford-East Hartford, CT
28
35
32
27
51
Houston-Baytown-Sugar Land, TX
783
685
856
1,032
1,024
Indianapolis, IN
68
80
56
49
53
Jacksonville, FL
70
41
63
102
153
Kansas City, MO-KS
40
53
75
49
55
Las Vegas-Paradise, NV
167
139
95
85
52
Los Angeles-Long Beach-Santa Ana, CA
1,451
1,649
1,759
1,588
1,722
Louisville, KY-IN
60
40
42
33
34
Memphis, TN-MS-AR
242
272
287
326
306
Miami-Fort Lauderdale-Miami Beach, FL
769
742
773
997
1,326
Milwaukee-Waukesha-West Allis, WI
28
18
16
9
32
Minneapolis-St. Paul-Bloomington, MN-WI
79
74
65
59
75
Nashville-Davidson-Murfreesboro, TN
145
126
112
100
138
New Orleans-Metairie-Kenner, LA
259
190
133
157
75
New York-Newark-Edison, NY-NJ-PA
3,058
2,241
2,905
2,913
3,089
Oklahoma City, OK
42
28
18
12
26
Orlando, FL
106
183
217
277
184
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD
361
284
315
253
287
Phoenix-Mesa-Scottsdale, AZ
468
363
424
486
468
Pittsburgh, PA
2
15
18
17
17
Portland-Vancouver-Beaverton, OR-WA
35
43
40
34
32
Providence-New Bedford-Fall River, RI-MA
81
37
65
44
33
Richmond, VA
56
50
49
46
53
Riverside-San Bernardino-Ontario, CA
174
208
203
194
202
Rochester, NY
25
17
68
55
37
Sacramento-Arden-Arcade-Roseville, CA
33
8
78
40
100
Salt Lake City, UT
42
23
21
14
2
San Antonio, TX
164
178
156
142
190
San Diego-Carlsbad-San Marcos, CA
124
133
202
273
292
San Francisco-Oakland-Fremont, CA
258
165
156
263
277
San Jose-Sunnyvale-Santa Clara, CA
39
56
22
76
84
Seattle-Tacoma-Bellevue, WA
93
100
122
99
115
St. Louis, MO-IL
85
86
89
82
129
Tampa-St. Petersburg-Clearwater, FL
110
139
140
119
212
Virginia Beach-Norfolk-Newport News, VA-NC
100
105
85
89
80
Washington-Arlington-Alexandria, DC-VA-MD-WV
511
453
496
514
425
U.S. MSA TOTAL
13,150 12,137 13,585 13,990 15,069
2004
11.1
6.0
7.4
3.7
5.8
1.0
3.1
6.1
1.2
0.5
4.3
12.3
2.4
8.9
2.4
15.1
4.2
5.7
2.1
10.1
11.2
5.0
19.4
14.3
1.8
2.5
10.4
19.6
16.3
3.7
5.7
6.2
12.6
0.1
1.7
5.0
4.9
4.6
2.4
1.6
4.1
8.8
4.2
6.2
2.2
2.9
3.1
4.3
6.1
9.9
8.3
2005
14.5
6.1
7.9
5.2
3.4
0.3
4.0
6.5
0.9
0.4
4.4
13.6
2.2
5.3
2.9
13.0
4.9
3.3
2.7
8.1
12.8
3.3
21.6
13.7
1.2
2.4
8.9
14.4
12.0
2.4
9.5
4.9
9.4
0.6
2.1
2.3
4.3
5.3
1.6
0.4
2.2
9.4
4.5
4.0
3.2
3.1
3.1
5.2
6.4
8.7
7.6
2006
15.8
4.9
10.6
8.5
3.3
0.6
5.2
7.2
1.8
1.1
3.9
13.5
2.1
3.5
2.7
15.5
3.4
4.9
3.8
5.3
13.6
3.4
22.5
14.1
1.1
2.0
7.7
13.0
15.4
1.5
10.9
5.4
10.5
0.8
1.9
4.0
4.1
5.0
6.6
3.8
2.0
8.0
6.9
3.7
1.2
3.7
3.2
5.2
5.2
9.4
8.4
2007
17.6
5.9
8.8
8.4
2.2
0.8
8.1
4.9
1.5
1.6
5.6
14.3
1.7
4.2
2.3
18.3
2.9
7.8
2.5
4.6
12.3
2.7
25.5
18.4
0.6
1.8
6.6
15.2
15.5
1.0
13.6
4.3
11.6
0.7
1.6
2.7
3.8
4.8
5.3
1.9
1.3
7.1
9.2
6.3
4.2
3.0
2.9
4.4
5.4
9.7
8.6
2008
20.2
7.9
7.0
9.9
1.9
0.6
6.1
6.8
0.9
0.7
4.8
15.2
4.0
3.4
4.3
18.2
3.1
11.8
2.8
2.8
13.4
2.8
23.9
24.5
2.1
2.3
9.1
7.3
16.4
2.2
9.1
4.9
11.2
0.7
1.5
2.1
4.4
4.9
3.6
4.8
0.2
9.5
9.8
6.6
4.7
3.5
4.6
7.8
4.8
8.0
9.3
* Late and late latent syphilis includes late latent syphilis, latent syphilis of unknown duration, neurosyphilis, and late syphilis with clinical manifestations other
than neurosyphilis.
MSAs selected based on largest population in 2000 U.S. Census.
Syphilis Tables
127
Table 39.
Rank*
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
Congenital syphilisReported cases and rates in infants <1 year of age by state, ranked
by rates: United States, 2008
State
Louisiana
Texas
Maryland
Arizona
Nevada
Arkansas
Alabama
New Mexico
Tennessee
Illinois
California
U.S. TOTAL
New York
Michigan
North Carolina
Georgia
Florida
Oklahoma
Pennsylvania
Connecticut
West Virginia
Virginia
New Jersey
South Carolina
Missouri
Ohio
Kentucky
Wisconsin
YEAR 2010 TARGET
Alaska
Colorado
Delaware
Hawaii
Idaho
Indiana
Iowa
Kansas
Maine
Massachusetts
Minnesota
Mississippi
Montana
Nebraska
New Hampshire
North Dakota
Oregon
Rhode Island
South Dakota
Utah
Vermont
Washington
Wyoming
Cases
23
127
23
30
9
9
12
4
10
20
62
431
23
10
10
11
17
3
8
2
1
4
4
2
2
3
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
* States were ranked in descending order by rate, number of cases, and alphabetically by state. States with no cases were not ranked.
Mother's state of residence used to assign case.
Total includes cases reported by the District of Columbia with 0 cases and a rate of 0.0, but excludes outlying areas (Guam with 0 cases and rate of 0.0, Puerto Rico
with 8 cases and rate of 16.5, and Virgin Islands with 0 cases and rate of 0.0).
128
Syphilis Tables
Table 40.
Congenital syphilisReported cases and rates in infants <1 year of age by state/area and
region listed in alphabetical order: United States and outlying areas, 20042008
State/Area*
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
U.S. TOTAL
Northeast
Midwest
South
West
Guam
Puerto Rico
Virgin Islands
OUTLYING AREAS
TOTAL
2004
11
0
26
4
68
2
0
1
1
16
6
0
3
26
4
0
2
1
19
0
10
0
23
1
3
3
0
0
1
0
13
3
22
9
0
2
2
0
0
1
10
0
9
65
1
0
6
0
0
1
0
375
36
62
173
104
0
11
0
11
386
2005
5
0
28
7
75
1
1
0
0
16
1
0
0
23
2
0
0
0
13
0
16
0
17
3
0
3
0
0
1
0
16
6
10
11
0
2
1
0
1
0
4
0
4
67
0
0
3
0
0
2
0
339
28
52
148
111
1
13
0
14
353
Cases
2006
9
0
16
10
69
2
0
0
1
21
9
0
0
15
0
0
1
1
16
0
19
0
13
1
0
3
0
0
16
0
15
7
24
7
0
0
2
0
3
0
2
0
6
79
2
0
3
0
0
0
0
372
42
33
185
112
0
15
0
15
387
2007
9
0
30
12
87
2
2
0
1
20
9
0
0
10
2
1
0
0
37
0
23
0
15
0
0
1
0
0
7
0
11
6
16
7
0
1
3
2
8
0
1
0
4
99
0
0
1
2
1
1
0
431
37
31
227
136
2
10
0
12
443
2008
12
0
30
9
62
0
2
0
0
17
11
0
0
20
0
0
0
1
23
0
23
0
10
0
0
2
0
0
9
0
4
4
23
10
0
3
3
0
8
0
2
0
10
127
0
0
4
0
1
1
0
431
37
36
253
105
0
8
0
8
439
2004
18.5
0.0
27.8
10.4
12.5
2.9
0.0
8.8
12.6
7.3
4.3
0.0
13.3
14.4
4.6
0.0
5.0
1.8
29.1
0.0
13.4
0.0
17.7
1.4
7.0
3.9
0.0
0.0
2.8
0.0
11.3
10.6
8.8
7.5
0.0
1.3
3.9
0.0
0.0
7.8
17.7
0.0
11.3
17.0
2.0
0.0
5.8
0.0
0.0
1.4
0.0
9.1
5.3
7.0
11.3
10.2
0.0
21.5
0.0
19.6
9.3
2006
14.2
0.0
15.6
24.4
12.3
2.8
0.0
0.0
11.7
8.9
6.1
0.0
0.0
8.3
0.0
0.0
2.4
1.7
25.2
0.0
24.5
0.0
10.2
1.4
0.0
3.7
0.0
0.0
40.0
0.0
13.0
23.4
9.6
5.5
0.0
0.0
3.7
0.0
2.0
0.0
3.2
0.0
7.1
19.8
3.7
0.0
2.8
0.0
0.0
0.0
0.0
8.7
6.2
3.7
11.5
10.5
0.0
30.9
0.0
27.9
9.0
2007
14.2
0.0
29.3
29.3
15.5
2.8
4.8
0.0
11.7
8.4
6.1
0.0
0.0
5.5
2.3
2.5
0.0
0.0
58.4
0.0
29.7
0.0
11.8
0.0
0.0
1.2
0.0
0.0
17.5
0.0
9.6
20.0
6.4
5.5
0.0
0.7
5.6
4.1
5.4
0.0
1.6
0.0
4.7
24.8
0.0
0.0
0.9
2.3
4.8
1.4
0.0
10.1
5.4
3.4
14.1
12.7
59.0
20.6
0.0
22.4
10.3
2008
19.0
0.0
29.3
22.0
11.0
0.0
4.8
0.0
0.0
7.2
7.4
0.0
0.0
11.1
0.0
0.0
0.0
1.7
36.3
0.0
29.7
0.0
7.8
0.0
0.0
2.5
0.0
0.0
22.5
0.0
3.5
13.4
9.2
7.8
0.0
2.0
5.6
0.0
5.4
0.0
3.2
0.0
11.9
31.8
0.0
0.0
3.7
0.0
4.8
1.4
0.0
10.1
5.4
4.0
15.7
9.8
0.0
16.5
0.0
14.9
10.2
Syphilis Tables
129
Table 41.
Congenital SyphilisReported cases and rates in infants <1 year of age by race/ethnicity
of mother: United States, 20042008
2008
2007
2006
2005
2004
Year
of
Birth
Race/Ethnicity
White, Non-Hispanic
Black, Non-Hispanic
Hispanic
Asian/Pacific Islander
American Indian/Alaska Native
Other
Unknown
Total
White, Non-Hispanic
Black, Non-Hispanic
Hispanic
Asian/Pacific Islander
American Indian/Alaska Native
Other
Unknown
Total
White, Non-Hispanic
Black, Non-Hispanic
Hispanic
Asian/Pacific Islander
American Indian/Alaska Native
Other
Unknown
Total
White, Non-Hispanic
Black, Non-Hispanic
Hispanic
Asian/Pacific Islander
American Indian/Alaska Native
Other
Unknown
Total
White, Non-Hispanic
Black, Non-Hispanic
Hispanic
Asian/Pacific Islander
American Indian/Alaska Native
Other
Unknown
Total
Cases
41
168
145
6
2
1
12
375
31
156
124
15
5
2
6
339
39
151
151
10
5
5
11
372
53
191
144
20
8
4
11
431
65
215
133
7
6
1
4
431
NA = Not applicable.
130
Syphilis Tables
Table 42.
State/Area
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
U.S. TOTAL
Guam
Puerto Rico
Virgin Islands
OUTLYING AREAS
TOTAL
2004
0
0
2
0
1
0
0
0
0
1
0
0
2
0
0
0
0
0
2
0
0
3
2
0
0
0
0
0
1
0
0
0
4
1
0
0
0
1
1
0
4
0
1
3
1
0
0
0
0
0
0
30
0
1
0
1
31
2005
0
0
1
0
1
0
0
0
0
1
0
0
0
0
0
0
0
0
4
0
0
1
0
0
0
0
0
0
0
0
0
0
1
5
0
1
0
0
0
0
0
0
0
1
0
0
0
0
0
0
1
17
0
3
0
3
20
Cases
2006
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
1
0
0
0
1
0
0
0
0
0
0
0
0
0
5
5
0
0
0
0
0
0
0
0
0
5
0
0
1
0
0
0
0
19
0
0
0
0
19
2007
0
0
0
0
1
0
0
0
0
3
0
0
0
0
0
0
0
0
4
0
0
1
0
0
0
0
0
0
0
0
0
0
5
2
0
0
0
0
0
0
0
0
0
5
0
0
0
0
0
2
0
23
0
0
0
0
23
2008
0
0
0
0
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
0
0
0
0
0
0
0
0
0
0
2
4
0
1
0
0
0
0
1
0
0
8
0
0
0
1
0
0
0
25
0
0
0
0
25
Chancroid Tables
2004
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2006
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2007
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
2008
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
131
Table 43.
Year
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
19,000
15,000
16,000
15,000
17,000
49,000
26,000
51,000
75,000
36,000
57,000
116,000
76,000
83,000
57,000
133,000
134,000
106,000
157,000
124,000
136,000
102,000
163,000
148,000
172,000
235,000
139,000
172,000
142,000
160,000
208,000
176,000
188,000
224,000
179,000
157,000
216,000
203,000
269,000
266,000
371,000
317,000
292,000
Genital
Warts
56,000
72,000
87,000
61,000
119,000
128,000
165,000
198,000
202,000
181,000
217,000
221,000
269,000
200,000
218,000
191,000
256,000
203,000
224,000
263,000
275,000
351,000
290,000
220,000
275,000
282,000
218,000
167,000
239,000
253,000
191,000
145,000
211,000
240,000
220,000
233,000
266,000
264,000
316,000
357,000
422,000
312,000
385,000
Vaginal
Trichomoniasis*
579,000
515,000
463,000
421,000
529,000
484,000
574,000
466,000
427,000
500,000
473,000
324,000
329,000
363,000
358,000
369,000
268,000
424,000
381,000
291,000
338,000
293,000
191,000
165,000
213,000
198,000
182,000
207,000
199,000
141,000
245,000
176,000
164,000
171,000
222,000
210,000
150,000
179,000
221,000
165,000
200,000
205,000
204,000
Other
Vaginitis*
1,155,000
1,277,000
1,460,000
1,390,000
1,500,000
1,281,000
1,810,000
1,858,000
1,907,000
1,919,000
1,690,000
1,713,000
2,149,000
1,662,000
1,670,000
1,742,000
1,859,000
1,932,000
2,450,000
2,728,000
3,118,000
3,087,000
3,583,000
3,374,000
4,474,000
3,822,000
3,428,000
3,755,000
4,123,000
3,927,000
3,472,000
3,100,000
3,200,000
3,077,000
3,470,000
3,365,000
3,315,000
3,516,000
3,602,000
4,071,000
3,891,000
3,723,000
3,571,000
Pelvic Inflammatory
Disease
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
423,000
283,000
374,000
424,000
381,000
425,000
457,000
403,000
431,000
413,000
358,000
377,000
335,000
407,000
332,000
262,000
286,000
260,000
233,000
250,000
254,000
244,000
197,000
123,000
132,000
176,000
106,000
146,000
104,000
* Women only.
Women 1544 only.
NA = Not available.
NOTE: Standard errors for estimates under 100,000 are not available. The relative standard error for estimates 100,000300,000 are between 20% and 30%;
300,000600,000 are between 16% and 20%; 600,0001,000,000 are between 13% and 16%; and 1,000,0005,000,000 are between 9% and 13%.
SOURCE: IMS Health, Integrated Promotional Services, IMS Health Report, 19662008 Hardcopy. See Appendix (Other Data Sources) for more information.
132
APPENDIX
APPENDIX
Reporting Formats
STD morbidity data presented in this report are
compiled from a combination of data reported
on standardized hardcopy report forms and
electronic data received via the National Electronic
Telecommunications System for Surveillance (NETSS).
133
National Electronic
Telecommunications System for
Surveillance (NETSS, electronic
format)
Notifiable STD data reported electronically through
NETSS comprise the nationally notifiable disease
information that is published in the Morbidity and
Mortality Weekly Report (MMWR).
As of December 31, 2003, all 50 states and Washington,
D.C. had converted from summary hardcopy reporting
to electronic submission of line-listed (i.e., case-specific)
STD data via NETSS (42 reporting areas are submitting
congenital syphilis surveillance data via NETSS).
Puerto Rico converted to electronic reporting in 2006.
Guam and the Virgin Islands continue to report using
summary hardcopy forms.
Jurisdictions differ in their ability to resolve
differences in total cases derived from summary
hardcopy monthly, quarterly, and annual reports
(as well as electronically submitted line-listed data).
Thus, depending on the database used, there may be
discrepancies in the total number of cases among the
figures and tables for earlier years. In most instances,
these discrepancies are less than 5% of total reported
cases and have minimal impact on national case totals
and rates. However, for a specific jurisdiction, the
discrepancies may be larger.
Surveillance data and updates sent to CDC via
NETSS and on hardcopy forms through June 10,
2009 have been included in this report. Data received
after this date will appear in subsequent annual
Surveillance Reports. The data presented in the
figures and tables in this document supersede those in
all earlier publications.
Reporting Practices
Although most state and local STD programs
generally adhere to the national notifiable STD case
definitions collaboratively developed by the Council
of State and Territorial Epidemiologists and CDC,
there may be differences in the policies and systems
for collecting surveillance data. Thus, comparisons of
case numbers and rates between jurisdictions should
be interpreted with caution. However, since case
definitions and surveillance activities within a given
area remain relatively stable over time, trends should
be minimally affected by these differences. In many
state and local STD jurisdictions, the reporting from
publicly supported institutions (e.g., STD clinics)
has been more complete than from other sources
(e.g., private practitioners). Thus, trends may not be
representative of all segments of the population.
135
Chlamydia Morbidity
Trends in chlamydia morbidity reporting from
many state and local jurisdictions are more reflective
of changes in diagnostic, screening, and reporting
practices than of actual trends in disease incidence.
In particular, morbidity trends are likely highly
influenced by changes in test technology, as use
of more sensitive NAATs tests increases. As more
jurisdictions develop chlamydia prevention and
control programs, including improved surveillance
systems to monitor trends, the data should improve
and become more representative of true trends in
disease.
137
139
Table A1. Selected STDsPercentage of unknown, missing, or invalid values for selected variables
by state and by nationally notifiable STD, 2008
Primary and Secondary Syphilis
Percent
Percent
Unknown Percent Percent Unknown
Race/
Unknown Unknown
Sex
Ethnicity
Age
Sex
Partner
State
2.2
Alabama
2.2
0.0
0.0
100.0
Alaska*
0.0
0.0
0.0
58.0
Arizona
2.8
0.0
0.0
30.6
Arkansas
0.0
0.0
0.0
10.1
California
3.4
0.0
0.1
12.5
Colorado
3.1
0.0
0.0
2.9
Connecticut
2.9
0.0
0.0
100.0
Delaware
0.0
0.0
0.0
26.0
District of Columbia
2.7
0.0
0.0
3.1
Florida
5.9
0.0
0.1
20.7
Georgia
0.8
0.0
0.0
0.0
Hawaii
0.0
0.0
0.0
28.6
Idaho*
28.6
0.0
0.0
27.1
Illinois
4.0
0.0
0.0
7.9
Indiana
0.0
0.0
0.0
18.8
Iowa
0.0
0.0
0.0
6.7
Kansas
0.0
0.0
0.0
21.5
Kentucky
5.4
0.0
0.0
100.0
Louisiana
1.1
0.0
0.0
0.0
Maine
0.0
0.0
0.0
10.6
Maryland
0.8
0.0
0.0
6.9
Massachusetts
5.1
0.0
0.0
17.1
Michigan
2.4
0.0
0.0
9.5
Minnesota
3.4
0.0
0.0
1.6
Mississippi
2.7
0.0
0.0
1.3
Missouri
0.0
0.0
0.0
100.0
Montana*
14.3
0.0
0.0
33.3
Nebraska
20.0
0.0
0.0
2.6
Nevada
18.2
0.0
0.0
5.0
New Hampshire
0.0
0.0
0.0
9.3
New Jersey
0.4
0.0
0.0
6.8
New Mexico
6.8
0.0
0.0
19.5
New York
9.7
0.0
0.0
100.0
North Carolina
0.0
0.0
0.0
0.0
North Dakota*
0.0
0.0
0.0
8.0
Ohio
7.4
0.0
0.0
7.0
Oklahoma
0.0
0.0
0.0
100.0
Oregon
3.8
0.0
0.0
1.1
Pennsylvania
4.0
0.0
0.0
0.0
Rhode Island
0.0
0.0
0.0
6.1
South Carolina
1.0
0.0
0.0
0.0
South Dakota*
0.0
0.0
0.0
1.2
Tennessee
0.0
0.0
0.0
2.3
Texas
0.6
0.0
0.0
16.0
Utah
0.0
0.0
0.0
45.5
Vermont
0.0
0.0
0.0
2.6
Virginia
0.4
0.0
0.0
1.7
Washington
4.4
0.0
0.0
23.1
West Virginia
0.0
0.0
0.0
7.7
Wisconsin
1.5
0.0
0.0
100.0
Wyoming*
33.3
0.0
0.0
18.3
U.S. TOTAL
3.2
0.0
0.0
Gonorrhea
Percent
Unknown Percent Percent
Race/
Unknown Unknown
Ethnicity
Age
Sex
0.1
23.5
0.0
0.0
0.3
0.0
0.1
21.8
0.0
0.0
7.4
0.0
0.5
32.2
0.0
0.1
30.5
0.0
0.1
25.1
0.0
0.0
2.4
0.0
0.5
28.7
0.0
13.0
0.0
0.2
0.7
39.3
0.0
0.0
33.8
0.0
0.0
27.8
0.0
0.0
8.8
0.0
0.2
12.6
0.0
0.0
7.1
0.0
0.0
21.6
0.0
0.2
29.6
0.0
0.5
14.0
0.0
5.2
0.0
0.0
0.1
29.0
0.0
0.1
27.5
0.0
0.8
39.8
0.0
0.0
13.3
0.0
0.0
21.1
0.0
0.0
15.2
0.0
0.8
32.8
0.0
0.1
24.0
0.0
0.0
27.8
0.0
8.0
0.0
0.0
0.0
30.7
0.0
0.1
20.0
0.0
0.0
35.1
0.0
0.5
7.4
0.0
0.0
30.8
0.0
1.9
26.0
0.0
0.2
6.4
0.0
0.0
8.2
0.0
0.0
20.5
0.0
10.4
0.0
0.0
0.3
26.5
0.0
0.0
1.9
0.0
0.0
7.1
0.0
0.1
4.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
14.7
0.0
0.2
24.0
0.0
0.0
9.0
0.0
25.5
0.0
0.2
0.0
26.6
0.0
0.3
20.3
0.0
Chlamydia
Percent
Unknown Percent Percent
Race/
Unknown Unknown
Ethnicity
Age
Sex
27.2
0.0
0.0
0.0
0.5
0.0
0.0
28.6
0.0
0.0
6.1
0.0
34.2
0.0
0.4
0.2
59.7
0.0
0.1
36.8
0.0
0.0
3.2
0.0
36.6
0.0
0.7
0.3
17.4
0.0
1.0
47.6
0.0
0.0
50.3
0.0
30.0
0.0
0.3
0.0
12.1
0.0
0.3
16.6
0.0
0.0
11.0
0.0
32.7
0.0
0.0
0.3
36.2
0.0
0.8
18.8
0.0
0.0
15.7
0.0
36.2
0.0
0.1
0.1
36.8
0.0
0.4
42.1
0.0
0.0
15.3
0.0
25.0
0.0
0.0
0.0
23.2
0.0
0.3
24.9
0.0
0.2
34.2
0.0
37.8
0.0
0.0
0.0
11.4
0.0
0.1
44.4
0.0
0.0
17.4
0.0
44.7
0.0
0.0
0.4
9.5
0.0
0.1
26.8
0.0
2.7
33.6
0.0
9.3
0.0
0.5
0.0
17.1
0.0
0.0
22.7
0.0
0.1
20.9
0.0
32.1
0.0
0.4
0.1
2.7
0.0
0.0
10.0
0.0
0.1
5.1
0.0
0.0
0.0
0.0
0.0
0.2
0.0
0.2
23.6
0.0
0.3
23.4
0.0
13.9
0.0
0.0
0.3
29.6
0.0
0.2
35.3
0.0
0.3
26.4
0.0
140
Table A2.
Disease
Chlamydia
Gonorrhea
Primary Syphilis
Secondary Syphilis
Early Latent Syphilis
Chancroid
Non-STD Clinic
Male
189,994
89,741
1,889
5,589
6,054
9,401
10
Female
719,718
136,913
216
1,211
2,330
5,298
12
Total*
911,842
227,213
2,105
6,803
8,387
14,718
22
Male
95,798
49,495
1,224
2,203
2,696
2,411
0
STD Clinic
Female
89,943
27,825
149
622
997
1,285
0
Total
Total*
185,879
77,368
1,373
2,825
3,695
3,698
0
Male
Female
Total
313,779
153,103
3,230
8,025
8,997
12,821
11
893,004
182,577
372
1,870
3,399
7,102
14
1,210,523
336,742
3,602
9,898
12,401
19,945
25
141
Table A3.
251
252
253
254
256
257
259
2511
2513
2516
Baseline
HP 2010
Year Baseline 2004 2005 2006 2007 2008 Target
HP 2010 Objective
251 a, b, c
251 d
252 a, b
253
254
256
257
259
2511 a, b, c
2513
2516 a, b
5.0%
6.9%
6.9%
7.1%
7.5%
7.8%
3.0%
12.2%
15.7%
15.3%
20.8%
15.4%
20.5%
14.8%
20.8%
15.3%
22.4%
16.3%
23.7%
3.0%
3.0%
10.1%
9.7%
9.2%
13.1%
13.2%
12.8%
6.8%
123.0
279.0
112.4
267.0
114.6
275.0
119.7
289.0
118.0
291.0
111.6
285.0
19.0
42.0
3.2
2.7
2.9
3.3
3.8
4.5
0.2
17.0%
10.0%
NA
NA
NA
NA
14.0%
8.0%
NA
NA
NA
NA
NA
5.0%
27.0%
NA
NA
NA
NA
NA
15.0%
27.0
9.1
8.2
8.7
10.1
10.1
1.0
50.0
NA
53.0
NA
52.0
NA
56.0
27.0
NA
27.0
NA
27.0
NA
30.0
58.0
NA
63.0
NA
62.0
NA
65.0
5.0
NA
NA
NA
NA
NA
90.0
25
32
35
37
38
42
62
41
47
51
52
52
56
62
Data Source
Regional Infertility Prevention Projects (IPP), STD Surveillance System (STDSS), NCHHSTP, CDC.
National Job Training Program, STD Surveillance System (STDSS), NCHHSTP, CDC.
STD Surveillance System (STDSS), NCHHSTP, CDC.
STD Surveillance System (STDSS), NCHHSTP, CDC.
National Health and Nutrition Examination Survey (NHANES) , NCHS, CDC.
National Survey of Family Growth (NSFG) , NCHS, CDC.
National Survey of Family Growth (NSFG) , NCHS, CDC.
STD Surveillance System, NCHHSTP, CDC, National Vital Statistics System- Natality (NVSS-N), NCHS, CDC.
Youth Risk Behavior Surveillance System (YRBSS), NCCDPHP, CDC.
Survey of STD Programs, National Coalition of STD Directors (NCSD); IHS.
Healthcare Effectiveness Data and Information Set (HEDIS), National Committee for Quality Assurance (NCQA).
142
Table A4.
Government Performance and Results Act (GPRA) Sexually Transmitted Diseases Goals
and Measures
GPRA Goals
Baseline
GPRA Goals
1
1a
1b
1c
2
2a
2b
2c
2d
2002
Actual Performance
Long-Term
Goal
2007
2008
2010
197,000
146,000
104,000
168,000
10.1%
5.6%
278.0
13.2%
6.9%
291.0
12.8%
7.4%
285.0
15.1%
7.4%
296
2.4
3.8
4.5
2.2
3.8
1.1
10.2
8:1
6.6
1.1
10.1
7:1
7.6
1.5
10.1
8:1
7.2
1.2
9.4
6.7:1
Data Source
143
A sexually transmitted disease characterized by painful genital ulceration and inflammatory inguinal
adenopathy. The disease is caused by infection with Haemophilus ducreyi.
Case classification
Probable: a clinically compatible case with both a) no evidence of Treponema pallidum infection by darkfield
microscopic examination of ulcer exudate or by a serologic test for syphilis performed 7 days after onset of
ulcers and b) either a clinical presentation of the ulcer(s) not typical of disease caused by herpes simplex virus
(HSV) or a culture negative for HSV.
Confirmed: a clinically compatible case that is laboratory confirmed
Infection with Chlamydia trachomatis may result in urethritis, epididymitis, cervicitis, acute salpingitis, or
other syndromes when sexually transmitted; however, the infection is often asymptomatic in women. Perinatal
infections may result in inclusion conjunctivitis and pneumonia in newborns. Other syndromes caused by C.
trachomatis include lymphogranuloma venereum (see Lymphogranuloma Venereum) and trachoma.
Case classification
A sexually transmitted infection commonly manifested by urethritis, cervicitis, or salpingitis. Infection may be
asymptomatic.
145
Case classification
Syphilis, primary
Clinical description
A stage of infection with Treponema pallidum characterized by one or more chancres (ulcers); chancres might
differ considerably in clinical appearance.
Laboratory criteria for diagnosis
Demonstration of T. pallidum in clinical specimens by darkfield microscopy, direct fluorescent antibody
(DFA-TP), or equivalent methods
Case classification
Probable: a clinically compatible case with one or more ulcers (chancres) consistent with primary syphilis and a
reactive serologic test (nontreponemal: Venereal Disease Research Laboratory [VDRL] or rapid plasma reagin
[RPR]; treponemal: fluorescent treponemal antibody absorbed [FTA-ABS] or microhemagglutination assay for
antibody to T. pallidum [MHA-TP])
Confirmed: a clinically compatible case that is laboratory confirmed
Syphilis, secondary
Clinical description
A stage of infection caused by T. pallidum and characterized by localized or diffuse mucocutaneous lesions,
often with generalized lymphadenopathy. The primary chancre may still be present.
Laboratory criteria for diagnosis
Demonstration of T. pallidum in clinical specimens by darkfield microscopy, DFATP, or equivalent
methods
Case classification
Probable: a clinically compatible case with a nontreponemal (VDRL or RPR) titer 4
Confirmed: a clinically compatible case that is laboratory confirmed
Syphilis, latent
Clinical description
A stage of infection caused by T. pallidum in which organisms persist in the body of the infected person
without causing symptoms or signs. Latent syphilis is subdivided into early, late, and unknown categories
based on the duration of infection.
146
Case classification
Probable: no clinical signs or symptoms of syphilis and the presence of one of the following:
No past diagnosis of syphilis, a reactive nontreponemal test (i.e., VDRL or RPR), and a reactive
treponemal test (i.e., FTA-ABS or MHA-TP)
A past history of syphilis therapy and a current nontreponemal test titer demonstrating fourfold or
greater increase from the last nontreponemal test titer
Clinical description
A subcategory of latent syphilis. When initial infection has occurred within the previous 12 months, latent
syphilis is classified as early latent.
Case classification
Probable: latent syphilis (see Syphilis, latent) in a person who has evidence of having acquired the infection
within the previous 12 months based on one or more of the following criteria:
Documented seroconversion or fourfold or greater increase in titer of a nontreponemal test during the
previous 12 months
A history of symptoms consistent with primary or secondary syphilis during the previous 12 months
A history of sexual exposure to a partner who had confirmed or probable primary or secondary syphilis
or probable early latent syphilis (documented independently as duration <1 year)
Reactive nontreponemal and treponemal tests from a person whose only possible exposure occurred
within the preceding 12 months
Clinical description
A subcategory of latent syphilis. When initial infection has occurred >1 year previously, latent syphilis is
classified as late latent.
Case classification
Probable: latent syphilis (see Syphilis, latent) in a patient who has no evidence of having acquired the disease
within the preceding 12 months (see Syphilis, early latent) and whose age and titer do not meet the criteria
specified for latent syphilis of unknown duration.
Clinical description
A subcategory of latent syphilis. When the date of initial infection cannot be established as having occurred
within the previous year and the patients age and titer meet criteria described below, latent syphilis is classified
as latent syphilis of unknown duration.
Case classification
Probable: latent syphilis (see Syphilis, latent) that does not meet the criteria for early latent syphilis, and the
patient is aged 1335 years and has a nontreponemal titer 32
Neurosyphilis
Note
Since neurosyphilis can occur at almost any stage of syphilis, between 1996 and 2005, it was classified and
reported as one of several mutually exclusive stages of syphilis. In 2005, the Division of STD Prevention
requested that STD control programs discontinue classifying and reporting neurosyphilis as a distinct stage of
syphilis. Since 2005, if the patient has confirmed or probable neurosyphilis, the case should be reported as the
appropriate state of syphilis and neurological manifestations should be noted.
STD Surveillance 2008
147
Clinical description
Evidence of central nervous system infection with T. pallidum
Laboratory criteria for diagnosis
A reactive serologic test for syphilis and reactive VDRL in cerebrospinal fluid (CSF)
Case classification
Probable: syphilis of any stage, a negative VDRL in CSF, and both the following:
Elevated CSF protein or leukocyte count in the absence of other known causes of these abnormalities
Clinical symptoms or signs consistent with neurosyphilis without other known causes for these clinical
abnormalities
Confirmed: syphilis of any stage that meets the laboratory criteria for neurosyphilis
Syphilis, late, with clinical manifestations other than neurosyphilis (late benign syphilis
and cardiovascular syphilis)
Clinical description
Clinical manifestations of late syphilis other than neurosyphilis may include inflammatory lesions of the
cardiovascular system, skin, and bone. Rarely, other structures (e.g., the upper and lower respiratory tracts,
mouth, eye, abdominal organs, reproductive organs, lymph nodes, and skeletal muscle) may be involved. Late
syphilis usually becomes clinically manifest only after a period of 1530 years of untreated infection.
Laboratory criteria for diagnosis
Demonstration of T. pallidum in late lesions by fluorescent antibody or special stains (although organisms are
rarely visualized in late lesions)
Case classification
Probable: characteristic abnormalities or lesions of the cardiovascular system, skin, bone, or other structures
with a reactive treponemal test, in the absence of other known causes of these abnormalities, and without CSF
abnormalities and clinical symptoms or signs consistent with neurosyphilis
Confirmed: a clinically compatible case that is laboratory confirmed
Comment
Analysis of CSF for evidence of neurosyphilis is necessary in the evaluation of late syphilis with clinical
manifestations.
Syphilitic Stillbirth
Clinical description
A fetal death that occurs after a 20-week gestation or in which the fetus weighs >500 g and the mother had
untreated or inadequately treated* syphilis at delivery
Comment
For reporting purposes, syphilitic stillbirths should be reported as cases of congenital syphilis.
*Inadequate treatment consists of any nonpenicillin therapy or penicillin administered <30 days before delivery.
148
A condition caused by infection in utero with Treponema pallidum. A wide spectrum of severity exists, and
only severe cases are clinically apparent at birth. An infant or child (aged <2 years) may have signs such as
hepatosplenomegaly, rash, condyloma lata, snuffles, jaundice (nonviral hepatitis), pseudoparalysis, anemia, or
edema (nephrotic syndrome and/or malnutrition). An older child may have stigmata (e.g., interstitial keratitis,
nerve deafness, anterior bowing of shins, frontal bossing, mulberry molars, Hutchinson teeth, saddle nose,
rhagades, or Clutton joints).
Case classification
Probable: a condition affecting an infant whose mother had untreated or inadequately treated* syphilis at
delivery, regardless of signs in the infant, or an infant or child who has a reactive treponemal test for syphilis
and any one of the following:
Any evidence of congenital syphilis on physical examination
Any evidence of congenital syphilis on radiographs of long bones
A reactive cerebrospinal fluid (CSF) venereal disease research laboratory (VDRL)
An elevated CSF cell count or protein (without other cause)
A reactive fluorescent treponemal antibody absorbed19S-IgM antibody test or IgM enzyme-linked
immunosorbent assay
Confirmed: a case that is laboratory confirmed
Comment
Congenital and acquired syphilis may be difficult to distinguish when a child is seropositive after infancy. Signs
of congenital syphilis may not be obvious, and stigmata may not yet have developed. Abnormal values for
CSF VDRL, cell count, and protein, as well as IgM antibodies, may be found in either congenital or acquired
syphilis. Findings on radiographs of long bones may help because radiographic changes in the metaphysis
and epiphysis are considered classic signs of congenitally acquired syphilis. The decision may ultimately be
based on maternal history and clinical judgment. In a young child, the possibility of sexual abuse should
be considered as a cause of acquired rather than congenital syphilis, depending on the clinical picture. For
reporting purposes, congenital syphilis includes cases of congenitally acquired syphilis among infants and
children as well as syphilitic stillbirths.
*Inadequate treatment consists of any nonpenicillin therapy or penicillin administered <30 days before delivery.
149
Case classification
Probable: a clinically compatible case (in which primary and secondary syphilis have been excluded by
appropriate serologic tests and darkfield microscopy, when available) with either a diagnosis of genital herpes
based on clinical presentation (without laboratory confirmation) or a history of one or more previous episodes
of similar genital lesions
Confirmed: a clinically compatible case that is laboratory confirmed
Comment
Genital herpes should be reported only once per patient. The first diagnosis for a patient with no previous
diagnosis should be reported.
An infection characterized by the presence of visible, exophytic (raised) growths on the internal or external
genitalia, perineum, or perianal region
Case classification
Probable: a clinically compatible case without histopathologic diagnosis and without microscopic or serologic
evidence that the growth is the result of secondary syphilis
Confirmed: a clinically compatible case that is laboratory confirmed
Comment
Genital warts should be reported only once per patient. The first diagnosis for a patient with no previous
diagnosis should be reported.
150
Granuloma Inguinale
Clinical description
A slowly progressive ulcerative disease of the skin and lymphatics of the genital and perianal area caused by
infection with Calymmatobacterium granulomatis. A clinically compatible case would have one or more painless
or minimally painful granulomatous lesions in the anogenital area.
Case classification
Confirmed: a clinically compatible case that is laboratory confirmed
Lymphogranuloma Venereum
Clinical description
Infection with L1, L2, or, L3 serovars of Chlamydia trachomatis may result in a disease characterized by genital
lesions, suppurative regional lymphadenopathy, or hemorrhagic proctitis. The infection is usually sexually
transmitted.
Case classification
Probable: a clinically compatible case with one or more tender fluctuant inguinal lymph nodes or characteristic
proctogenital lesions with supportive laboratory findings of a single C. trachomatis complement fixation titer
of >64
Confirmed: a clinically compatible case that is laboratory confirmed
Cervical inflammation that is not the result of infection with Neisseria gonorrhoeae or Trichomonas vaginalis.
Cervical inflammation is defined by the presence of one of the following criteria:
Mucopurulent secretion (from the endocervix) that is yellow or green when viewed on a white, cottontipped swab (positive swab test)
Induced endocervical bleeding (bleeding when the first swab is placed in the endocervix)
No evidence of N. gonorrhoeae by culture, Gram stain, or antigen or nucleic acid detection, and no
evidence of T. vaginalis on wet mount
151
Case classification
Confirmed: a clinically compatible case in a female who does not have either gonorrhea or trichomoniasis
Comment
Mucopurulent cervicitis (MPC) is a clinical diagnosis of exclusion. The syndrome may result from infection
with any of several agents (see Chlamydia trachomatis, Genital Infections). If gonorrhea, trichomoniasis, and
chlamydia are excluded, a clinically compatible illness should be classified as MPC. An illness in a female that
meets the case definition of MPC and C. trachomatis infection should be classified as chlamydia.
Urethral inflammation that is not the result of infection with Neisseria gonorrhoeae. Urethral inflammation may
be diagnosed by the presence of one of the following criteria:
A visible abnormal urethral discharge, or
A positive leukocyte esterase test from a male aged <60 years who does not have a history of kidney
disease or bladder infection, prostate enlargement, urogenital anatomic anomaly, or recent urinary tract
instrumentation, or
Microscopic evidence of urethritis (5 white blood cells per high-power field) on a Gram stain of a
urethral smear
No evidence of N. gonorrhoeae infection by culture, Gram stain, or antigen or nucleic acid detection
Case classification
Confirmed: a clinically compatible case in a male in whom gonorrhea is not found, either by culture, Gram
stain, or antigen or nucleic acid detection
Comment
Nongonococcal urethritis (NGU) is a clinical diagnosis of exclusion. The syndrome may result from infection
with any of several agents (see Chlamydia trachomatis, Genital Infection). If gonorrhea and chlamydia are
excluded, a clinically compatible illness should be classified as NGU. An illness in a male that meets the case
definition of NGU and C. trachomatis infection should be classified as chlamydia.
A clinical syndrome resulting from the ascending spread of microorganisms from the vagina and endocervix
to the endometrium, fallopian tubes, and/or contiguous structures. In a female who has lower abdominal pain
and who has not been diagnosed as having an established cause other than pelvic inflammatory disease (PID)
(e.g., ectopic pregnancy, acute appendicitis, and functional pain), all the following clinical criteria must be
present:
Lower abdominal tenderness, and
Tenderness with motion of the cervix, and
Adnexal tenderness
In addition to the preceding criteria, at least one of the following findings must also be present:
Meets the surveillance case definition of C. trachomatis infection or gonorrhea
Temperature >100.4 F (>38.0 C)
Leukocytosis >10,000 white blood cells/mm3
Purulent material in the peritoneal cavity obtained by culdocentesis or laparoscopy
152
Case classification
Comment
Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance, 1997. MMWR
1997;46(No. RR-10;1).
153
Alabama
Alaska
Arizona
Arkansas
California
Los Angeles
San Francisco
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Chicago
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Baltimore
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
New York City
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Philadelphia
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
American Samoa
Federated States of Micronesia
Government of the Marshall Islands
Northern Marianas (CNMI)
Guam
Puerto Rico
Republic of Palau
Virgin Islands
Charles Woernle
Mollie Rosier
Judy Norton
Kevin Detner
Gail Bolan
Peter Kerndt
Susan Philip
Ralph Wilmoth
Matthew Cartter
James Welch
Shannon Hader
Karla Schmitt
Vacant
Peter Whiticar
Kathy Cohen
Charlie Rabins
Will Wong
Larry Harris
Mary Jones
Brenda Walker
Robert Brawley
Lisa Ann Longfellow
James Markiewicz
Barbara Conrad
Vacant
Thomas Bertrand
Kristine Judd
Christine Jones
Craig Thompson
Michael Herbert
Laurie Kops
Phil Medina
Richard Whitley
Denise Rondeau
Gary Ludwig
Daniel Burke
F. Bruce Coles
Susan Blank
Evelyn Foust
Vacant
Jan Keagy
Jan Fox
Vada Latin
Weston Ruhrig
Caroline Johnson
Utpala Bandy
Andre Rawls (Acting)
Laurie Gill
Jeanece Seals
Ann Robbins
Emily Holmes
Daniel Daltry
Kathryn Hafford
Mark Aubin
Caroline Williams
Sandra Breitborde
Brownen Anderson
Laumoli Salamo
Vita Skilling
Justina Langidrik
Joseph Villagomez
Josie O'Mallan
Greduvel Duran-Guzman
Victor Yano
Darlene Carty
Charles Woernle
Joe McLaughlin
Kenneth Komatsu
Jim Phillips
Gilberto Chavez
Gilberto Chavez
Gilberto Chavez
Ken Gershman
Matthew Cartter
Paula Eggers (Acting)
John Davies-Cole
Richard Hopkins
Susan Lance
Sarah Park
Christine Hahn
Craig Conover
Craig Conover
James Howell
Patricia Quinlisk
Charles Hunt
Kraig Humbaugh
Raoult Ratard
Dora Mills
David Blythe
David Blythe
Alfred DeMaria
Corrine Miller
Ruth Lynfield
Mary Currier
Sarah Patrick
Steve Helgerson
Thomas Safranek
Ishan Azzam
Jose Montero
Christina Tan
C. Mack Sewell
Perry Smith
Perry Smith
Megan Davies
Kirby Kruger
Forrest Smith
Kristy Bradley
Katrina Hedberg
Veronica Urdaneta
Veronica Urdaneta
Utpala Bandy
James Gibson
Lon Kightlinger
Tim Jones
Vincent Fonseca
Robert Rolfs
Patsy Kelso
Keri Hall
Anthony Marfin
Loretta Haddy
Jeffrey Davis
Tracy Murphy
Sharmain Edwards
Nena Nena
154
Anthony Merriweather
Donna Cecere
Roxanne Ereth
Mark Barnes
Romni Neiman
Mary Hayes
Wendy Wolf
Ralph Wilmoth
Heidi Jenkins
Catherine Mosley
John Heath
Karla Schmitt
Vacant
Roy Ohye
Annabeth Elliott
Ed Renier
John Paffel
Clay Koher
Karen Thompson
Derek Coppedge
Chang Lee
Lisa Ann Longfellow
Jennah Godo
Glen Oltoff
Victoria Stovall
Thomas Bertrand
Kristine Judd
Peter Carr
Craig Thompson
Michael Herbert
Lisa Underwood
Phil Medina
Julia Spaulding
Drew Thomits
Patricia Mason
Carmelita Garcia
Dennis Murphy
Steve Rubin
Evelyn Foust
Julie Wagendorf
Amy LaGesse
Kristen Eberly
Doug Harger
Steve Kowalewski
Melinda Salmon
Michael Gosciminski
Vickie Boazman-Holmes (Acting)
David Morgan
Jane Russell
Jim Lee
Lynn Meinor
Daniel Daltry
Kathryn Hafford (Acting)
Mark Aubin
Caroline Williams
Anthony Wade
Canyon Hardesty
Fara Utu
Maylean Ekiek
Zachraias Zachraias
John Moreno
Bernadette Schumann
Trinidad Garcia
Johana Ngiruchelbad
Gritell Martinez
Appendix: Contributors
James Hosfschneider
Lourdes Duguies
John Rullan
Julie Erb-Alvarez
Eugene Tull
Sharon Massingale
Bernard Jilly
Victor Waddell
Glen Baker
Paul Kimsey
Sue Sabat
Sally Liska
David Butcher
John Fontana
Jane Getchell
Maurice Knuckles
Max Salfinger
Elizabeth Franko
A. Christian Whelen
Christopher Ball
Tom Johnson
Susan Gerber
Judith Lovchik
Christopher Atchison
Dennis Dobson
Stephanie Gibson
Stephen Martin
Kenneth Pote
Jack DeBoy
Jack DeBoy
Mary Gilchrist
Frances Downes
Joanne Bartkus
Daphne Ware
Bill Whitmar
Anne Weber
Steve Hinrichs
L. Dee Brown
Christine Bean
Dennis Flynn
David Mills
Lawrence Sturman
Sara Beatrice
Leslie Wolf
Myra Kosse
Rosemarie Gearhart
Garry McKee
Michael Skeels
S.I. Shahied
Kerry Buchs
Ewa King
Arthur Wozniak
Michael Smith
David Smalley
Susan Neill
Patrick Luedtke
Mary Celotti
James Pearson
Romesh Gautom
Andrea Labik
Charles Brokopp
Richard Harris
Utoofili Mago
Paul Lalita
Kevin Villagomez
Josie O'Mallan
Myriam Garcia-Negron
Francis Permeteet
Joseph Mark